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GENERAL REMARKS 
 
1. Melting points were recorded by open capillary method and are 
uncorrected. 
2. Infrared spectra were recorded on Shimadzu FT IR-8400 (Diffuse 
reflectance attachment) using KBr. Spectra were calibrated against the 
polystyrene absorption at 1610 cm-1. 
3. 1H & 13C NMR spectra were recorded on Bruker Avance II 400 
spectrometer. Making a solution of samples in DMSO d6 and CDCl3 
solvents using tetramethylsilane (TMS) as the internal standard unless 
otherwise mentioned, and are given in the δ scale. The standard 
abbreviations s, d, t, q, m, dd, dt, br s refer to singlet, doublet, triplet, 
quartet, multiplet, doublet of a doublet, doublet of a triplet, AB quartet and 
broad singlet respectively. 
4. Mass spectra were recorded on Shimadzu GC MS-QP 2010 spectrometer 
operating at 70 eV using direct injection probe technique. 
5. Analytical thin layer chromatography (TLC) was performed on Merck-
precoated silica gel-G F254 aluminium plates. Visualization of the spots on 
TLC plates was achieved either by exposure to iodine vapor or UV light. 
6. The chemicals used for the synthesis of intermediates and end products 
were purchased from Spectrochem, Sisco Research Laboratories (SRL), 
Thomas-Baker, Sd fine chemicals, Loba chemie and SU-Lab. 
7. With solvents microwave assisted reactions were carried out in Qpro-M 
microwave synthesizer operating at 1000 W. While solvent less microwave 
assisted reactions were carried out in domestic microwave oven LG MS-
192 W. 
8. All evaporation of solvents was carried out under reduced pressure on 
Heidolph LABOROTA-400-efficient. 
9. % Yield reported are isolated yields of material judged homogeneous by 
TLC and before recrystallization. 
10. The structures and names of all compounds given in the experimental 
section and in physical data table were generated using ACD Chemsketch 
version 6.0. 
11. Elemental analysis was carried out on Vario EL Carlo Erba 1108. 
Abbreviations used
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ABBREVIATIONS USED 
 
 
MF Molecular Formula 
MW Molecular Weight 
MP Melting Point 
BP Boiling Point 
Sub. Substitution 
MW Microwave 
min. Minute 
hrs / h Hours 
Con. / con. Concentrated 
sec. Second 
i.e. That is 
e.g. For example 
viz namely 
RT Room temperature 
TLC Thin Layer Chromatography 
FT-IR Fourier Transformed Infrared 
NMR Nuclear Magnetic Resonance 
UV Ultraviolet 
GC-MS Gas Chromatograph coupled with Mass Spectrometer 
APT Attached Proton Test 
DEPT Distortionless Enhancement Polarization Transfer 
ABT 2-Amino Benzothiazole 
SC Side Chain 
IMB Isatin Mannich Base 
AAC Aryl Amino Coumarin 
APH Acetophenone Phenyl Hydrazone 
PA Pyrazole Aldehyde 
TMS Trimethylsilane 
DMSO Dimethylsulphoxide 
Abbreviations used
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DMF Dimethylformamide 
TEA Triethylamine 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
VH Vilsmeier–Haack 
DDQ Dicyclohexyldicarbodimide 
BEMP 2-tert-butylimino-2-diethylamino-1, 3-dimethylperhydro-1, 3, 2-diazaphosphorine on polystyrene 
MTT 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide 
CDK Cyclin Dependent Kinases 
AKT Enzymes, member of serine / threonine-specific protein kinase family 
FAK Focal Adhesion Kinases 
JNK c-Jun N-terminal Kinases 
LXR Live-X-Receptor 
HIV Human Immunodeficiency Virus 
HTLV Human T-Lymphotropic virus 
LAI Leaf Area Index 
LAV Lymphadenopathy associated virus 
EDF Epidermal Growth Factor 
PDGF Platelers Derived Growth Factor 
CNS Central Nervous System 
MAO Monoaminooxidase 
IC50 Concentration for inhibiting growth of 50% organisms 
MIC Minimum Inhibitory Concentration 
ED50 Effective Dose 50 
LD50 Lethal Dose 50 
ANP Anti-Natriuretic Peptide 
NMDA N-methyl-D-aspartate 
i. p. Intraperitoneal 
PTZ Pentylenetetrazole 
MPA Mercapto Propionic Acid 
ADT After-Discharge Threshold 
Abbreviations used
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GABA Gamma Amino Butyric Acid 
MES Maximal Electroshock 
ScPTZ Subcutaneous Pentylenetetrazole 
ScSTY Subcutaneous Strychnine 
QSAR Quantitative Structure Activity Relationship 
SAR Structure Activity Relationship 
AchE Acetylcholine Esterase 
HRV Human rhinovirus 
3CP 3C Protease 
HCV Human corona virus 
DNA Deoxyribonucleic Acid 
ATRA All Trans Retinoic Acid 
EAC Ehrlich Ascites Carcinoma 
GI Gastrointestinal 
SARS Severe Acute Respiratory Syndrome 
GPCRs G Protein-Coupled Receptors 
ADAMTS ADAM metallopeptidase with thrombospondin type 1 
RTK Receptor Tyrosine Kinase 
FGFr Fibroblast Growth Factor receptor 
VEGF Vascular Endothelial Growth Factor 
ATP Adenosine Triphosphate 
PTK Protein Tyrosine Kinase 
DHPM Dihydropyrimidine 
DBU Diazabicycloundecene 
DBN Diazabicyclononene 
EDG Electrone Donating Group 
EWG Electrone Withdrawing Group 
MRSA Methicillin Resistance Staphylococcus 
MRCNS Methicillin Resistance Coagulase Negative Staphylococci 
CAP Community Acquired Pathogens 
POCl3 Phosphorous oxychloride 
ZnCl2 Zinc chloride 
Abbreviations used
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ClCH2COCl Chloroacetyl chloride 
AlCl3 Aluminium trichloride 
EtOH Ethanol 
MeOH Methanol 
NaOH Sodium hydroxide 
HCl Hydrochloric acid 
K2CO3 Potassium carbonate 
H2SO4 Sulphuric acid 
KSCN Potassium thiocyanate 
BH3.THF Borane in tetrahydrofuran 
KBr Potassium bromide 
CDCl3 Deuteriated chloroform 
BF3.Et2O Borone trifluoride in diethylether 
HCN Hydrogen cyanide 
TiCl4 Titanium tetrachloride 
KOH Potassium hydroxide 
NaH Sodium hydride 
CaH2 Calcium hydride 
LiH Lithium hydride 
KF Potassium fluoride 
Al2O3 Aluminium trioxide 
Br2 Bromine 
FeCl3 Ferric chloride 
InCl3 Indium trichloride 
BiCl3 Bismuth trichloride 
LaCl3 Lanthanium trichloride 
LiClO4 Lithium perchlorate 
VCl3 Vanadium trichloride 
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A.1   INTRODUCTION TO INDOLE SYSTEM 
 
Indole (2, 3-benzopyrrole, ketole, 1-benzazole; C8H7N) is an aromatic 
heterocyclic organic compound. It has a bicyclic structure, consisting of a six-
membered benzene ring fused to a five-membered nitrogen-containing pyrrole 
ring. The participation of the nitrogen lone electron pair in the aromatic ring 
means that indole is not a base, and it does not behave like a simple amine.  
 
Indole is a solid at room temperature. Indole can be produced by 
bacteria as a degradation product of the amino acid tryptophan. It occurs 
naturally in human feces and has an intense fecal odor. At very low 
concentrations, however, it has a flowery smell, and is a constituent of many 
flower scents (such as orange blossoms) and perfumes. It also occurs in coal 
tar.  
 
 
 
 
 
 
 
 
 
 
 
Many researchers have described synthesis of indole and its 
derivatives along with its applications in literature. 1-47 
 
A.1.1   PHYSICAL PROPERTIES OF INDOLE 
 
Indole is a white coloured solid, melting at 52-54°C and boiling at 253-
254 °C. 0.19 gm of indole is soluble in 100 ml of hot water. Indole is soluble in 
alchohol, ethylacetate etc. Indole is having planar molecular shape, 1.22 
g/cm3 density and 2.11 D dipole moment in benzene. All indole derivatives 
show certain family resemblances to indole 4, but striking changes can be 
brought about by substitution of groups in the pyrrole ring. Thus, the fecal-like 
N
H
1
2
34
5
6
7
Fig. A.1
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odor of skatole is the most pronounced of all the methylindoles, less 
pronounced for the 2-methylindole and the 2, 3-dimethyl indole; 1-
methylindole, on the other hand, resembles methylaniline in odor. Introduction 
of carboxyl groups or phenolic hydroxyl groups causes elimination of the odor, 
and the naphthindoles are also without odor.  
 
All the common indole derivatives, like indole, form well-defined 
crystalline picrates, yellow to red in color. Formation of picrates is usually a 
suitable procedure for identification and purification. 
 
A.2   INTRODUCTION TO INDOLINE SYSTEM 
 
Indoline (2, 3-dihydro-1H-indole; C8H9N) is an aromatic heterocyclic 
organic compound. It has a bicyclic structure, consisting of a six-membered 
benzene ring fused to a five-membered nitrogen-containing ring. The 
compound is based on the indole structure, but the C2-C3 bond is saturated by 
oxidation / dehydrogenation it can be converted to indoles. 
 
 
 
 
 
 
 
 
 
 
A.2.1   REDUCTION OF INDOLE 
 
Under this title, only reduction of (un)substituted-1H-indole system is 
discussed, reduction of other indole analogues is not discussed as well. Many 
methods have been employed in the reduction of indoles, the nature of the 
product(s) depending upon the method used. 
 
The indole nucleus is not reduced by sodium-amyl alcohol 48 or by 
sodium-butyl alcohol, 49 but indolines are produced by electrolytic reduction of 
N
H
1
2
34
5
6
7
Fig. A.2
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indoles in acid 50-52 and by reduction with phosphonium iodide in hydrogen 
iodide saturated hydriodic acid. 53 
 
1. METAL-ACID REDUCTION 
 
The reduction of indole with zinc dust, 51 tin, 51, 54 or zinc amalgam 55 in 
hydrochloric acid affords indolines, but the yield of indoline produced from 
indole by such reductions is lowered by simultaneous polymerization of indole 
in the acidic media. This side reaction has been eliminated 56 by effecting this 
reduction with zinc dust in 85% phosphoric acid, under nitrogen to prevent 
aerial oxidation.  
 
2. BIRCH REDUCTION 
 
Early studies 62 led to the conclusion that sodium-ammonia reduction of 
indole affords indoline. However, the product from this reaction has been 
shown to be a mixture of indole and a product resulting from reduction in the 
benzenoid ring. 63 It was found that lithium-ammonia has very little reducing 
effect upon indole owing to the formation of the nonreducible indole lithium 
salt. 64-66  
 
3. REDUCTIONS WITH SODIUM BOROHYDRIDE, LITHIUM ALUMINUM 
HYDRIDE, AND BORANE 
 
Indole is not reduced by either sodium borohydride 67 or lithium 
aluminum hydride, 67, 68 nor are other 1-unsubstituted indoles 69-70 reduced 
with lithium aluminum hydride. This nonreducibility has been illustrated in 
numerous cases in studies connected with the indole alkaloids where sodium 
borohydride 71 and lithium aluminum hydride 72 reductions of functional 
group(s) present in these complex molecules have been affected without 
reduction of the indole nucleus. Indole is reduced to indoline in 48% yield, 
however, by borane in tetrahydrofuran. 73 Although 1-methyl- and 1, 3-
dimethylindole have been reported 68 to be reduced by lithium aluminum 
hydride to the corresponding indolines in 25-30% yields, later related studies 
48 failed to support these observations. 1, 2, 3, 4-Tetrahydro-9-
methylcarbazole remains unreduced when treated with lithium aluminum 
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hydride, 48 and 1, 3-disubstituted oxindoles afford 1, 3-disubstituted indoles 
upon reduction with this reagent. 
 
4. CATALYTIC HYDROGENATION 
 
Two early detailed studies on the catalytic hydrogenation of indoles 
were carried out. 74, 75 Whereas metal-acid reductions of indoles afford 
indolines as end products, catalytic hydrogenation of indoles often proceeds 
further than the indoline stage or occurs at positions alternative to the indolic 
2, 3 double bond, and may even cause rupture of the pyrrolic ring. 76 
Hydrogenation of indole with a nickel catalyst in ethanolic solution affords 1-
ethyloctahydroindole by saturation of the aromatic system and reductive 
ethylation of the nitrogen atom. 77 Catalysts used for the hydrogenation of 
indoles to indolines are platinum, nickel, nickel salts, copper, copper salts, 76 
and palladium hydroxide-barium sulfate. 78 It is interesting that under vigorous 
conditions using a copper chromite catalyst, hydrogenation of 2, 3-
dimethylindole has been reported 59 to afford only trans-2, 3-dimethylindoline, 
the cis isomer being the expected sole product from this reaction. It is 
suggested 59 that under the vigorous conditions used the hydrogenation 
reaches equilibrium involving appreciable dehydrogenation of the indoline and 
thus the indoline formed is the more stable trans isomer. Presumably such an 
equilibration-dehydrogenation, if it occurs, would have to involve the formation 
of some 2, 3-dimethyl-3H-indole in order that it could ultimately effect the 
formation of the trans-indoline. However, the establishment of the trans 
configuration of the product in this work 59 leaves much to be desired and 
further investigation of this product would be of interest. 1, 2, 3, 4-
tetrahydrocarbazole, 48 and its 9-methyl derivative 48, 75 afford, as expected, 
the cis-indolines upon catalytic hydrogenation. 
 
2, 3-disubstituted indoles 57 have been hydrogenated to the 
corresponding 2, 3-disubstituted indolines in very high yields, often 
quantitative, using a platinum catalyst in ethanolic 42% w/w aqueous 
fluoroboric acid at room temperature and atmospheric pressure. It is claimed 
57 that this procedure is extremely valuable since chemical reduction of 
indoles to indolines is often inconvenient and other methods of catalytic 
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hydrogenation of 2, 3-dialkylindoles often afford relatively much lower yields. It 
is essential, however, that the indole being hydrogenated must either be acid 
stable or be very rapidly reduced relative to being polymerized. 57  
 
When the above-mentioned hydrogenation of 1, 2, 3, 4-tetrahydro-9-
methylcarbazole is continued, a second product is formed 79 which is probably 
dodecahydro-9-methylcarbazole. 79 Under the appropriate conditions indole, 
2- and 3-methylindole, and 1, 2-dimethylindole can be catalytically 
hydrogenated to the corresponding octahydroindoles. 76 The A-B ring junction 
in such compounds is cis-fused as shown in Fig. A.3. 58-61, 80-84 
 
  
 
 
 
 
 
 
 
 
Several examples are known 49, 58, 85, 86 in which catalytic hydrogenation 
of an indole ring affords the 4, 5, 6, 7-tetrahydroindole derivatives. In one of 
these cases 85 an aliphatic nitro group in the molecule remains unreduced 
under conditions which would normally effect its conversion to an amino 
group. 
 
5. REDUCTIVE CLEAVAGE OF SUBSTITUENTS FROM THE INDOLE 
NUCLEUS 
 
2-ethoxyindole affords 66% of indole and 9.8% of indoline upon 
reduction with borane in tetrahydrofuran. 73 Similar cleavage of a 2-substituent 
occurs when compound (1) is exhaustively hydrogenated in the presence of a 
platinum catalyst to afford skatole and piperidine hydrobromide. 87 If this 
hydrogenation is arrested after the uptake of three moles of hydrogen or if it is 
affected in the presence of palladium-carbon instead of platinum, it affords 
compound (2). 87 (Fig. A.4) 
 
Fig. A.3
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A.2.2   PREPARATION OF 2-METHYL INDOLINE 
 
2-methyl indoline derivatives were reported to synthesize from 
corresponding indole derivatives using cyano sodium borohydride 88, 92 as a 
reducing agent and glacial acetic acid as a catalyst. 
 
Kikugawa 89 produced 2-methyl indoline from 2-methyl indole using 
sodium borohydride, aluminium trichloride and pyridine as a catalyst. 
 
Clive et. al. 90 reported preparation of 2-methyl indoline from 2-
(phenylseleno) methyl indoline using triphenylstannane (Ph3SnH). 
 
Mills et. al. 91 reported different preparation methods for the 2-methyl 
indoline. (a) Treatment of ethyl acetoacetate with phenyl hydrazine and 
cyclization using sulfuric acid and ammonia and (b) From ethyl (2-allylphenyl) 
carbamate using benzene selenyl chloride and triphenylstannane. 
 
Jackman and Scarmoutzos 93 synthesized 2-methyl indoline from 2-
methyl indole using trimethylamine and borane. 
 
Kotsuki et. al. 94 produced 2-methyl indoline by reducing 2-methyl 
indole using zinc borohydride and diethylether as a solvent. 
 
Indoles were hydrogenated using heterogeneous catalysts in 
hydrocarbon solvents to achieve selective hydrogenation of the heterocyclic 
ring by Shaw and Stapp. 95 Hydrogenation of indoles using Pt, Re, or in some 
cases, Ni catalysts (with or without sulfur compounds) occurred exclusively in 
Fig. A.4
1 2
Part-A                                                        Studies on 2-methyl indoline derivatives….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                          18 
 
the heterocyclic ring to give indolines, but conversions were affected by 
indole-indoline equilibrium. 
 
The regioselective hydroamination and cyclization of aliphatic and 
aromatic amino olefins in the presence of (LaHL2)2 (L = η5-
pentamethylcyclopentadienyl) 96 and borontrifluoride using diethylether and 
the divalent samarium complexes Cp2'Sm and Cp2'Sm (THF)2 (Cp' = η5-
Me5C5) 97 and to give 2-methyl indoline was reported. Thus, 
CH2=CH(CH2)3NH2 was treated with a catalytic amount of (LaHL2)2 in a 
hydrocarbon solvent (toluene, cyclohexane or pentane) to give 2-methyl 
indoline.  Kinetic and mechanistic evidence presented that the turnover-
limiting step is intramolecular olefin insertion into the La-N bond followed by 
rapid protonolysis of the resulting La-C bond. 
 
Lawin et. al. 98 reported the preparation of 2-methyl indoline from 2-
methyl indole through electrolytic reduction.  
 
Meyers and Melot 99 carried out N-alkylation on indoline followed by 
methylation at C2 position in the presence of t-butyllithium and dealkylation 
using hydrazinehydrate resulted into corresponding indoline. 
 
Yadav et. al. 100 reported that N-allyl anilines underwent 3-aza-Cope 
rearrangement in the presence of Zn+2 montmorillonite under microwave 
irradiation in the absence of solvent to afford indoline derivatives in high 
yields. Similarly aryl allyl thioethers were rearranged to 
dihydrobenzothiophenes. 
 
Jimenez et. al. 101 reported mixtures of products, while 2-allyl aniline 
underwent reduction through beta-cyclodextrin medium. 
 
 N-methyl-2-methyl indoline was synthesized from N-methyl-2-methyl 
indole using tin and concentrated hydrochloric acid, 102 indium and ammonium 
chloride, 103 and from t-butyl 2-methyl-1H-indole-1-carboxylate using rhodium 
phosphine complex, 104 PhTRAP-ruthenium catalyst, 105 and palladium and 
polymethylhydrosiloxane. 106 
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Furthermore, literature 107-118 revealed many synthetic procedures to 
synthesize 2-methyl indoline and its derivatives through cyclization and 
reduction. 
 
A.2.3   N-ALKYLATION ON 2-METHYL INDOLINE 
 
Indolines (1) (n = 1, 2, R = H, Me; NR1R2 = piperidino, morpholino, 2-
methylpiperidino-1-indolinyl, tetrahydro-2-isoquinolyl; R1 = R2 = ethyl, propyl, 
isopropyl, etc.) were prepared by Sheinkman et. al. 119 in 18-96% yield by 
reaction of (2) with HNR1R2. (2) were prepared by reaction of Cl(CH2)nCOCl 
with the respective indoline. (3) was obtained by reaction of 1-(2-chloroethyl) 
piperidine and indole and also by reduction of (1) (R = H, n = 1, NR1R2 = 
piperidino) using LiAlH4. (1) had weak anesthetic activity; (1) (R = H, n = 1, R1 
= R2 = isopropyl) was the most active anesthetic; (1) (NR1R2 = piperidino, R = 
H, Me, n = 1, 2) were the most effective local anesthetics. (Fig. A.5) 
 
 
 
 
 
 
 
 
 
 
 
 
The title compounds (1) (R = diethylamino, morpholino; R1 = R3 = H; 
R1R3 = bond; R2 = R5 = H, methyl; R4 = H, methyl, ethyl), (2), and (3) (R6 = H, 
methyl; R7 = diethylamino, morpholino) were prepared by Mutschler et. al. 120 
by the reaction of diethylamine or morpholine with the corresponding 
chloroacetylindoles or chloroacetylindolines, which were prepared by the 
reaction of the parent compounds with chloroacetylchloride. (Fig. A.6) 
 
Fig. A.5
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Alyab'eva et. al. 121 prepared Indolylbenzoates (1) (R1 = H, Me; R2 = H, 
MeO; R3 = H, NO2) in 40-92% yield by reaction of 5-substituted-2-chloro-
benzoicacid with indoline (2) in the presence of K2CO3 and CuO.  Cyclization 
of (1) (R3 = H) with polyphosphoric acid gave 10-90% pyrroloacridinone (3).  
Treatment of (3) (R1 = R2 = H; R1 = Me, R2 = H) with MnO2 gave 75-78% (4).  
Reaction of (3) (R1 = R2 = H) with LiAlH4 gave 84% (5); while 71% (5) and 
22% (6) were obtained on treatment of (3) (R1 = Me, R2 = H) with LiAlH4. (Fig. 
A.7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. A.6 
Fig. A.7 
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Kabbe et. al. 122 synthesized N-2-dimethyl indoline-1-carboxamide 
(alkylurea) derivatives from 2-methyl indoline using methyl isocyanate for the 
treatment of lipometabolic diseases / disorders. 
 
Bermudez et. al. 123 reported that Indazole (1) is a potent and selective 
5-HT3 receptor antagonist. On those basis, a novel series of potent 5-HT3 
receptor antagonists, 1-indoline- and 1-indole carboxamides (2) [R = H , F, Cl, 
OCH3, NO2; R1 = H, methyl, ethyl, phenyl; R2 = H, methyl; R1R2 = (CH2)2, 
(CH2)4, (CH2)5; R3 = H, methyl; n = 2, 3] and (3) (R1 = H, methyl, ethyl, 
phenyl), respectively, were described. The activity of (2) suggested that 
aromaticity of the 5-membered ring was not an essential requirement for the 
potency provided that an in plane orientation of the CO group was favored.  
On the basis of this hypothesis indene (4) was prepared.  In (4) the in plane 
orientation of the CO group was maintained by conjugation with the aromatic 
ring through the sp2-hybridized C. (4) was also a potent 5-HT3 receptor 
antagonist. (Fig. A.8 & 9) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. A.8 
Fig. A.9 
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Spang et. al. 124 carried out formylation on 2-methyl indoline and 
prepared Schiff bases using differently substituted primary aromatic amines. 
 
Indolines such as (1), (2), and (3) were prepared efficiently by Nicolaou 
et. al. 125 on solid supports by reaction of a resin-based selenyl bromide with 
substituted o-allylaniline derivatives to give resin-bound selenylmethyl indoline 
derivatives which could be functionalized and reductively cleaved to give 
methylindoline derivatives. The supported selenylmethyl indoline 
intermediates could either be cleaved directly by Bu3SnH-mediated reduction 
to 2-methylindolines, acylated with phosgene and amines and reductive 
cleaved with Bu3SnH to give methylindoline urea derivatives, or acylated with 
alkenoic acids or alkylated with allylic bromides to give amide and amine 
derivatives which underwent stereoselective radical cyclization upon resin 
cleavage to give polycyclic indolines. Treatment of o-allylaniline with resin-
bound selenyl bromide in the presence of SnCl4 gave a resin-bound 
selenylmethyl indoline; reduction of the resin-bound indoline with tributyltin 
hydride in the presence of AIBN gave (1) in 89% purity. Treatment of the 
resin-bound selenylmethyl indoline with a toluene solution of phosgene 
followed by addition of triethylamine and piperazine gave a resin-bound 
indoline urea derivative, which was acylated with 1-naphthalenecarboxylic 
acid and DCC and reductively cleaved with Bu3SnH in the presence of AIBN 
to give piperazinylcarbonyl methylindoline (2) in 19% yield. Treatment of the 
resin-bound selenylmethyl indoline with MeCH=CHCH2Br and sodium hydride 
gave a resin-bound crotylindoline methylselenyl derivative which underwent 
stereoselective radical cyclization and cleavage to give 
tetrahydropyrroloindoline derivative (3) in 19% yield. The solid phase 
preparation of indolines cleavable by radical reduction allowed for the facile 
preparation of medicinally valuable methyl indoline derivatives and for the 
assembly of complex indoline natural product derivatives. Preparation of 
methyl indoline derivatives on solid phase allowed access to combinatorial 
libraries of structurally complex indoline derivatives. (Fig. A.10) 
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Ellis et. al. 126 replaced hydrogen atom of secondary amine in 2-methyl 
indoline with 1-bromo-9-chloroacridine using HMPT and carried out cytotoxic 
activity against 60 human cancer cell lines. 
 
Furthermore using a polymer-bound selenenyl bromide resin, o-allyl 
and o-prenyl anilines were cycloloaded to afford a series of solid-supported 
indoline and indole scaffolds. 127 These scaffolds were then functionalized and 
cleaved via four distinct methods, namely traceless reduction, radical 
cyclization, radical rearrangement, and oxidative elimination, to afford 2-
methyl indolines, e.g. (1), polycyclic indolines, e.g. (2), 2-methyl indoles, e.g. 
(3), and 2-propenyl indolines, e.g. (4), respectively. Numbers of small 
combinatorial libraries of compounds reminiscent of certain designed ligands 
of biological interest were constructed demonstrating the potential utility of the 
developed methodology to chemical and biological studies and the drug 
discovery process. (Fig. A.11) 
 
 
 
 
 
 
 
 
 
 
 
Fig. A.10
Fig. A.11
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Zhao et. al. 128 optimized the lead compound 2-[-4-(4-
chlorobenzyl)piperazin-1-yl]-1-(2, 3-dihydroindol-1-yl) ethanone by systematic 
structure-activity relation (SAR) studies and synthesized numbers of N-
substituted (substituted-piperazinyl) 2-methyl indoline derivatives which led to 
the two potent compounds, 2 - [4 - (4 - chlorobenzyl) piperazine – 1 - yl] – 1 - 
(2 – methyl - 2, 3-dihydroindol – 1 - yl) ethanone and 2 - [4 - (4 - 
chlorobenzyl)piperazine – 1 - yl] – 1 - (2 – methyl - 2, 3 – dihydroindol – 1 - 
yl)ethanone as mixed D2/D4 receptor antagonists. 
 
Tyunova et. al. 129 developed a convenient and efficient protocol for the 
synthesis of combinatorial library of 3-(2-thieno-sulfonyl) propionylamides. 
The synthetic route involved initial sulfochlorination of thiophene (or 2-
bromothiophene), conversion of the resulting sulfochlorides into sulphinates 
followed by their reaction with acrylic acid. The resulting 
thienosulfonylpropionic acids were converted into the corresponding acid 
chlorides, which were used for acylation of primary and secondary aliphatic, 
aromatic and heteroaromatic amines. Several physico-chemical molecular 
parameters were calculated for the synthesized compounds, related to their 
potential pharmacokinetic profile. 
 
Bordon et. al. 130 synthesized new 2-methyl indoline derivatives (1) [Y = 
N, O, S, CHR3, CR3; the dotted lines = single or double bond; R, R1 = H, halo, 
OH, alkyl, alkoxy, CN, NO2, NR4R5, CF3, CF3O, aryl, heteroaryl, S(O)nNR4R5 ; 
n = 0 - 2; R3 = H, halo, alkyl, CN, NO2, NR4R5, CF3, aryl; R2 = R4, OR4, SR4 or 
NR4R5; R4 = H, alkyl, cycloalkyl, aryl; either R4 and R5 is selected among the 
values of R4 or heterocyclic containing N, O and S, all optionally substituted], 
these products being in all the isomer forms - racemates, enantiomers or 
diastereomers - and pharmaceutically acceptable salts, for use as drugs.  
Thus, trans-N-[6-(5, 6-dichloro-1H-benzimidazol-1-yl) 9H-purin-2-yl]-1, 4-
cyclohexanediamine (2-HCl) was prepared, from 2, 6-dichloropurine via 
amination with 5, 6-dichloro-1H-benzimidazole in butanol followed by fusion 
with trans-1, 4-diaminocyclohexane.  The protein kinase inhibitory activity of 
(2) as hydrochloride was detected [IC50 = 1.3 µM vs CIV-CDK; 98% inhibition 
SRC kinase at the rate 20 µM; 93% inhibition CDK1 at the rate 20 µM; 98% 
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inhibition ZAP kinase at the rate 20 µM; 93% inhibition casein kinase (2) at the 
rate 20 µM; 100% inhibition AKT kinase at the rate 20 µM; IC50 = 2 µM vs FAK 
kinase; IC50 = 0.84 µM vs JNK3 kinase]. (Fig. A.12) 
 
 
 
 
 
 
 
 
 
 
Gonzales et. al. 131 synthesized different N-(4-sulfamoylphenyl) amide 
derivatives of 2-methyl indoline as voltage-gated sodium channels inhibitors.  
 
Dehmlow et. al. 132 reported preparation of indolyl hexafluoropropanols 
as Live-X-Receptor (LXR) modulators for the treatment of diabetes and 
related diseases. The invention relates to compounds (1) [wherein R1 - R6 = 
H, alkyl, etc.; A = (un)substituted aryl or heterocyclyl; m, p = 0-3; n = 0 or 1; R3 
and R4 are absent when a is a double bond, with limitations, and 
pharmaceutically acceptable salts and esters thereof], their pharmaceutical 
compositions, processes for their preparations, and their use in the treatment 
and prophylaxis of diseases modulated by LXRα and/or LXRβ agonists, such 
as diabetes.  For instance, (2), which showed IC50 values of 0.02 µM and 
0.006 µM against LXRα and LXRβ, respectively, in the binding assay, was 
synthesized in multiple steps from 2-methyl-2,3-dihydro-1H-indole, 
hexafluoroacetone sesquihydrate and methyl-3-(chloromethyl) benzoate. (Fig. 
A.13)  
 
 
 
 
 
 
Fig. A.12
Fig. A.13
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Literature also revealed different synthetic methodologies 133-143 for the 
synthesis of N-substituted-2-methyl indoline derivatives. 
 
 
A.2.4   MANNICH REACTION ON 2-METHYL INDOLINE 
 
Abonia et. al. 144 in their effort to synthesize pyrroloquinolines, 
synthesized 1-(benzotriazol-1(2)-ylmethyl)indolines for which they carried out 
Mannich reaction on 2-methyl indoline using benzotriazole as a secondary 
amine, formaldehyde and diethylether as a solvent and stirred for 30 minutes 
at room temperature. This Mannich base was reacted with unactivated and 
electron-rich alkenes in the presence of p-toluenesulfonic acid catalyst to give 
pyrroloquinolines but the pharmacological importance of the synthesized 
molecules was not reported. 
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1.1   AIM OF CURRENT WORK  
 
Since last few years, our group is involved in the synthesis of nitrogen 
containing heterocycles viz. pyrrole, indole, 2-methyl indole, dihydropyridine, 
dihydropyrimidine, 4-hydroxy quinolones etc. Where, pyrrole, indole, 
dihydropyridine, dihydropyrimidine, 4-hydroxy quinolone and 2-methyl indole 
showed good anti tubercular, anti diabetic, anti cancer and multi drug 
resistance reversal activity. Looking to the interesting biological profile 
showed by indole, 2-methyl indole and 2-methyl indoline from the literature 
survey and development of a simple preparation method for 2-methyl indole 
by our group we decided to prepare 2-methyl indoline and to explore the 
chemistry involving 2-methyl indoline moiety. 
 
Literature revealed that different types of N-alkylation reactions have 
been carried out on 2-methyl indoline which include introduction of acetyl 
group, introduction of chloroacetyl group and further treatment with secondary 
amines, formylation at N1 position and preparation of Schiff bases, preparation 
of amide linkages and alkylation by means of one and two carbon chains. 
Recently a Mannich reaction has been carried out on N1 position in 2-methyl 
indoline using benzotriazole and formaldehyde. Looking to the reactivity of N1 
position for Mannich reaction, the secondary nitrogen is more active than C3 
while in 2-methyl indole, Mannich reaction goes on both N1 and C3 positions 
depending upon the reaction conditions. 
 
Mannich bases can be synthesized by Mannich reaction on nitrogen of 
secondary amine having hydrogen atom with pronounced activity using 
simplified methodology and easy work up and this inspired us to develop 
some new N-substituted 2-methyl indoline derivatives by Mannich reaction. 
Literature also revealed that secondary amines viz. morpholine, piperidine, 
pyrrolidine, piperazine derivatives and other secondary amines like 
dimethylamine, diethylamine etc. and primary and secondary aromatic amines 
have not been used yet that is why we used primary and secondary amines to 
                                                 
a R. Abonia, A. Albornoz, B. Insuasty, J. Quiroga, H. Meier, A. Hormaza, M. Nogueras,  
  A. Sanchez, J. Cobo and J. N. Low; Tetrahedron, 2001, 57(23), 4933. 
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acquire Mannich bases having desired scaffolds. These interesting Mannich 
bases derived from 2-methyl indoline are not only structurally novel but the 
biological evaluation is reported here for the first time. Biological importance 
of such an important scaffold is the rational behind the current work done in 
this chapter.  
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1.2   REACTION SCHEMES 
 
1.2.1 PREPARATION OF 2 – METHYL INDOLINE 
 
STEP – 1 
 
Reagents / Reaction Condition (a): Phenyl hydrazine, Acetone / Addition at 
RT. 
 
STEP – 2 
 
 
Reagents / Reaction Condition (b): Polyphosphoric acid / 120°C. 
 
 
STEP – 3 
 
 
Reagents / Reaction Condition (c): TFA, 1 M BH3.THF / 0-5°C. (Method – A) 
         Zinc dust, 85% phosphoric acid. (Method – B) 
 
 
NH
NH2 + CH3
CH3
O NH
N CH3
CH3
a
NH
N CH3
CH3
N
H
CH3
b
N
H
CH3
N
H
CH3
c
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1.2.2 PREPARATION OF 2-METHYL INDOLINE N-MANNICH BASES  
 
(1) 
 
Reagents / Reaction Condition (d): Secondary amines, Diethylether, 
Formaldehyde (37-41%), Con. HCl / RT, stirring. 
 
(2) 
 
Reagents / Reaction Condition (e): Primary amines, Diethylether, 
Formaldehyde (37-41%), Con. HCl / RT, stirring. 
 
 
 
 
 
 
N
H
CH3
N
CH3
N
R2
R1
d
N
H
CH3
N
CH3
NH
R1
e
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1.3   PLAUSIBLE REACTION MECHANISM 
 
1.3.1   SCHEME - 1 
 
 
 
 
O
H
H
N+
OH
H
H
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R1
H
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+ H+- H2O
OH +
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H N
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+
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1.3.2   SCHEME - 2 
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1.4   EXPERIMENTAL 
 
1.4.1 PREPARATION OF 2 – METHYL INDOLINE 
 
STEP – 1 PREPARATION OF ACETONE PHENYL HYDRAZONE 
 
25 ml of phenyl hydrazine was added drop wise to a magnetically 
stirred solution of 20 ml of acetone. After the completion of the addition, 5 ml 
of acetone was added to the reaction mixture and the reaction mixture was 
heated on the water bath to remove the excess of the acetone. Afterwards the 
reaction mixture was cooled to room temperature and it was made anhydrous 
by means of anhydrous sodium sulphate or anhydrous calcium chloride. The 
solution was filtered to give the dark yellow solution of phenyl hydrazone. 
Yield - 80 %, BP - 140-142°C (141-142°C b) 
 
STEP – 2 PREPARATION OF 2-METHYL INDOLE 
 
30 gm of acetone phenyl hydrazone was added drop wise to a beaker 
containing 75 gm of polyphosphoric acid with constant stirring. The reaction 
mixture was heated on water bath for 2-3 hours, where the orange coloured 
solution became dark red-brown. After that the temperature of the reaction 
mixture was raised to 120°C and then it was cooled to room temperature. 
After that 400 ml of distilled water was added to the reaction mixture to 
decompose the polyphosphoric acid, the whole content was steam distilled to 
acquire the 2-Methyl Indole as white coloured shining crystals. Yield - 79 %, 
MP - 58-59°C (56-57°C c) 
 
STEP – 3 PREPARATION OF 2-METHYL INDOLINE 
 
METHOD – (A) 
 
0.05 mole 2-methyl indole was dissolved in 110 ml of trifluoroacetic 
acid under nitrogen atmosphere. The solution was cooled in an ice bath and 
90 ml of about 1 M BH3.THF in tetrahydrofuran solution was added slowly 
                                                 
b H. M. Kissman, D. W. Farnsworth and B. Witkop; J. Am. Chem. Soc., 1952, 74, 3948. 
c C. F. H. Allen and J. Vanallan; Organic Syntheses, 1955, Coll. Vol. 3, p. 597. 
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over about 30 minutes. Thereafter, 50 ml of water was added, the resulting 
solution was stirred at room temperature for about 90 minutes. The progress 
and the completion of the reaction were checked by silica gel-G F254 thin layer 
chromatography using toluene : ethyl acetate (7 : 3) as a mobile phase. After 
the reaction to be completed the mixture was then evaporated under reduced 
pressure to about 30 ml of semi-solid viscous oil. The oil was partitioned 
between methylene dichloride and aqueous sodium hydroxide solution 
(pH>10). The organic layer was dried over anhydrous potassium carbonate, 
filtered and evaporated under reduced pressure to obtain 5.65 gm of a slightly 
greenish transparent oily 2-methyl indoline product. Yield - 85%, BP – 224-
226 °C (225-227°C d) 
 
REVERSE ADDITION METHOD:  
 
0.05 mole 2-methyl indole was dissolved in 90 ml of 1 M BH3.THF 
solution in tetrahydrofuran by stirring under nitrogen atmosphere while cooling 
in an ice bath and the stirring was continued for about 15 minutes. Thereafter, 
110 ml of trifluoroacetic acid was added drop-wise with continued stirring, 
cooling and maintaining a nitrogen atmosphere. 50 ml of water was added to 
the mixture, followed by methylene dichloride and aqueous sodium hydroxide 
solution (pH>10). The solution then was stirred about 30 minutes and a 
sample was taken for TLC, the progress and the completion of the reaction 
were checked by silica gel-G F254 thin layer chromatography using toluene : 
ethyl acetate (7 : 3) as a mobile phase. The organic layer was dried over 
anhydrous potassium carbonate, filtered and evaporated under reduced 
pressure to obtain 5.70 gm of a slightly greenish transparent oily 2-methyl 
indoline product. Yield - 86%, BP – 224-226 °C (225-227°C d) 
 
METHOD – (B) 
 
To 0.36 mole of untreated zinc dust in a nitrogen atmosphere was 
added all at once 200 ml of 85 % phosphoric acid. The mixture was rapidly 
heated to 70-80°C on a steam bath and 0.12 mole of 2-methyl indole was 
added in portions during 30 minutes with vigorous mechanical stirring 
                                                 
d J. T. Shaw and F. T. Ryson; J. Am. Chem. Soc., 1956, 78, 2538. 
Chapter – 1                                                           Preparation and Yield optimization.....
 
Department of Chemistry, Saurashtra University, Rajkot-360 005                             42 
 
(efficient mechanical stirring was found to be extremely difficult if the mixture 
was kept at room temperature during the addition of indole, and the yields of 
indoline were only 5-15 %). After the addition to be completed stirring was 
continued for 3-4 hours at 80°C under nitrogen. 100 ml water was added with 
cooling and the mixture was basified slowly with 40% aqueous sodium 
hydroxide. The thick slurry was steam distilled and the extraction of the 
distillate with chloroform gave, after drying and concentration in vacuuo, 
greenish oil. Distillation under reduced pressure gave 65 % of 2-methyl 
indoline as slightly greenish transparent oil. BP – 224-226 °C (225-227°C d) 
 
1.4.2 PREPARATION OF 2-METHYL INDOLINE MANNICH BASES 
 
(1) GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-101 TO 
DNJ-111 
 
It was prepared according to the method described by Abonia et. al. a 
0.01 mole of 2-methyl indoline was charged into 50 ml erlenmeyer flask and 
0.015 mole of formaldehyde (37-41% w/w solution) and 10 ml diethylether 
were added into above flask and the mixture was magnetically stirred for 
some time at room temperature under acidic condition. 0.01 mole of an 
appropriate secondary amine was added drop wise into above reaction 
mixture. Stirring was continued for further half an hour at room temperature. 
The progress and the completion of the reaction were checked by silica gel-G 
F254 thin layer chromatography using hexane : ethyl acetate (9 : 1) as a mobile 
phase. After the reaction to be completed, the reaction mixture was extracted 
using ethyl acetate (30 ml X 3). The combined organic layer was washed 
using water (20 ml X 2). The organic layer was dried over anhydrous sodium 
sulphate and the solvent was removed under reduced pressure to acquire the 
product. (Physical data of the synthesized end products are summarized in 
the table 1.5.1) 
 
(2) GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-201 TO 
DNJ-210 
 
It was prepared according to the method described by Abonia et. al. a 
0.01 mole of 2-methyl indoline was charged into 50 ml erlenmeyer flask and 
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0.015 mole of formaldehyde (37-41% w/w solution) and 10 ml diethylether 
were added into above flask and the mixture was magnetically stirred for 
some time at room temperature under acidic condition. 0.01 mole of an 
appropriately substituted primary amine was added drop wise into above 
reaction mixture. Stirring was continued for further half an hour at room 
temperature. The progress and the completion of the reaction were checked 
by silica gel-G F254 thin layer chromatography using hexane : ethyl acetate (9 : 
1) as a mobile phase. After the reaction to be completed, the reaction mixture 
was extracted using ethyl acetate (30 ml X 3). The combined organic layer 
was washed using water (20 ml X 2). The organic layer was dried over 
anhydrous sodium sulphate and the solvent was removed under reduced 
pressure to acquire the product. (Physical data of the synthesized end 
products are summarized in the table 1.5.2) 
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1.5   PHYSICAL DATA TABLES  
 
1.5.1 Physical data of N-substituted 2-methyl indoline N-Mannich bases 
(DNJ-101 to DNJ-111) 
 
 
 
 
 
 
 
 
 
Code Substitution R1 & R2 
MF MW (g/m) Rf 
% 
Yield
DNJ-101 Piperidine C15H22N2 230 0.54 55 
DNJ-102 Morpholine C14H20N2O 232 0.52 61 
DNJ-103* Piperazine C14H21N3 231 0.53 75 
DNJ-104 1-methyl piperazine C15H23N3 245 0.55 77 
DNJ-105 1-ethyl piperazine C16H25N3 259 0.57 65 
DNJ-106 Pyrrolidine C14H20N2 216 0.51 50 
DNJ-107 1-benzyl piperazine C21H27N3 321 0.63 79 
DNJ-108 N, N-dimethyl amine C12H18N2 190 0.49 67 
DNJ-109 N, N-diethyl amine C14H22N2 218 0.52 56 
DNJ-110 N, N-dipropyl amine C16H26N2 246 0.56 72 
DNJ-111 N, N-dibutyl amine C18H30N2 274 0.60 49 
 
Rf value was calculated using solvent system = Hexane : Ethyl Acetate (9 
: 1) 
 
* MP = 160-162°C
N
CH3
N
R2
R1
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1.5.2 Physical data of N-substituted 2-methyl indoline N-Mannich bases 
(DNJ-201 to DNJ-210) 
 
 
 
 
 
 
 
 
 
 
Code Substitution R1 
MF MW (g/m) Rf 
% 
Yield
DNJ-201 Aniline C16H18N2 238 0.56 61 
DNJ-202 3-chloro aniline C16H17ClN2 272  0.58 55 
DNJ-203 3-trifluoromethyl aniline C17H17F3N2 306  0.58 77 
DNJ-204 3-methyl aniline C17H20N2 252  0.58 75 
DNJ-205 3-methoxy aniline C17H20N2O 268  0.59 50 
DNJ-206 N-methyl aniline C17H20N2 252  0.57 65 
DNJ-207 N, N-diphenyl amine C22H22N2 314  0.64 67 
DNJ-208 3-amino pyridine C15H17N3 239  0.55 79 
DNJ-209 4-amino pyridine C15H17N3 239 0.54 72 
DNJ-210 Furfuryl amine C15H18N2O 242 0.53 56 
 
Rf value was calculated using solvent system = Hexane : Ethyl Acetate 
(9 : 1) 
N
CH3
NH
R1
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1.6   SPECTRAL DISCUSSION 
 
1.6.1   MASS SPECTRAL STUDY 
 
Mass spectra of the synthesized compounds were recorded on 
Shimadzu GC-MS QP-2010 model using direct injection probe technique. 
The molecular ion peak was found in agreement with molecular weight of the 
respective compound. Characteristic M+2 ion peaks with one-third intensity of 
molecular ion peak were observed in case of compounds having chlorine 
atom. Fragmentation pattern can be observed to be particular for these 
compounds and the characteristic peaks obtained for each compound. 
Probable fragmentation pattern for DNJ-102 and DNJ-206 can be discussed 
as under. 
 
2-methyl-1-(morpholin-4-ylmethyl) indoline (DNJ-102) 
 
1. The target compound showed characteristic molecular ion peak. 
2. C2-C3 and C5-C6 bond cleavage gave characteristic peak at 190 m/e. 
[1] 
3. C3-N4 and C5-N4 bond cleavage gave characteristic peak at 160 m/e. 
[2] 
4. N4-C7 bond cleavage gave characteristic peak, which is the BASE 
PEAK at 146 m/e. [3] 
5. C7-N8 bond cleavage gave two characteristic peaks. One peak at 130 
m/e and second peak at 100 m/e , which is the second intense peak in 
the spectrum. [4] 
6. After cleaved from bond C7-N8, C9-C17 bond cleavage gave 
characteristic peak at 118 m/e. [5] 
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1.6.1.1   FRAGMENTATION PATTERN FOR DNJ-102 
 
 
N – Methyl – N - [(2 – methyl - 2, 3 – dihydro - 1H – indol – 1 - yl) methyl] 
aniline (DNJ-206) 
 
1. The target compound showed characteristic molecular ion peak. 
2. Cleavage of the bonds between C15-C16 and C18-C19 gave 
characteristic peak at 216 m/e. [1] 
3. Cleavage of the bonds between C14-C15 and C14-C19 gave 
characteristic peak 190 m/e. [2] 
11
12
16
13
15
14
10
9
N
8
CH317
7
N
4 35
26
O
1
[1]
N
CH3
N
CH3
CH3
+.
190 m/eN
CH3
NH2
+.
160 m/e
N
CH3
CH3
+.
146 m/e
[2]
[3]
NH
CH3
CH3
N
O
+.
+.
130 m/e
100 m/e
11
12
16
13
15
14
10
9
NH
8
CH317
+.
130 m/e[4]
[5]
NH
+.
118 m/e[4]
232 m/e
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4. N11-C14 bond cleavage gave characteristic peak at 177 m/e. [3] 
5. Cleavage of the bonds between N11-C12 and N11-C14 gave 
characteristic peak at 160 m/e. [4] 
6. N11-C10 bond cleavage gave two characteristic peaks. One peak at 146 
m/e which is the BASE PEAK and second peak at 106 m/e. [5] 
7. N1-C10 bond cleavage gave two characteristic peaks. One peak at 130 
m/e and second peak at 120 m/e which is the second intense peak in 
the spectrum. [6] 
 
1.6.1.2   FRAGMENTATION PATTERN FOR DNJ-206 
 
 
4
5
9
6
8
7
3
2
N
1
CH313
10
N
11
CH3 12
14
1915
1816
17
N
CH3
N
CH3
CH3CH2
216 m/e
+.
[1]
N
CH3
N
CH3
CH3
190 m/e
+.
[2]
N
CH3
NH
CH3
+.
177 m/e
N
CH3
NH2
+.
[3]
[4] N CH3
CH3
146 m/e
NH
CH3
106 m/e
+.
+.
N
H
CH3
130 m/e
N
CH3 CH3
120 m/e
+.
+.
[6]
[5]
252 m/e
160 m/e
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1.6.2   IR SPECTRAL STUDY 
 
IR spectra of the synthesized compounds were recorded on Shimadzu 
FT-IR 8400 spectrophotometer using Diffused Reflectance Attachment (DRA) 
system using Potassium Bromide.  
 
In case of DNJ-101 to DNJ-111, there is no characteristic peak 
obtained in the spectra except C-H stretching and bending and ring skeleton 
due to the absence of the functional group. In case of DNJ-103 secondary 
amine of piperazine gave stretching frequency in the region of 3310 to 3500 
cm-1 and bending vibrations in the region of 1550 to 1650 cm-1. Aliphatic C-N 
vibrations are found near 1220 cm-1. C-O-C ether linkage also showed a 
characteristic frequency in DNJ-102. 
 
DNJ-201 to DNJ-210 compounds showed N-H stretching vibrations in 
the region of 3310 to 3500 cm-1 DNJ-206 and DNJ-207. Frequency for m di 
substitution has been found in DNJ-202 to DNJ-205. DNJ-202 and DNJ-203 
showed C-X stretching frequency. C-O-C ether linkage also showed a 
characteristic frequency in DNJ-205 and DNJ-210. 
 
1.6.3   1H & 13C NMR SPECTRAL STUDY 
 
1H & 13C NMR (DEPT 135) spectra of the synthesized compounds 
were recorded on Bruker Avance II 400 spectrometer. Making a solution of 
samples in CDCl3 solvent using tetramethylsilane (TMS) as the internal 
standard unless otherwise mentioned. Numbers of protons and carbons 
identified from NMR spectrum and their chemical shift (δ ppm) were in the 
agreement of the structure of the molecule. J values were calculated to 
identify o, m and p coupling. In some cases, aromatic protons were obtained 
as multiplet. 1H & 13C NMR (DEPT 135) spectral interpretation can be 
discussed as under. 
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1H NMR spectral interpretation of 2-methyl-1-(morpholin-4-ylmethyl) 
indoline (DNJ-102) 
 
1. Three most shielded protons of methyl group (C17) gave multiplet at 
1.28 δ ppm. Usually these protons should show their multiplicity as 
doublet due to the presence of single proton at C9, but two nitrogen 
atoms are present in the molecule and thus due to their effect these 
methyl protons coupled with one proton of methine group (C9) and 
another two protons of methylene group (C10) and gave multiplet. 
2. Four protons of two morpholinyl methylene groups attached with the 
nitrogen atom gave triplet at 2.45 δ ppm, while another four protons of 
rest of the two morpholinyl methylene groups attached with the oxygen 
atom gave triplet at 3.73 δ ppm. 
3. Two protons of C10 carbon atom splitted into two which showed singlet 
for each proton at 2.62 δ ppm and at 2.83 δ ppm respectively. 
4. One proton of methine group (C9) gave quartet at 3.14 δ ppm which 
actually should show multiplet due to the presence of three protons of 
methyl group (C17) and two protons of methylene group (C10). 
5. Two protons of methylene group (C7) became deshielded due to the 
two nitrogen atoms and gave singlet at 4.44 δ ppm. 
6. Two aromatic protons of C13 and C15 methine groups gave multiplet at 
6.63 δ ppm while another two aromatic protons of C14 and C16 methine 
groups gave multiplet at 7.00 δ ppm. 
 
13C NMR spectral interpretation of 2-methyl-1-(morpholin-4-ylmethyl) 
indoline (DNJ-102) 
 
1. Methyl group-C17 carbon gave peak at 14.35 δ ppm chemical shift. 
2. 37.55 δ ppm chemical shift is due to the methylene group C10 carbon. 
3. Two methylene groups of morpholine ring, C3 and C5 carbons gave 
peak at 51.48 δ ppm chemical shift. 
4. C9 carbon attached to the C17 methyl group and nitrogen atom of the 
indoline ring showed chemical shift in downfield at 59.46 δ ppm due to 
the adjacent nitrogen atom. 
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5. Another two methylene groups of morpholine ring C2 and C6 showed 
chemical shift in the downfield at 67.05 δ ppm which is due to the 
oxygen atom directly attached to both the methylene groups. 
6. Bridged methylene C7 carbon gave peak in downfield at 71.45 δ ppm 
comparatively to other methylene groups due to the two nitrogen atoms 
of morpholine ring and indoline ring. 
7. 77.86, 77.54 and 77.22 δ ppm are the characteristic peaks due to the 
solvent CDCl3. 
8. 107.13, 118.06, 124.22, 127.47, 152.47 and 170.84 δ ppm chemical 
shifts are due to the aromatic carbon atoms of phenyl ring C13, C15, C16, 
C14, C11 and C12 respectively. 
 
Peaks obtained in the DEPT-135 were in the agreement of the carbons 
present in the molecule. 
 
 
1H NMR spectral interpretation of 2-methyl-1-(morpholin-4-ylmethyl) 
indoline (DNJ-206) 
 
1. Three most shielded protons of methyl group (C13) gave multiplet at 
1.32 δ ppm. As discussed earlier, these protons should show their 
multiplicity as doublet due to the presence of single proton at C2, but 
two nitrogen atoms are present in the molecule and thus due to their 
effect these methyl protons coupled with one proton of methane group 
(C2) and another two protons of methylene group (C3) and gave 
multiplet. 
2. Two protons of methylene groups (C3) gave quartet at 2.59 δ ppm 
which actually should give double doublet but it merged to give quartet. 
3. Three protons of methyl group (C12) attached to the nitrogen atom gave 
singlet at 2.85 δ ppm. 
4. One proton of methine group (C2) gave quintet at 4.43 δ ppm which 
actually should show multiplet due to the presence of three protons of 
methyl group (C13) and two protons of methylene group (C3). 
5. Two protons of methylene group (C10) became deshielded due to the 
two nitrogen atoms and gave triplet at 4.76 δ ppm. Actually these two 
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protons should give singlet at this chemical shift but these two protons 
will couple with three protons of methyl group (C12) and will show 
multiplet. In this case, some of the peaks have been merged to each 
other and thus it showed triplet. 
6. Rests of the peaks are due to the aromatic protons, where two 
aromatic protons of methine groups (C15 & C19) gave multiplet at 6.68 δ 
ppm. Two protons of methine groups (C6 & C8) gave multiplet at 6.93 δ 
ppm while another two aromatic protons (C9 & C17) gave multiplet at 
7.05 δ ppm. Rests of the three protons (C7, C16 & C18) gave multiplet at 
7.25 δ ppm. Due to the unusual splitting J values could not be 
calculated. 
 
13C NMR spectral interpretation of 2-methyl-1-(morpholin-4-ylmethyl) 
indoline (DNJ-206) 
 
1. C13 carbon atom became most shielded and showed chemical shift at 
19.67 δ ppm. 
2. Methylene group of C3 carbon atom gave peak at 37.58 δ ppm. 
3. Methyl group attached to the aromatic nitrogen atom N11 showed 
chemical shift at 38.16 δ ppm. 
4. C2 carbon attached to the methyl group C13 gave peak at 59.01 δ ppm. 
5. Bridged methylene C10 carbon gave peak in down field at 65.80 δ ppm 
comparatively to other methylene groups due to the two nitrogen atoms 
of aromatic ring and indoline ring. 
6. 107.17, 117.90, 124.12, 126.69, 129.28 and 151.30 δ ppm chemical 
shifts are due to the aromatic carbon atoms of phenyl ring of indoline 
C6, C8, C9, C7, C4 and C5 respectively. 
7. C15 and C19 carbons of aromatic ring attached to the nitrogen N11 
showed chemical shift at 112.53 δ ppm. While another two carbons C16 
and C18 showed chemical shift at 127.52 δ ppm. 
8. 116.28 and 149.34 δ ppm chemical shifts are due to the carbon atoms 
of the aromatic ring attached to the nitrogen atom N11 C17 and C14 
respectively. 
 
Chapter – 1                                                           Preparation and Yield optimization.....
 
Department of Chemistry, Saurashtra University, Rajkot-360 005                             53 
 
Peaks obtained in the DEPT-135 were in the agreement of the carbons 
present in the molecule. 
 
 
1.6.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on 
Vario EL Carlo Erba 1108 which showed calculated and found percentage 
values of Carbon, Hydrogen and Nitrogen in support of the structure of 
synthesized compounds. The spectral and elemental analysis data are given 
for individual compounds. 
 
1.7   ANALYTICAL DATA  
 
2-METHYL-1-(PIPERIDIN-1-YLMETHYL) INDOLINE (DNJ-101): IR (KBr, cm-
1): 3070 (Ar-H), 2960 (–CH3), 2860 (–CH2), 1605, 1500, 1483, 1460 (Ar-H), 
1368 (C-N, Ar, 3°); MS m/z = 230 (M+); Anal. Calcd. for C15H22N2: C, 78.21; H, 
9.63; N, 12.16. Found: C, 78.19; H, 9.64; N, 12.17.  
 
2-METHYL-1-(MORPHOLIN-4-YLMETHYL) INDOLINE (DNJ-102): IR (KBr, 
cm-1): 3068 (Ar-H), 2957 (–CH3), 2852 (–CH2), 1606, 1486, 1455 (Ar-H), 1365 
(C-N, Ar, 3°), 1067 (C-O-C ); 1H NMR (400 MHz, CDCl3): δ (ppm) 1.28 (3H, 
m), 2.45 (4H, t), 2.62 (1H, s), 2.83 (1H, s), 3.14 (1H, qt), 3.73 (4H, t), 4.44 
(2H, s), 6.63 (2H, m), 7.00 (2H, m); 13C NMR (400 MHz, CDCl3): δ (ppm) 
170.84, 152.47, 127.47, 124.22, 118.06, 107.13, 71.45, 67.05, 59.46, 51.48, 
37.55, 14.35; MS m/z = 232 (M+); Anal. Calcd. for C14H20N2O: C, 72.38; H, 
8.68; N, 12.06. Found: C, 72.36; H, 8.64; N, 12.09. 
 
2-METHYL-1-(PIPERAZIN-1-YLMETHYL) INDOLINE (DNJ-103): IR (KBr, 
cm-1): 3234 (-NH), 3020 (Ar-H), 2966 (–CH3), 2839 (–CH2), 1604, 1556, 1538, 
1463 (Ar-H), 1371 (C-N, Ar, 3°), 1314 (C-N, Ar, 2°); 1H NMR (400 MHz, 
CDCl3): δ (ppm) 1.31 (3H, m), 1.89 (1H, s), 2.58 (8H, m), 2.87 (2H, d), 3.14 
(1H, qt), 4.42 (2H, s), 6.59 (2H, m), 6.98 (2H, m); 13C NMR (400 MHz, CDCl3): 
δ (ppm) 157.37, 133.13, 132.08, 128.86, 122.26, 112.39, 75.54, 63.98, 56.09, 
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45.48, 41.99, 24.52; MS m/z = 231 (M+); Anal. Calcd. for C14H21N3: C, 72.69; 
H, 9.15; N, 18.16. Found: C, 72.71; H, 9.14; N, 18.15. 
 
2-METHYL-1-[(4-METHYL PIPERAZIN-1-YL) METHYL] INDOLINE (DNJ-
104): IR (KBr, cm-1): 3065 (Ar-H), 2958 (–CH3), 2862 (–CH2), 1562, 1499 
1475, 1458 (Ar-H), 1368 (C-N, Ar, 3°); MS m/z = 245 (M+); Anal. Calcd. for 
C15H23N3: C, 73.43; H, 9.45; N, 17.13. Found: C, 73.41; H, 9.45; N, 17.15. 
 
1-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-2-METHYL INDOLINE (DNJ-105): 
IR (KBr, cm-1): 3066 (Ar-H), 2958 (–CH3), 2860 (–CH2), 1560, 1499, 1473, 
1458 (Ar-H), 1370 (C-N, Ar, 3°); MS m/z = 259 (M+); Anal. Calcd. for 
C16H25N3: C, 74.09; H, 9.71; N, 16.20. Found: C, 74.11; H, 9.69; N, 16.20. 
 
2-METHYL-1-(PYRROLIDIN-1-YLMETHYL) INDOLINE (DNJ-106): IR (KBr, 
cm-1): 3071 (Ar-H), 2956 (–CH3), 2856 (–CH2), 1562, 1505, 1475, 1463 (Ar-
H), 1365 (C-N, Ar, 3°); MS m/z = 216 (M+); Anal. Calcd. for C14H20N2: C, 
77.73; H, 9.32; N, 12.95. Found: C, 77.75; H, 9.31; N, 12.94. 
 
1-[(4-BENZYLPIPERAZIN-1-YL) METHYL]-2-METHYL INDOLINE (DNJ-
107): IR (KBr, cm-1): 3067 (Ar-H), 2962 (–CH3), 2860 (–CH2), 1562, 1500, 
1470, 1462 (Ar-H), 1366 (C-N, Ar, 3°); MS m/z = 321 (M+); Anal. Calcd. for 
C21H27N3: C, 78.46; H, 8.47; N, 13.07. Found: C, 78.44; H, 8.49; N, 13.07. 
 
N, N-DIMETHYL-1-(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHAN 
AMINE (DNJ-108): IR (KBr, cm-1): 3064 (Ar-H), 2960 (–CH3), 2862 (–CH2), 
1562, 1498, 1470, 1458 (Ar-H), 1369 (C-N, Ar, 3°); MS m/z = 190 (M+); Anal. 
Calcd. for C12H18N2: C, 75.74; H, 9.53; N, 14.72. Found: C, 75.71; H, 9.55; N, 
14.73. 
 
N-ETHYL-N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] 
ETHAN AMINE (DNJ-109): IR (KBr, cm-1): 3060 (Ar-H), 2964 (–CH3), 2862 (–
CH2), 1562, 1501, 1475, 1462 (Ar-H), 1373 (C-N, Ar, 3°); MS m/z = 218 (M+); 
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Anal. Calcd. for C14H22N2: C, 77.01; H, 10.16; N, 12.83. Found: C, 77.04; H, 
10.15; N, 12.81. 
 
N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL]-N-PROPYL 
PROPAN-1-AMINE (DNJ-110): IR (KBr, cm-1): 3062 (Ar-H), 2962 (–CH3), 
2864 (–CH2), 1562, 1499, 1470, 1458 (Ar-H), 1375 (C-N, Ar, 3°); MS m/z = 
246 (M+); Anal. Calcd. for C16H26N2: C, 77.99; H, 10.64; N, 11.37. Found: C, 
78.01; H, 10.64; N, 11.35. 
 
N-BUTYL-N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] 
BUTAN-1-AMINE (DNJ-111): IR (KBr, cm-1): 3062 (Ar-H), 2962 (–CH3), 2862 
(–CH2), 1560, 1500, 1470, 1462 (Ar-H), 1374 (C-N, Ar, 3°); MS m/z = 274 
(M+); Anal. Calcd. for C18H30N2: C, 78.77; H, 11.02; N, 10.21. Found: C, 78.80; 
H, 11.05; N, 10.19. 
 
N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] ANILINE (DNJ-
201): IR (KBr, cm-1): 3256 (-NH), 3049 (Ar-H), 2914 (–CH3), 2818 (–CH2), 
1558, 1495 1470, 1458 (Ar-H), 1380 (C-N, Ar, 3°), 1333 (C-N, Ar, 2°); MS m/z 
= 238 (M+); Anal. Calcd. for C16H18N2: C, 80.63; H, 7.61; N, 11.75. Found: C, 
80.65; H, 7.59; N, 11.75. 
 
3-CHLORO-N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] 
ANILINE (DNJ-202): IR (KBr, cm-1): 3318 (-NH), 3047 (Ar-H), 2962 (–CH3), 
2864 (–CH2), 1562, 1503, 1470, 1460 (Ar-H), 1377 (C-N, Ar, 3°), 1327 (C-N, 
Ar, 2°), 898 (1,3-di sub.), 750 (C-Cl); MS m/z = 272 (M+); Anal. Calcd. for 
C16H17ClN2: C, 70.45; H, 6.28; N, 10.27. Found: C, 70.49; H, 6.24; N, 10.31. 
 
N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL]-3-
(TRIFLUOROMETHYL) ANILINE (DNJ-203): IR (KBr, cm-1): 3346 (-NH), 
3030 (Ar-H), 2965 (–CH3), 2887 (–CH2), 1609, 1508, 1489, 1450 (Ar-H), 1374 
(C-N, Ar, 3°), 1329 (C-N, Ar, 2°), 993 (C-F), 855 (1,3-di sub.); 1H NMR (400 
MHz, CDCl3): δ (ppm) 1.29 (3H, m), 3.66 (2H, qt), 4.11 (1H, qt), 4.63 (2H, q), 
4.90 (1H, s), 6.60 (1H, t), 6.74 (2H, m), 6.88 (2H, m), 7.07 (1H, m), 7.23 (2H, 
m); 13C NMR (400 MHz, CDCl3): δ (ppm) 171.34, 150.63, 147.66, 147.04, 
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146.78, 129.90, 129.79, 129.75, 129.71, 129.64, 129.44, 127.56, 127.44, 
127.40, 127.20, 126.71, 124.73, 124.68, 124.56, 124.05, 118.79, 118.35, 
117.99, 116.36, 116.26, 115.69, 114.82, 114.78, 114.74, 114.32, 114.28, 
109.66, 109.62, 109.49, 109.45, 108.94, 107.43, 107.24, 106.97, 106.77, 
60.50, 56.66, 37.51, 14.19; MS m/z = 306 (M+); Anal. Calcd. for C17H17F3N2: 
C, 66.66; H, 5.59; N, 9.15. Found: C, 66.70; H, 5.54; N, 9.19. 
 
3-METHYL-N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] 
ANILINE (DNJ-204): IR (KBr, cm-1): 3341 (-NH), 3056 (Ar-H), 2956 (–CH3), 
2860 (–CH2), 1558, 1501, 1471, 1462 (Ar-H), 1386 (C-N, Ar, 3°), 1330 (C-N, 
Ar, 2°), 846 (1,3-di sub.); MS m/z = 252 (M+); Anal. Calcd. for C17H20N2: C, 
80.91; H, 7.99; N, 11.10. Found: C, 80.95; H, 7.97; N, 11.08. 
 
3-METHOXY-N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] 
ANILINE (DNJ-205): IR (KBr, cm-1): 3273 (-NH), 3051 (Ar-H), 2964 (–CH3), 
2864 (–CH2), 1562, 1500, 1470, 1460 (Ar-H), 1380 (C-N, Ar, 3°), 1337 (C-N, 
Ar, 2°), 1066 (C-O-C ), 885 (1,3-di sub.); MS m/z = 268 (M+); Anal. Calcd. for 
C17H20N2O: C, 76.09; H, 7.51; N, 10.44. Found: C, 76.05; H, 7.53; N, 10.48. 
 
N-METHYL-N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] 
ANILINE (DNJ-206): IR (KBr, cm-1): 3025 (Ar-H), 2953 (–CH3), 2870 (–CH2), 
1600, 1562, 1486, 1452 (Ar-H), 1362 (C-N, Ar, 3°); 1H NMR (400 MHz, 
CDCl3): δ (ppm) 1.32 (3H, m), 2.59 (2H, qt), 2.85 (3H, s), 4.43 (1H, q), 4.76 
(2H, t), 6.68 (2H, m), 6.93 (2H, m), 7.05 (2H, m), 7.25 (3H, m); 13C NMR (400 
MHz, CDCl3): δ (ppm) 151.30, 149.34, 129.28, 127.52, 126.69, 124.12, 
117.90, 116.28, 112.53, 107.17, 65.80, 59.01, 38.16, 37.58, 19.67; MS m/z = 
252 (M+); Anal. Calcd. for C17H20N2: C, 80.91; H, 7.99; N, 11.10. Found: C, 
80.87; H, 8.01; N, 11.12. 
 
N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL]-N-PHENYL 
ANILINE (DNJ-207): IR (KBr, cm-1): 3230 (-NH), 3014 (Ar-H), 2988 (–CH3), 
2850 (–CH2), 1550, 1502, 1473, 1460 (Ar-H), 1377 (C-N, Ar, 3°); MS m/z = 
314 (M+); Anal. Calcd. for C22H22N2: C, 84.04; H, 7.05; N, 8.91. Found: C, 
84.08; H, 7.03; N, 8.89. 
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N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] PYRIDIN-3-
AMINE (DNJ-208): IR (KBr, cm-1): 3341 (-NH), 3077 (Ar-H), 2945 (–CH3), 
2862 (–CH2), 1560, 1500, 1470, 1462 (Ar-H), 1363 (C-N, Ar, 3°), 1325 (C-N, 
Ar, 2°); MS m/z = 239 (M+); Anal. Calcd. for C15H17N3: C, 75.28; H, 7.16; N, 
17.56. Found: C, 75.32; H, 7.13; N, 17.55. 
 
N-[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] PYRIDIN-4-
AMINE (DNJ-209): 3292 (-NH), 3026 (Ar-H), 2941 (–CH3), 2866 (–CH2), 
1558, 1496, 1470, 1460 (Ar-H), 1382 (C-N, Ar, 3°), 1323 (C-N, Ar, 2°); MS 
m/z = 239 (M+); Anal. Calcd. for C15H17N3: C, 75.28; H, 7.16; N, 17.56. Found: 
C, 75.31; H, 7.16; N, 17.53. 
 
(2-FURYL METHYL)[(2-METHYL-2, 3-DIHYDRO-1H-INDOL-1-YL) METHYL] 
AMINE (DNJ-210): IR (KBr, cm-1): 3275 (-NH), 3020 (Ar-H), 2965 (–CH3), 
2862 (–CH2), 1560, 1500, 1473, 1460 (Ar-H), 1371 (C-N, Ar, 3°), 1335 (C-N, 
Ar, 2°), 1071 (C-O-C ); MS m/z = 242 (M+); Anal. Calcd. for C15H18N2O: C, 
74.35; H, 7.49; N, 11.56. Found: C, 74.31; H, 7.51; N, 11.59. 
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1.8   RESULTS AND DISCUSSION 
 
In this chapter, known methods were adopted for the preparation of 2-
methyl indole as well as 2-methyl indoline with slight modifications in the 
previously reported methods. 2-methyl indole was reduced to 2-methyl 
indoline using trifluoroacetic acid and 1 M BH3.THF in tetrahydrofuran 
(Method – A) along with its yield optimization. In this preparation method use 
of trifluoroacetic acid was essential because the TLC analysis of a sample 
obtained by mixing 2-methyl indole and 1 M BH3.THF in tetrahydrofuran under 
nitrogen atmosphere with cooling and then worked up without addition of 
trifluoroacetic acid, showed only the presence of unreacted 2-methyl indole. In 
and another reduction method, indole was reduced using zinc dust and 85% 
phosphoric acid (Method – B) where % yield was comparatively low as 
compare to Method – A. Reduction of indole was carried out under nitrogen to 
prevent the aerial oxidation as indole is a unstable compound. Its aerial 
oxidation results into dimerization or polymerization. 
 
Abonia et. al. a reported preparation method for the preparation of N-
Mannich bases of 2-methyl indoline where they used benzotriazole as 
secondary amine and formaldehyde (37-41% w/w solution). They mixed all 
the three reagents in diethylether and stirred the reaction mixture at the room 
temperature and obtained solid product. While the same method was adopted 
in this chapter also using different liquid secondary amines and primary 
aromatic amines were used to obtain N-Mannich bases and oily liquid type 
products were obtained in all the cases, but solid product was obtained in 
case of piperazine. The same was not happened in case of diphenylamine. 
Thus it may be concluded that the physical state of the product may depend 
upon the secondary / primary amine used.  
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1.9   CONCLUSION 
 
In this chapter, along with yield optimization of the 2-methyl indoline, 
simple, easy and fast method was adopted first time to prepare new Mannich 
bases of 2-methyl indoline using formaldehyde solution and primary and 
secondary amine. DEPT-135 experiment has proved the possible mechanistic 
path governing this reaction, which is probably hitherto unknown in literature. 
Antimicrobial data of the synthesized compounds are reported in Chapter – 6.  
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1.10  SPECTRAL REPRESENTATION OF SYNTHESIZED 
COMPOUNDS 
 
1.10.1   Mass Spectrum of DNJ-102 
 
 
1.10.2   IR Spectrum of DNJ-102 
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1.10.3   1H NMR Spectrum of DNJ-102 
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1.10.4   13C NMR & DEPT 135 Spectrums of DNJ-102 
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1.10.5   Mass Spectrum of DNJ-103 
 
 
 
1.10.6   IR Spectrum of DNJ-103 
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1.10.7   1H NMR Spectrum of DNJ-103 
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1.10.8   13C NMR & DEPT 135 Spectrums of DNJ-103 
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1.10.9   Mass Spectrum of DNJ-203 
 
 
 
1.10.10   IR Spectrum of DNJ-203 
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1.10.11   1H NMR Spectrum of DNJ-203 
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1.10.12   13C NMR & DEPT 135 Spectrums of DNJ-203 
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1.10.13   Mass Spectrum of DNJ-206 
 
 
 
1.10.14   IR Spectrum of DNJ-206 
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1.10.15   1H NMR Spectrum of DNJ-206 
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1.10.16   13C NMR & DEPT 135 Spectrums of DNJ-206 
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2.1   AIM OF CURRENT WORK  
 
Earlier it is already discussed that our group is involved in the synthesis 
of nitrogen containing heterocycles as they show good biological activity in 
different classes. Indole nucleus is known to possess different biological 
activities, thus it was decided to explore the chemistry involving isatin and 2-
methyl indoline moiety. 
 
Literature revealed that different types of N-alkylation reactions have 
been carried out on 2-methyl indoline and isatin, which include introduction of 
acetyl group, introduction of chloroacetyl group and further treatment with 
secondary amines, preparation of amide linkages and alkylation by means of 
one and two carbon chains. Looking to the reactivity of N-1 position in both 
the molecules, Mannich reaction had been carried out on 2-methyl indoline in 
chapter-1 and on isatin in chapter-3. Besides Mannich reaction, 2-methyl 
indoline and isatin can be suitable moieties for N-alkylation reactions. 
Literature survey revealed that very few N-Alkylation reactions have been 
carried out on 2-methyl indoline as well as on isatin moiety where two to three 
carbon atom chains have been introduced at N-1 position using basic 
conditions conventionally. 
 
There are many molecules available in the market existing as potent 
drug viz. Chlorpromazine, Fluphenazine, Prochlorperazine, Acetophenazine 
etc which are having excellent antipsychotic activity. These all molecules 
contain phenothiazine core moiety as well as long alkyl chain having two to 
three carbon atoms along with different substituents at the end of the alkyl 
chain on N atom. This inspired us to develop similar type of compounds using 
different alkyl chains as in above mentioned drugs but on indole nucleus. 
Thus we used 2-methyl indoline and isatin to develop new molecules. So this 
was one of the principal rational to carry out the work done in this chapter. 
 
Besides this, green chemistry and especially microwave assisted 
organic synthesis has drawn a remarkable attention of all chemistry 
researchers towards its advantages. There are many reactions reported 
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involving microwave assisted organic synthesis. Microwave chemistry is one 
of the best tools to carry out different reactions on desired molecules with 
lesser reaction time, lesser energy, easy work up and higher yields with better 
purity. In this chapter microwave assisted organic synthesis has been adopted 
to minimize the reaction time as compared to conventional heating and to 
optimize the results. 
 
Small library of structurally simple but new derivatives of 2-methyl 
indoline and isatin derivatives was prepared through microwave irradiation, 
which is reported herein for the first time. In this chapter, few different types of 
alkyl chains were synthesized by which we could carry out N-Alkylation on 2-
methyl indoline and isatin. Synthesis and biological evaluation of such 
important scaffolds was the rational behind the current work done in this 
chapter.  
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2.2   REACTION SCHEMES 
 
2.2.1 PREPARATION OF 2-METHYL-1-[3-(SUBSTITUTED-1-YL) PROPYL] 
INDOLINE 
STEP – 1 
 
Reagents / Reaction Condition (a): Secondary amines, Toluene/ 75°C, 4 
hours. 
STEP – 2 
 
Reagents / Reaction Condition (b): 2-methyl indoline, K2CO3, DMF/ MW, 480 
W. 
 
2.2.2 PREPARATION OF 2-METHYL-1-[2-(SUBSTITUTED-1-YL)-2-
OXOETHYL] INDOLINE 
STEP – 1 
 
 
Reagents / Reaction Condition (c): Secondary amines, Benzene, TEA/ 0-5°C, 
12 hours, stirring. 
Br Cl Cl N
R1
R2
a
C lN
R 1
R 2
b
N
C H 3
N
R 2
R 1
Cl
Cl
O
Cl
N
O R2
R1
c
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STEP – 2 
 
Reagents / Reaction Condition (d): 2-methyl indoline, K2CO3, DMF/ MW, 480 
W. 
 
2.2.3 PREPARATION OF 1-[3-(SUBSTITUTED-1-YL) PROPYL] - 1H-
 INDOLE-2, 3-DIONE 
 
Reagents / Reaction Condition (e): Isatin, K2CO3, DMF/ MW, 480 W. 
 
2.2.4 PREPARATION OF 1-(2-SUBSTITUTED-4-YL-2-OXOETHYL)-1H-
INDOLE-2, 3-DIONE 
 
Reagents / Reaction Condition (g): Isatin, K2CO3, DMF/ MW, 480 W. 
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f
Chapter – 2                                                        Microwave assisted simple and fast….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                          77 
 
2.3   PLAUSIBLE REACTION MECHANISM 
 
2.3.1   SCHEME - 1 
 
 
2.3.2   SCHEME - 2 
 
 
N
CH3
H
N-
CH3
Base
+ N
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R2
Cl
N
CH3
N
R2
R1
:
:
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O
H
O
N-
O
O
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+ N
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R1
O
:
:
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2.3.3   SCHEME - 3 
 
 
 
2.3.4   SCHEME - 4 
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2.4   EXPERIMENTAL 
 
2.4.1 PREPARATION OF 2 – METHYL INDOLINE 
 
 It was prepared according to method described in Chapter – 1. 
 
2.4.2 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-301 TO 
DNJ-305 
 
STEP – 1 GENERAL PROCEDURE FOR THE PREPARATION OF SIDE 
CHAINS SC-01 TO SC-05 
 
 It was prepared according to the method described by Liu et. al. a To a 
stirred solution of 0.127 mole of 1-bromo-3-chloro propane in 100 ml toluene, 
0.28 mole of an appropriate secondary amine was added at 75°C. The 
reaction mixture was stirred at this temperature for 4 hours. The progress and 
the completion of the reaction were checked by silica gel-G F254 thin layer 
chromatography using dichloromethane : methanol (20 : 1) as mobile phase. 
After the reaction to be completed, it was filtered to remove the precipitation, 
and the filtrate was concentrated under vacuum to afford crude liquid which 
was used as such without further purification as the material was pure enough 
for the subsequent reactions. 
 
Code 
No. 
Substitution 
R1 & R2 
% Yield 
SC-01 Piperidine 66 
SC-02 Morpholine 70 
SC-03 1-Methyl Piperazine 62 
SC-04 1-Ethyl Piperazine 64 
SC-05 1-Benzyl Piperazine 60 
 
STEP – 2 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-
301 TO DNJ-305 
                                                 
a H. Liu, L. Smith, Y. Mao, W. Pan, Y.-J. Xu, S. Burdzovic-Wizeman, M. Duneton and W. 
Wong; Synth. Commun., 2006, 36 (3), 347.  
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 0.01 mole of an appropriate side chain (SC-01 to SC-05) was charged 
into 250 ml erlenmeyer flask loosely covered with gravity funnel. 0.015 mole 
of anhydrous potassium carbonate was added followed by addition of 0.01 
mole of 2-methyl indoline into above flask. 1 ml of dimethylformamide was 
added in order to make slurry. The reaction mixture was irradiated under 
microwave irradiation into household microwave oven (LG MS-192 W) at 480 
W for desired time. The progress and the completion of the reaction were 
checked by silica gel-G F254 thin layer chromatography using toluene : ethyl 
acetate (7 : 3) as mobile phase. The reaction mixture was then taken into 50 
ml water and it was extracted with ethyl acetate (30 ml X 3), the combined 
organic layer was washed using water (20 ml X 2). The organic layer was 
dried on anhydrous sodium sulphate and the solvent was removed under 
reduced pressure to acquire the product. (Physical data of the synthesized 
end products are summarized in the table 2.5.1) 
  
Code 
No. 
Substitution  
R1 & R2 
Reaction Time 
(min.) (at 480 W) % Yield 
DNJ-301 Piperidine 6.0 80 
DNJ-302 Morpholine 6.3 84 
DNJ-303 1-Methyl Piperazine 7.0 79 
DNJ-304 1-Ethyl Piperazine 6.5 81 
DNJ-305 1-Benzyl Piperazine 7.1 85 
 
2.4.3 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-401 TO 
DNJ-405 
 
STEP – 1 GENERAL PROCEDURE FOR THE PREPARATION OF SIDE 
CHAINS SC-06 TO SC-10 
 
 It was prepared according to the method described by Charles and 
Sharma. b A solution of 0.01 mole chloroacetyl chloride in 40 ml dry benzene 
was added drop wise to a cooled and stirred mixture of 0.01 mole an 
appropriate secondary amine and 0.01 mole triethylamine in 40 ml dry 
                                                 
b E. S. Charles and S. Sharma; Ind. J. Chem., 1987, 26B(8), 752  
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benzene. The reaction mixture was stirred at room temperature for 12 hours. 
The progress and the completion of the reaction were checked by silica gel-G 
F254 thin layer chromatography using toluene : ethyl acetate (7 : 3) as mobile 
phase. The reaction mixture was then filtered to remove precipitates of 
triethylamine hydrochloride. The residue was washed with benzene and the 
solvent was removed under reduced pressure to give crude product which 
was used as such without further purification as the material was pure enough 
for the subsequent reactions.   
 
Code 
No. 
Substitution  
R1 & R2 
% Yield 
SC-06 Piperidine 56 
SC-07 Morpholine 59 
SC-08 1-Methyl Piperazine 62 
SC-09 1-Ethyl Piperazine 55 
SC-10 1-Benzyl Piperazine 50 
 
STEP – 2 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-
401 TO DNJ-405 
 
 0.01 mole of an appropriate side chain (SC-06 to SC-10) was charged 
into 250 ml erlenmeyer flask loosely covered with gravity funnel. 0.015 mole 
of anhydrous potassium carbonate was added followed by addition of 0.01 
mole of 2-methyl indoline into above flask. 1 ml of dimethylformamide was 
added in order to make slurry. The reaction mixture was irradiated under 
microwave irradiation into household microwave oven (LG MS-192 W) at 480 
W for desired time. The progress and the completion of the reaction were 
checked by silica gel-G F254 thin layer chromatography using toluene : ethyl 
acetate (7 : 3) as mobile phase. The reaction mixture was then taken into 50 
ml water and it was extracted with ethyl acetate (30 ml X 3), the combined 
organic layer was washed using water (20 ml X 2). The organic layer was 
dried on anhydrous sodium sulphate and the solvent was removed under 
reduced pressure to acquire the product. (Physical data of the synthesized 
end products are summarized in the table 2.5.2) 
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Code 
No. 
Substitution  
R1 & R2 
Reaction Time 
(min.) (at 480 W) % Yield 
DNJ-401 Piperidine 5.5 82 
DNJ-402 Morpholine 6.1 80 
DNJ-403 1-Methyl Piperazine 6.0 77 
DNJ-404 1-Ethyl Piperazine 6.2 79 
DNJ-405 1-Benzyl Piperazine 7.0 81 
 
 
2.4.4 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-501 TO 
DNJ-505 
 
 0.01 mole of an appropriate side chain (SC-01 to SC-05) was charged 
into 250 ml erlenmeyer flask loosely covered with gravity funnel. 0.015 mole 
of anhydrous potassium carbonate was added followed by addition of 0.01 
mole of isatin into above flask. 1 ml of dimethylformamide was added in order 
to make slurry. The reaction mixture was irradiated under microwave 
irradiation into household microwave oven (LG MS-192 W) at 480 W for 
desired time. The progress and the completion of the reaction were checked 
by silica gel-G F254 thin layer chromatography using toluene : ethyl acetate (7 : 
3) as mobile phase. The reaction mixture was then taken into 50 ml water and 
it was extracted with ethyl acetate (30 ml X 3), the combined organic layer 
was washed using water (20 ml X 2). The organic layer was dried on 
anhydrous sodium sulphate and the solvent was removed under reduced 
pressure to acquire the product. (Physical data of the synthesized end 
products are summarized in the table 2.5.3) 
  
Code 
No. 
Substitution  
R1 & R2 
Reaction Time 
(min.) (at 480 W) % Yield 
DNJ-501 Piperidine 6.5 81 
DNJ-502 Morpholine 7.0 83 
DNJ-503 1-Methyl Piperazine 7.4 77 
DNJ-504 1-Ethyl Piperazine 7.5 79 
DNJ-505 1-Benzyl Piperazine 7.3 82 
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2.4.5 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-601 to 
DNJ-605  
 
 0.01 mole of an appropriate side chain (SC-06 to SC-10) was charged 
into 250 ml erlenmeyer flask loosely covered with gravity funnel. 0.015 mole 
of anhydrous potassium carbonate was added followed by addition of 0.01 
mole of isatin into above flask. 1 ml of dimethylformamide was added in order 
to make slurry. The reaction mixture was irradiated under microwave 
irradiation into household microwave oven (LG MS-192 W) at 480 W for 
desired time. The progress and the completion of the reaction were checked 
by silica gel-G F254 thin layer chromatography using toluene : ethyl acetate (7 : 
3) as mobile phase. The reaction mixture was then taken into 50 ml water and 
it was extracted with ethyl acetate (30 ml X 3), the combined organic layer 
was washed using water (20 ml X 2). The organic layer was dried on 
anhydrous sodium sulphate and the solvent was removed under reduced 
pressure to acquire the product. (Physical data of the synthesized end 
products are summarized in the table 2.5.4) 
  
Code 
No. 
Substitution  
R1 & R2 
Reaction Time 
(min.) (at 480 W) % Yield 
DNJ-601 Piperidine 7.5 79 
DNJ-602 Morpholine 7.0 81 
DNJ-603 1-Methyl Piperazine 7.4 75 
DNJ-604 1-Ethyl Piperazine 7.5 80 
DNJ-605 1-Benzyl Piperazine 7.3 74 
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2.5   PHYSICAL DATA TABLES  
 
2.5.1 Physical data of 2-methyl-1-[3-(substituted-1-yl) propyl] indoline 
(DNJ-301 to DNJ-305)  
 
 
 
 
 
 
 
 
 
 
 
 
Code Substitution R1 & R2 
MF MW Rf 
DNJ-301 Piperidinyl C17H26N2 258 0.60 
DNJ-302 Morpholinyl C16H24N2O 260 0.59 
DNJ-303 1-methyl piperazinyl C17H27N3 273 0.62 
DNJ-304 1-ethyl piperazinyl C18H29N3 287 0.64 
DNJ-305 1-benzyl piperazinyl C23H31N3 349 0.70 
 
Rf value was calculated using solvent system = Toluene : Ethyl Acetate 
(7 : 3) 
N
CH3
N
R2
R1
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2.5.2 Physical Data of 2-methyl-1-[2-(substituted-1-yl)-2-oxoethyl] 
indoline (DNJ-401 to DNJ-405) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code Substitution R1 & R2 
MF MW (g/m) Rf 
DNJ-401 Piperidinyl C16H22N2O 258 0.46 
DNJ-402 Morpholinyl C15H20N2O2 260  0.44 
DNJ-403 1-methyl piperazinyl C16H23N3O 273  0.45 
DNJ-404 1-ethyl piperazinyl C17H25N3O 287  0.48 
DNJ-405 1-benzyl piperazinyl C22H27N3O 349  0.53 
 
Rf value was calculated using solvent system = Toluene : Ethyl Acetate 
(7 : 3) 
N
CH3
N
O
R2
R1
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2.5.3 Physical data of 1-[3-(substituted-1-yl) propyl]-1H-indole-2, 3-
dione (DNJ-501 to DNJ-505) 
  
 
 
 
 
 
 
 
 
 
 
 
 
Code Substitution R1 & R2 
MF MW (g/m) 
MP 
(°C) Rf 
DNJ-501 Piperidinyl C16H20N2O2 272  160-162 0.56 
DNJ-502 Morpholinyl C15H18N2O3 274  168-170 0.55 
DNJ-503 1-methyl piperazinyl C16H21N3O2 287  178-180 0.57 
DNJ-504 1-ethyl piperazinyl C17H23N3O2 301  166-168 0.59 
DNJ-505 1-benzyl piperazinyl C22H25N3O2 363  174-176 0.62 
 
Rf value was calculated using solvent system = Toluene : Ethyl Acetate 
(7 : 3) 
N
O
N
R 2
R 1
O
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2.5.4 Physical data of 1-(2-substituted-4-yl-2-oxoethyl)-1H-indole-2, 3-
dione (DNJ-601 to DNJ-605) 
 
 
  
 
 
 
 
 
 
 
 
Code Substitution R1 & R2 
MF MW (g/m) 
MP 
(°C) Rf 
DNJ-601 Piperidinyl C15H16N2O3 272  178-180 0.43 
DNJ-602 Morpholinyl C14H14N2O4 274  168-170 0.42 
DNJ-603 1-methyl piperazinyl C15H17N3O3 287  162-164 0.44 
DNJ-604 1-ethyl piperazinyl C16H19N3O3 301  184-186 0.48 
DNJ-605 1-benzyl piperazinyl C21H21N3O3 363  174-176 0.43 
 
Rf value was calculated using solvent system = Toluene : Ethyl Acetate 
(7 : 3) 
N
O
O
N
R1
R2
O
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2.6   SPECTRAL DISCUSSION 
 
2.6.1   MASS SPECTRAL STUDY 
 
 Mass spectra of the synthesized compounds were recorded on 
Shimadzu GC-MS QP-2010 model using direct injection probe technique. 
The molecular ion peak was found in agreement with molecular weight of the 
respective compound. Characteristic M+2 ion peaks with one-third intensity of 
molecular ion peak were observed in case of compounds having chlorine 
atom. Fragmentation pattern can be observed to be particular for these 
compounds and the characteristic peaks obtained for each compound. 
Probable fragmentation pattern for DNJ-302, DNJ-402, DNJ-502 and DNJ-
602 can be discussed as under. 
 
2-methyl-1-(3-morpholin-4-ylpropyl) indoline (DNJ-302) 
 
1. The target compound showed characteristic molecular ion peak. 
2. O1-C2 and O1-C6 bond cleavages gave characteristic peak at 245 m/e. 
[1] 
3. After O1-C2 and O1-C6 bond cleavages, C2-C3 bond cleavage gave 
characteristic peak at 229 m/e. [2] 
4. After C2-C3 bond cleavage, C5-C6 bond cleavage gave characteristic 
peak at 223 m/e. [3] 
5. After C5-C6 bond cleavage, C3-N4 bond cleavage and subsequently N4-
C5 bond cleavage gave two characteristic peaks at 208 m/e and 186 
m/e respectively. [4] & [5] 
6. After C3-N4 and N4-C5 bond cleavages, C7-N4 bond cleavage gave 
characteristic peak at 172 m/e. [6] 
7. After C7-N4 bond cleavage, C7-C8 and C8-C9 bond cleavages gave two 
characteristic peaks at 158 m/e and 146 m/e (BASE PEAK). [7] & [8] 
8. After C7-C8 and C8-C9 bond cleavages, C9-N10 and C11-C19 bond 
cleavages gave two characteristic peaks at 130 m/e and 118 m/e. [9] & 
[10] 
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9. N4-C7 bond cleavage in the title compound gave characteristic peak at 
172 m/e, which could be the alternative possibility for this fragment. 
[11] 
10. C7-C8 bond cleavage in the title compound gave two characteristic 
peaks at 158 m/e and 100 m/e, which could be the alternative 
possibility. [12] 
11. C8-C9 bond cleavage in the title compound gave two characteristic 
peaks at 146 m/e (BASE PEAK) and 118 m/e, which could be the 
alternative possibility. [13] 
12. C9-N10 bond cleavage in the title compound gave characteristic peak at 
130 m/e, which could be the alternative possibility. [14] 
 
 
2.6.1.1   FRAGMENTATION PATTERN FOR DNJ-302 
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2-methyl-1-(2-morpholin-4-yl-2-oxoethyl) indoline (DNJ-402) 
 
1. The target compound showed characteristic molecular ion peak. 
2. O1-C2 and O1-C6 bond cleavages gave characteristic peak at 245 m/e. 
[1] 
3. After O1-C2 and O1-C6 bond cleavages, C2-C3 bond cleavage gave 
characteristic peak at 229 m/e. [2] 
4. After C2-C3 bond cleavage, C5-C6 bond cleavage gave characteristic 
peak at 223 m/e. [3] 
5. After C5-C6 bond cleavage, C3-N4 bond cleavage and subsequently N4-
C5 bond cleavage gave two characteristic peaks at 208 m/e and 186 
m/e respectively. [4] & [5] 
6. After C3-N4 and N4-C5 bond cleavages, C7-N4 bond cleavage or C7-O8 
bond cleavage gave characteristic peak at 172 m/e which subsequently 
cleaved and gave peak at 158 m/e. [6] & [7] 
7. C7-C9 bond cleavage gave characteristic peak at 146 m/e (BASE 
PEAK). [8] 
8. After C7-C9 bond cleavage, C9-N10 and C11-C19 bond cleavages gave 
two characteristic peaks at 130 m/e and 118 m/e. [9] & [10] 
9. N4-C7 bond cleavage in the title compound gave characteristic peak at 
172 m/e, which could be the alternative possibility for this fragment. 
[11] 
10. C7-C9 bond cleavage in the title compound gave two characteristic 
peaks at 146 m/e (BASE PEAK) and 118 m/e, which could be the 
alternative possibility. [12] 
11. C9-N10 bond cleavage in the title compound gave characteristic peak at 
130 m/e, which could be the alternative possibility. [13] 
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2.6.1.2   FRAGMENTATION PATTERN FOR DNJ-402 
 
 
 
1-(3-morpholin-4-ylpropyl)-1H-indole-2, 3-dione (DNJ-502) 
 
1. The target compound showed characteristic molecular ion peak. 
2. O1-C2 and O1-C6 bond cleavages gave characteristic peak at 262 m/e. 
[1] 
3. After O1-C2 and O1-C6 bond cleavages, C2-C3 bond cleavage gave 
characteristic peak at 246 m/e. [2] 
4. After C2-C3 bond cleavage, C5-C6 bond cleavage gave characteristic 
peak at 234 m/e. [3] 
5. After C5-C6 bond cleavage, C3-N4 bond cleavage and subsequently N4-
C5 bond cleavage gave two characteristic peaks at 218 m/e and 205 
m/e respectively. [4] & [5] 
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6. After C3-N4 and N4-C5 bond cleavages, C7-N4 bond cleavage gave 
characteristic peak at 189 m/e. [6] 
7. After C7-N4 bond cleavage, C7-C8 bond cleavage gave characteristic 
peak at 176 m/e. [7] 
8. After C7-C8 bond cleavage, C9-N10 and subsequently C11-C19 and C12-
C20 bond cleavages gave characteristic peak at 121 m/e. [8] 
9. N4-C7 bond cleavage in the title compound gave characteristic peak at 
189 m/e, which could be the alternative possibility for this fragment. [9] 
10. C7-C8 bond cleavage in the title compound gave two characteristic 
peaks at 176 m/e and 101 m/e, which could be the alternative 
possibility. [10] 
 
 
2.6.1.3   FRAGMENTATION PATTERN FOR DNJ-502 
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1-(2-morpholin-4-yl-2-oxoethyl)-1H-indole-2, 3-dione (DNJ-602) 
 
1. The target compound showed characteristic molecular ion peak. 
2. O1-C2 and O1-C6 bond cleavages gave characteristic peak at 262 m/e. 
[1] 
3. After O1-C2 and O1-C6 bond cleavages, C2-C3 bond cleavage gave 
characteristic peak at 246 m/e. [2] 
4. After C2-C3 bond cleavage, C5-C6 bond cleavage gave characteristic 
peak at 234 m/e. [3] 
5. After C5-C6 bond cleavage, C3-N4 bond cleavage and subsequently N4-
C5 bond cleavage gave two characteristic peaks at 218 m/e and 205 
m/e respectively. [4] & [5] 
6. After C3-N4 and N4-C5 bond cleavages, N4-C7 or C7-O8 bond cleavage 
gave characteristic peak at 176 m/e. [6] 
7. Afterwards C9-N10 and subsequently C11-C19 and C12-C20 bond 
cleavages gave characteristic peak at 121 m/e. [7] 
8. N4-C7 bond cleavage in the title compound gave characteristic peak at 
189 m/e, which could be the alternative possibility for this fragment. [8] 
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2.6.1.4   FRAGMENTATION PATTERN FOR DNJ-602 
 
 
 
2.6.2   IR SPECTRAL STUDY 
 
IR spectra of the synthesized compounds were recorded on Shimadzu 
FT IR 8400 spectrophotometer using Diffused Reflectance Attachment (DRA) 
System using Potassium Bromide. 
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in above compounds, additionally carbonyl frequency was found in DNJ-401 
to DNJ-405, DNJ-501 to DNJ-505 and DNJ-601 to DNJ-605 compounds. 
 
 
2.6.3   1H NMR SPECTRAL STUDY 
 
1H & 13C NMR spectra of the synthesized compounds were recorded 
on Bruker Avance II 400 spectrometer. Sample solutions were made in 
CDCl3 solvent using tetramethylsilane (TMS) as the internal standard unless 
otherwise mentioned. Numbers of protons and numbers of carbons identified 
from H NMR & C NMR spectrum and their chemical shift (δ ppm) were in the 
agreement of the structure of the molecule. J values were calculated to 
identify o, m and p coupling. In some cases, aromatic protons were obtained 
as multiplet. 1H & 13C NMR spectral interpretation can be discussed as under. 
 
1H NMR spectral interpretation of 2-methyl-1-(3-morpholin-4-ylpropyl) 
indoline (DNJ-302) 
 
1. Three most shielded protons of methyl group (C19) gave multiplet at 
1.28 δ ppm. Usually these protons should show their multiplicity as 
doublet due to the presence of single proton at C11, but two nitrogen 
atoms are present in the molecule and thus due to their effect these 
methyl protons coupled with one proton of methine group (C11) and 
another two protons of methylene group (C12) and gave multiplet. 
2. Two methylene protons of propyl chain (C8) gave multiplet at 2.20 δ 
ppm due to the presence of two methylene carbons (C7 & C9). 
3. Four protons of morpholinyl methylene carbons (C3 & C5) and two 
protons of methylene carbon of propyl chain (C7) gave multiplet at 3.31 
δ ppm. 
4. Two methylene protons of propyl chain (C9) gave triplet at 3.54 δ ppm. 
5. One proton of methine group (C11) gave quartet at 4.32 δ ppm which 
actually should show multiplet due to the presence of three protons of 
methyl group (C19) and two protons of methylene group (C12). 
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6. Four protons of morpholinyl methylene carbons (C2 & C6) gave triplet at 
5.00 δ ppm. 
7. Two aromatic protons of C15 and C17 methine groups gave multiplet at 
6.63 δ ppm while another two aromatic protons of C16 and C18 methine 
groups gave multiplet at 7.00 δ ppm. 
 
1H NMR spectral interpretation of 2-methyl-1-(2-oxo-2-piperidin-1-ylethyl) 
indoline (DNJ-402) 
 
1. Three most shielded protons of methyl group (C13) gave multiplet at 
1.28 δ ppm. Usually these protons should show their multiplicity as 
doublet due to the presence of single proton at C2, but two nitrogen 
atoms are present in the molecule and thus due to their effect these 
methyl protons coupled with one proton of methine group (C2) and 
another two protons of methylene group (C3) and gave multiplet. 
2. Four protons of two morpholinyl methylene groups attached with the 
nitrogen atom gave triplet at 2.45 δ ppm, while another four protons of 
rest of the two morpholinyl methylene groups attached with the oxygen 
atom gave triplet at 3.73 δ ppm. 
3. Two protons of C3 carbon atom splitted into two which showed singlet 
for each proton at 2.62 δ ppm and at 2.83 δ ppm respectively. 
4. One proton of methine group (C2) gave quartet at 3.14 δ ppm which 
actually should show multiplet due to the presence of three protons of 
methyl group (C13) and two protons of methylene group (C3). 
5. Two protons of methylene group (C10) became deshielded due to the 
two nitrogen atoms and gave singlet at 4.44 δ ppm. 
6. Two aromatic protons of C6 and C8 methine groups gave multiplet at 
6.63 δ ppm while another two aromatic protons of C7 and C9 methine 
groups gave multiplet at 7.00 δ ppm. 
 
1H NMR spectral interpretation of 1-(3-morpholin-4-ylpropyl)-1H-indole-2, 
3-dione (DNJ-502) 
 
1. Two methylene protons of C8 gave multiplet at 1.28 δ ppm. 
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2. Six protons of three methylene carbons (C3, C5 and C7) gave multiplet 
at 2.83 δ ppm. 
3. Two protons of methylene carbon (C9) of propyl chain gave triplet at 
3.73 δ ppm. 
4. Four protons of two morpholinyl methylene carbons (C2 & C6) gave 
triplet at 4.52 δ ppm. 
5. Two aromatic protons of C15 and C17 methine groups gave multiplet at 
6.63 δ ppm while another two aromatic protons of C16 and C18 methine 
groups gave multiplet at 7.00 δ ppm. 
 
1H NMR spectral interpretation of 1-(2-oxo-2-piperidin-1-ylethyl)-1H-
indole-2, 3-dione (DNJ-602) 
 
1. Four protons of two morpholinyl carbon atoms (C3 & C5) gave triplet at 
2.61 δ ppm. 
2. Four protons of two morpholinyl carbon atoms (C3 & C6) gave triplet at 
3.95 δ ppm. 
3. Two protons of methylene carbon atom (C9) gave singlet at 4.47 δ 
ppm. 
4. Two aromatic protons of C15 and C17 methine groups gave multiplet at 
6.63 δ ppm while another two aromatic protons of C16 and C18 methine 
groups gave multiplet at 7.00 δ ppm. 
 
 
2.6.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on 
Vario EL Carlo Erba 1108 which showed calculated and found percentage 
values of Carbon, Hydrogen and Nitrogen in support of the structure of 
synthesized compounds. The spectral and elemental analysis data are given 
for individual compounds. 
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2.7   ANALYTICAL DATA  
 
2-METHYL-1-(3-PIPERIDIN-1-YLPROPYL) INDOLINE (DNJ-301): IR (KBr, 
cm-1): 3060 (Ar-H), 2960 (–CH3), 2852 (–CH2), 1607, 1505, 1477, 1452 (Ar-
H), 1120 (C-N, Aliphatic, 3°); MS m/z = 258 (M+); Anal. Calcd. for C17H26N2: C, 
79.02; H, 10.14; N, 10.84. Found: C, 79.06; H, 10.12; N, 10.82.  
 
2-METHYL-1-(3-MORPHOLIN-4-YLPROPYL) INDOLINE (DNJ-302): IR 
(KBr, cm-1): 3106 (Ar-H), 2949 (–CH3), 2855 (–CH2), 1465 (Ar-H), 1112 (C-N, 
Aliphatic, 3°), 1050 (C-O-C); 1H NMR (400 MHz, CDCl3): δ (ppm) 1.28 (3H, 
m), 2.20 (2H, m), 3.31 (8H, m), 3.54 (2H, t), 4.32 (1H, qt), 5.00 (4H, t), 6.63 
(2H, m), 7.00 (2H, m); MS m/z = 260 (M+); Anal. Calcd. for C16H24N2O: C, 
73.81; H, 9.29; N, 10.76. Found: C, 73.84; H, 9.32; N, 10.80. 
 
2-METHYL-1-[3-(4-METHYL PIPERAZIN-1-YL) PROPYL] INDOLINE (DNJ-
303): IR (KBr, cm-1): 3055 (Ar-H), 2958 (–CH3), 2847 (–CH2), 1620, 1500, 
1460 (Ar-H), 1135 (C-N, Aliphatic, 3°); MS m/z = 273 (M+); Anal. Calcd. for 
C17H27N3: C, 74.68; H, 9.95; N, 15.37. Found: C, 74.65; H, 9.97; N, 15.38. 
 
1-[3-(4-ETHYL PIPERAZIN-1-YL) PROPYL]-2-METHYL INDOLINE (DNJ-
304): IR (KBr, cm-1): 3068 (Ar-H), 2945 (–CH3), 2849 (–CH2), 1630, 1524, 
1462 (Ar-H), 1129 (C-N, Aliphatic, 3°); MS m/z = 287 (M+); Anal. Calcd. for 
C18H29N3: C, 75.21; H, 10.17; N, 14.62. Found: C, 75.17; H, 10.19; N, 14.64. 
 
1-[3-(4-BENZYL PIPERAZIN-1-YL) PROPYL]-2-METHYL INDOLINE (DNJ-
305): IR (KBr, cm-1): 3057 (Ar-H), 2950 (–CH3), 2866 (–CH2), 1624, 1500, 
1455, 1423 (Ar-H), 1130 (C-N, Aliphatic, 3°); MS m/z = 349 (M+); Anal. Calcd. 
for C23H31N3: C, 79.04; H, 8.94; N, 12.02. Found: C, 79.03; H, 8.96; N, 12.01. 
 
2-METHYL-1-(2-OXO-2-PIPERIDIN-1-YL ETHYL) INDOLINE (DNJ-401): IR 
(KBr, cm-1): 3079 (Ar-H), 2951 (–CH3), 2872 (–CH2), 1727 (>CO), 1630, 1542, 
1477, 1439 (Ar-H), 1140 (C-N, Aliphatic, 3°); MS m/z = 258 (M+); Anal. Calcd. 
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for C16H22N2O: C, 74.38; H, 8.58; N, 10.84. Found: C, 74.34; H, 8.54; N, 
10.80. 
 
2-METHYL-1-(2-MORPHOLIN-4-YL-2-OXO ETHYL) INDOLINE (DNJ-402): 
IR (KBr, cm-1): 3110 (Ar-H), 2949 (–CH3), 2855 (–CH2), 1735 (>CO), 1613, 
1469, 1439 (Ar-H), 1113 (C-N, Aliphatic, 3°), 1050 (C-O-C); 1H NMR (400 
MHz, CDCl3): δ (ppm) 1.28 (3H, m), 2.45 (4H, t), 2.62 (1H, s), 2.83 (1H, s), 
3.14 (1H, s), 3.73 (4H, t), 4.44 (2H, s), 6.63 (2H, m), 7.00 (2H, m); MS m/z = 
260 (M+); Anal. Calcd. for C15H20N2O2: C, 69.20; H, 7.74; N, 10.76. Found: C, 
69.24; H, 7.70; N, 10.80. 
 
2-METHYL-1-[2-(4-METHYL PIPERAZIN-1-YL)-2-OXO ETHYL] INDOLINE 
(DNJ-403): IR (KBr, cm-1): 3082 (Ar-H), 2964 (–CH3), 2859 (–CH2), 1730 
(>CO), 1627, 1534, 1480, 1423 (Ar-H), 1120 (C-N, Aliphatic, 3°); MS m/z = 
273 (M+); Anal. Calcd. for C16H23N3O: C, 70.30; H, 8.48; N, 15.37. Found: C, 
70.26; H, 8.46; N, 15.40. 
 
1-[2-(4-ETHYL PIPERAZIN-1-YL)-2-OXO ETHYL]-2-METHYL INDOLINE 
(DNJ-404): IR (KBr, cm-1): 3105 (Ar-H), 2969 (–CH3), 2848 (–CH2), 1722 
(>CO), 1662, 1500, 1447 (Ar-H), 1110 (C-N, Aliphatic, 3°); MS m/z = 287 
(M+); Anal. Calcd. for C17H25N3O: C, 71.04; H, 8.77; N, 14.62. Found: C, 
71.08; H, 8.80; N, 14.65. 
 
1-[2-(4-BENZYL PIPERAZIN-1-YL)-2-OXO ETHYL]-2-METHYL INDOLINE 
(DNJ-405): IR (KBr, cm-1): 3068 (Ar-H), 2963 (–CH3), 2865 (–CH2), 1730 
(>CO), 1620, 1470, 1445 (Ar-H), 1130 (C-N, Aliphatic, 3°); MS m/z = 349 
(M+); Anal. Calcd. for C22H27N3O: C, 75.61; H, 7.79; N, 12.02. Found: C, 
75.57; H, 7.82; N, 12.05. 
 
1-(3-PIPERIDIN-1-YL PROPYL)-1H-INDOLE-2, 3-DIONE (DNJ-501): IR 
(KBr, cm-1): 3100 (Ar-H), 2963 (–CH3), 2846 (–CH2), 1724 (>CO, C12), 1680 
(>CO, C11), 1610, 1555, 1448 (Ar-H), 1120 (C-N, Aliphatic, 3°); MS m/z = 272 
(M+); Anal. Calcd. for C16H20N2O2: C, 70.56; H, 7.40; N, 10.29. Found: C, 
70.60; H, 7.42; N, 10.32. 
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1-(3-MORPHOLIN-4-YL PROPYL)-1H-INDOLE-2, 3-DIONE (DNJ-502): IR 
(KBr, cm-1): 3137 (Ar-H), 2953 (–CH3), 2863 (–CH2), 1730 (>CO, C12), 1682 
(>CO, C11), 1609, 1562, 1461 (Ar-H), 1118 (C-N, Aliphatic, 3°), 1050 (C-O-C); 
1H NMR (400 MHz, CDCl3): δ (ppm) 1.28 (2H, m), 2.83 (6H, m), 3.73 (2H, t), 
4.52 (4H, t), 6.63 (2H, m), 7.00 (2H, m); MS m/z = 274 (M+); Anal. Calcd. for 
C15H18N2O3: C, 65.68; H, 6.61; N, 10.21. Found: C, 65.70; H, 6.64; N, 10.24. 
 
1-[3-(4-METHYL PIPERAZIN-1-YL) PROPYL]-1H-INDOLE-2, 3-DIONE 
(DNJ-503): IR (KBr, cm-1): 3090 (Ar-H), 2969 (–CH3), 2855 (–CH2), 1721 
(>CO, C12), 1683 (>CO, C11), 1600, 1550, 1433 (Ar-H), 1127 (C-N, Aliphatic, 
3°); MS m/z = 287 (M+); Anal. Calcd. for C16H21N3O2: C, 66.88; H, 7.37; N, 
14.62. Found: C, 66.90; H, 7.40; N, 14.65. 
 
1-[3-(4-ETHYL PIPERAZIN-1-YL) PROPYL]-1H-INDOLE-2, 3-DIONE (DNJ-
504): IR (KBr, cm-1): 3081 (Ar-H), 2950 (–CH3), 2861 (–CH2), 1729 (>CO, 
C12), 1685 (>CO, C11), 1627, 1544, 1433 (Ar-H), 1115 (C-N, Aliphatic, 3°); MS 
m/z = 301 (M+); Anal. Calcd. for C17H23N3O2: C, 67.75; H, 7.69; N, 13.94. 
Found: C, 67.71; H, 7.66; N, 13.91. 
 
1-[3-(4-BENZYL PIPERAZIN-1-YL) PROPYL]-1H-INDOLE-2, 3-DIONE 
(DNJ-505): IR (KBr, cm-1): 3075 (Ar-H), 2960 (–CH3), 2840 (–CH2), 1730 
(>CO, C12), 1688 (>CO, C11), 1624, 1575, 1525, 1440 (Ar-H), 1122 (C-N, 
Aliphatic, 3°); MS m/z = 363 (M+); Anal. Calcd. for C22H25N3O2: C, 72.70; H, 
6.93; N, 11.56. Found: C, 72.68; H, 6.95; N, 11.60. 
 
1-(PIPERIDIN-1-YL ACETYL)-1H-INDOLE-2, 3-DIONE (DNJ-601): IR (KBr, 
cm-1): 3080 (Ar-H), 2963 (–CH3), 2854 (–CH2), 1723 (>CO, C12), 1687 (>CO, 
C11), 1663 (>CO, C7), 1615, 1519, 1450 (Ar-H), 1125 (C-N, Aliphatic, 3°); MS 
m/z = 272 (M+); Anal. Calcd. for C15H16N2O3: C, 66.16; H, 5.92; N, 10.29. 
Found: C, 66.20; H, 5.89; N, 10.31. 
 
1-(MORPHOLIN-4-YL ACETYL)-1H-INDOLE-2, 3-DIONE (DNJ-602): IR 
(KBr, cm-1): 3069 (Ar-H), 2953 (–CH3), 2864 (–CH2), 1713 (>CO, C12), 1682 
(>CO, C11), 1659 (>CO, C7), 1609, 1519, 1454 (Ar-H), 1117 (C-N, Aliphatic, 
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3°), 1048 (C-O-C); 1H NMR (400 MHz, CDCl3): δ (ppm) 2.61 (4H, t), 3.95 (4H, 
t), 4.47 (2H, s), 6.63 (2H, m), 7.00 (2H, m); MS m/z = 274 (M+); Anal. Calcd. 
for C14H14N2O4: C, 61.31; H, 5.14; N, 10.21. Found: C, 61.35; H, 5.10; N, 
10.24. 
 
1-[(4-METHYL PIPERAZIN-1-YL) ACETYL]-1H-INDOLE-2, 3-DIONE (DNJ-
603): IR (KBr, cm-1): 3070 (Ar-H), 2945 (–CH3), 2860 (–CH2), 1710 (>CO, 
C12), 1678 (>CO, C11), 1655 (>CO, C7), 1600, 1588, 1524, 1450 (Ar-H), 1111 
(C-N, Aliphatic, 3°); MS m/z = 287 (M+); Anal. Calcd. for C15H17N3O3: C, 
62.71; H, 5.96; N, 14.63. Found: C, 62.75; H, 5.92; N, 14.60. 
 
1-[(4-ETHYL PIPERAZIN-1-YL) ACETYL]-1H-INDOLE-2, 3-DIONE (DNJ-
604): IR (KBr, cm-1): 3064 (Ar-H), 2962 (–CH3), 2860 (–CH2), 1720 (>CO, 
C12), 1685 (>CO, C11), 1650 (>CO, C7), 1600, 1570, 1500, 1455 (Ar-H), 1123 
(C-N, Aliphatic, 3°); MS m/z = 301 (M+); Anal. Calcd. for C16H19N3O3: C, 
63.77; H, 6.36; N, 13.94. Found: C, 63.80; H, 6.33; N, 13.91. 
 
1-[(4-BENZYL PIPERAZIN-1-YL) ACETYL]-1H-INDOLE-2, 3-DIONE (DNJ-
605): IR (KBr, cm-1): 3077 (Ar-H), 2950 (–CH3), 2869 (–CH2), 1715 (>CO, 
C12), 1680 (>CO, C11), 1662 (>CO, C7), 1612, 1530, 1466, 1420 (Ar-H), 1122 
(C-N, Aliphatic, 3°); MS m/z = 363 (M+); Anal. Calcd. for C21H21N3O3: C, 
69.41; H, 5.82; N, 11.56. Found: C, 69.45; H, 5.85; N, 11.60. 
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2.8   RESULTS AND DISCUSSION 
 
Reactions under dry conditions (i.e., in the absence of a solvent, on a 
solid support with or without catalysts) were originally developed in the late 
1980s. Synthesis without solvents under microwave irradiation offers several 
advantages. The absent of solvent reduces the risk of explosions when the 
reaction takes place in a closed vessel in an oven. Moreover, aprotic dipolar 
solvents with high boiling points are expensive and difficult to remove from the 
reaction mixtures. During microwave induction of reactions under dry 
conditions, the reactants adsorbed on the surface of alumina, silica gel, clay, 
and others absorb microwaves whereas the support does not, nor does it 
restrict the transmission of microwaves. Consequently, such supported 
reagents efficiently induce reactions under safe and simple conditions with 
domestic microwave ovens instead of specialized expensive commercial 
microwave systems. 
 
The N-alkylation of heterocyclic compounds bearing an acidic 
hydrogen atom attached to nitrogen is generally accomplished by treatment of 
these compounds with an appropriate base followed by treatment of the 
resulting salts with an alkylating agent. 
 
In this chapter, dry conditions have been used in the synthesis of all 
the organic compounds. Anhydrous potassium carbonate was used as a solid 
support and as a basic media too. Dimethylformamide was used in very little 
amount to make a slurry at room temperature which has not been considered 
as a solvent. Household microwave oven (LG MS-192 W) was used as a 
microwave source operating range of 800 W. All the reactions were carried 
out at 480 W for desired time.  
 
There are so many reported methods in the literature for the N-
alkylation conventionally as well as microwave induced. Conventional 
methods are having tedious work up and purification procedures and are time 
consuming while microwave assisted methods are straight forward, fast, time 
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saving and eco-friendly. So in this chapter microwave induced dry method has 
been developed which produced high yielding end products.  
 
 
2.9   CONCLUSION 
 
Looking to the importance of indole nucleus and diversified biological 
profile shown by different indole derivatives, study on different 2-methyl 
indoline and isatin derivatives has been continued in this chapter. More over 
importance and advantages of microwave assisted organic synthesis 
attracted us to contribute in green chemistry by developing eco-friendly 
methods for the preparation of organic molecules. N-alkylation is one of the 
most important reactions to be carried out on different substrates from 
chemistry point of view as well as biological activity point of view. In current 
chapter, not only new and novel molecules have been prepared but simple 
and fast microwave assisted N-alkylation method is also developed. 
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2.10  SPECTRAL REPRESENTATION OF SYNTHESIZED 
COMPOUNDS 
 
2.10.1   Mass Spectrum of DNJ-302 
 
 
 
 
2.10.2   IR Spectrum of DNJ-302 
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2.10.3   1H NMR Spectrum of DNJ-302 
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2.10.4   Mass Spectrum of DNJ-402 
 
 
 
 
2.10.5   IR Spectrum of DNJ-402 
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2.10.6   1H NMR Spectrum of DNJ-402 
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2.10.7   Mass Spectrum of DNJ-502 
 
 
 
 
2.10.8   IR Spectrum of DNJ-502 
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2.10.9   1H NMR Spectrum of DNJ-502 
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2.10.10   Mass Spectrum of DNJ-602 
 
 
 
 
2.10.11   IR Spectrum of DNJ-602 
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2.10.12   1H NMR Spectrum of DNJ-602 
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B.1   INTRODUCTION TO ISATIN 
 
Isatin (1H-indole-2, 3-dione; C8H5NO2) is an aromatic heterocyclic 
organic compound. It has a bicyclic structure, consisting of a six-membered 
benzene ring fused to a five-membered nitrogen-containing ring. The 
compound's structure is based on the indoline structure but where two 
carbonyl groups are situated at 2- and 3-position of the five membered ring. 
 
 
 
 
 
 
 
 
In the course of studies of the action of various oxidizing agents on 
indigo, Erdmann 1-3 and Laurent 4-7 in 1841 independently discovered an 
oxidation product, which had the formula C8H6NO2 and to which the name 
given was isatin.  
 
In nature, isatin is found in plants of the genus Isatis, 8 in Calanthe 
discolor LINDL. 9 and in Couroupita guianensis Aubl. 10 and has also been 
found as a component of the secretion from the parotid gland of Bufo frogs, 11 
and in humans as it is a metabolic derivative of adrenaline. 12-14 Substituted 
isatins are also found in plants, for example the melosatin alkaloids (methoxy 
phenylpentyl isatins) obtained from the Caribbean tumorigenic plant Melochia 
tomentosa 15-17 as well as from fungi: 6-(3'-methylbuten-2'-yl)isatin was 
isolated from Streptomyces albus 18 and 5-(3'-methylbuten-2'-yl)isatin from 
Chaetomium globosum. 19 Isatin has also been found to be a component of 
coal tar. 20 
N
H
O
O
1
2
3
4
5
6
7
Fig. B.1.1
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B.2   PHYSICAL PROPERTIES OF ISATIN 
 
Isatin crystallizes from water, alcohol, or acetic acid in the form of red 
needles melting at 200-201°C. It is soluble in hot water, alcohol, acetic acid, 
and benzene but is sparingly soluble in ether. The substance is soluble in 
concentrated hydrochloric acid and in concentrated sulfuric acid. It dissolves 
in sodium or potassium hydroxide solution, forming the sodium or potassium 
salt of isatin. Heating the solution results in ring opening with the formation of 
the salt of isatic acid. Ring closure results when the solution is acidified, and 
isatin precipitates. 
 
B.3   SYNTHESIS OF ISATIN 
 
1. The Sandmeyer methodology 
 
The method developed by Sandmeyer is the oldest and the most 
frequently used for the synthesis of isatin. It consists in the reaction of aniline 
with chloral hydrate and hydroxylamine hydrochloride in aqueous sodium 
sulfate to form an isonitrosoacetanilide, which after isolation, when treated 
with concentrated sulfuric acid, furnishes isatin in >75% overall yield. 21 
Literature also reveals different applications 22-29 for the preparation of isatin 
derivatives using the Sandmeyer methodology and its disadvantages. 30-33 
 
2. Use of nitroacetanilides 
 
Nitroacetanilides, obtained by alkaline hydrolysis of 1-arylamino-1-
methylthio-2-nitroethenes are readily cyclized to isatin-3-oximes by the use of 
concentrated sulfuric acid or trifluoromethanesulfonic acid at room 
temperature; the later giving somewhat higher yields. 34  
 
3. The Stolle procedure 
 
The most important alternative to Sandmeyer’s procedure is the 
method of Stolle. In this method anilines are reacted with oxalyl chloride to 
form an intermediate chlorooxalylanilide which can be cyclized in the 
Part – B                                                                        Studies on isatin derivatives….. 
 
Department of Chemistry, Saurashtra University, Rajkot-360 005                           115
 
presence of a Lewis acid, usually aluminum chloride or BF3.Et2O 35, although 
TiCl4 36 has also been used to give the corresponding isatin. Literature also 
reveals different applications for the preparation of isatin derivatives using the 
Stolle procedure. 37-41 
  
4. The Martinet isatin synthesis 
 
The Martinet procedure for the synthesis of indole-2,3-diones involves 
the reaction of an aminoaromatic compound and either an oxomalonate ester 
or its hydrate in the presence of an acid to yield a 3-(3-hydroxy-2-
oxindole)carboxylic acid derivative which after oxidative decarboxylation 
yields the respective isatin. This method was applied with success for the 
synthesis of 5, 6-dimethoxyisatin from 4-aminoveratrole whereas the use of 2, 
4-dimethoxyaniline was less successful 42 but it is readily applied to 
naphthylamines. 43  
 
5. The Gassman procedure 
 
A fundamentally different and general procedure developed by 
Gassman is another option for the synthesis of isatins. 44, 45 This methodology 
consists in the formation and subsequent oxidation of an intermediate 3-
methylthio-2-oxindole 46-48 to give the corresponding substituted isatins in 40-
81% yield. Literature also reveals different applications for the preparation of 
isatin derivatives using the Gassman procedure. 49  
 
6. Metalation of anilide derivatives 
 
A more recent method for the synthesis of isatins is based upon the 
directed ortho-metalation (DoM) of N-pivaloyl-and N-(t-butoxycarbonyl)-
anilines. The corresponding dianions are treated with diethyl oxalate and the 
isatins are obtained after deprotection and cyclisation of the intermediate α-
ketoesters. This method has the advantage of being regioselective for the 
synthesis of 4-substituted isatins from meta-substituted anilines where the 
substituent is a metalation directing group (e.g. OMe). 50 (Fig. B.1.2) Literature 
also reveals different applications for the preparation of isatin derivatives via 
metalation of anilide derivatives. 51, 52 
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7. Miscellaneous procedures 
 
Many other alternate procedures for the preparation of isatins are 
discussed in last few years. 53-98  
 
B.4   N-ALKYLATION ON ISATIN 
 
Many methods have been devised for the N-alkylation of isatins. These 
derivatives are commonly synthesized from the reaction of the sodium salt of 
isatin with alkyl halides or sulphates. 99, 100 Various methods for the 
preparation of this salt have been reported, and include the reaction of isatin 
with sodium hydride, in toluene, 101 DMF, 102-133 Dioxane, 134 DMSO, 135, 136 
THF. 137-142 In case of carbonates it includes, the use of potassium carbonate 
in DMF, 108, 133, 143-155 acetone, 156-158 acetonirile, 159, 160 chloroform, 161 while 
the use of cesium carbonate in acetonitrile, 160 DMF, 162 and the use of 
sodium carbonate in acetone. 163, 164 Strong bases like NaOH with DMF 165, 166 
and methanol 166 and KOH with DMF, 167, 168 DMSO, 169 ethanol 170-173 and 
methanol 174-176 are also used for N-alkylation of isatin. TEA is also used for 
N-acylation with Benzene 103, 177 while DMF, 178 and THF 179 is used with TEA 
for alkylation. Sodium methoxide is used with acetonitrile, 180 methanol 181 and 
sodium ethoxide with ethanol. 103, 182, 183 In the later case an aldol reaction of 
the solvent also occurs with the C3 carbonyl of the isatin derivative. Heating in 
ortho-dichlorobenzene results in a retro-aldol reaction and the obtention of the 
N-alkylated isatin. The use of CaH2 in DMF has been reported 184-187 and this 
method was used for the synthesis of both mono and bis-N-alkylisatins. These 
Fig. B.1.2 
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later compounds have been previously prepared using dihaloalkanes and 
NaH in dioxane 134 or DMF 188 or by the use of LiH. 189 Some of these 
alkylation methodologies were evaluated for the synthesis of isatins bearing a 
glycosidic residue linked to the N-1 position. 190 Use of KF and Al2O3 with 
acetonitrile 191 and THF 191 is also reported for N-alkylation of isatin. Literature 
also revealed uses of different bases viz. pyridine in benzene, 192 
diisopropylethylamine in dichloromethane, 176 cuprous oxide in DMF, 193 
BEMP (2-tert-butylimino-2-diethylamino-1, 3-dimethylperhydro-1, 3, 2-
diazaphosphorine on polystyrene) in acetonitrile 194 and potassium t-butoxide 
in THF. 195 
 
An alternative method for preparing 1-alkylisatins consists in the 
reaction of isatin and alkyl halides in a benzene-chloroform/50% aq. KOH 
biphasic system, employing tetrabutylammonium hydrogensulfate as the 
phase transfer catalyst. 196  
 
N-propargylisatins, obtained from isatin and propargyl halides 184, 197 
can be converted to N-acetonylisatins through hydration with Hg(II) salts in 
acidic media. 198  
 
The synthesis of 1-methylisatin by the method of Stolle, using tris 
(methylphenylamino) methane instead of N-methylaniline, leads to the desired 
product in low yields. 199  
 
The reaction of isatin with vinyl acetate in the presence of Na2PdCl4 
yields 1-vinylisatin. 200 
 
On the other hand, O-alkylation at position 2 has been reported, along 
with the N-alkyl product, using γ- butyrolactone 201or allyl bromide 202 as 
alkylating agents and the sodium salt of isatin. O-methylisatin is described as 
the product of the reaction of methyl iodide with the silver salt of isatin, which 
can be prepared from isatin and silver acetate. 203 The alkoxy group has been 
reported to be displaced by nucleophiles such as hydrazines. 204 
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B.5   N-ACYLATION ON ISATIN 
 
The synthesis of N-acylisatins under a variety of conditions has been 
described using acyl chlorides or anhydrides under reflux. The reaction may 
be performed without additives 205 or by using perchloric acid in benzene, 
triethylamine in benzene, 103 pyridine in benzene, 206 or triethylamine in 
chloroform 207, 208 as catalysts; or by conversion of isatin to sodium isatide 
using NaH in toluene under reflux and subsequent reaction with acyl 
chlorides. 144  
The use of diacyl chlorides such as oxalyl 209, octanedioyl or 
nonanedioyl chlorides 210, yields bisacylisatins. Attempts to use 2, 2-
dimethylmalonyl chloride to furnish 2, 2-dimethylmalonyl-bis-isatin failed, and 
led instead to an unusual tricyclic compound which was characterized by 
spectroscopic methods and by X-ray diffraction. 211 (Fig. B.1.3) 
 
 
 
 
 
 
  
 
 
 
Other complex products have been obtained from the reaction of isatin 
and acetic anhydride in the presence of pyridine. 212 (Fig. B.1.4) 
 
Similarly, dimers may be formed in the acetylation of indolylglyoxalates 
with acetic anhydride in pyridine. 213 (Fig. B.1.5) 
 
Many authors 214-230 have reported N-acylation or N-acetylation on 
isatin. 
 
Fig. B.1.3 
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B.6   MANNICH REACTION ON ISATIN 
 
The Mannich reaction consists in the condensation of ammonia or a 
primary or secondary amine, usually as the hydrochloride, with formaldehyde 
and a compound containing at least one hydrogen atom of pronounced 
reactivity. The essential feature of the reaction is the replacement of the active 
hydrogen atom by an aminomethyl or substituted aminomethyl group. The 
Mannich reaction is readily applied to isatins.  
 
Varma and Nobles 231 synthesized a series of Isatin-N-Mannich bases 
derived from isatin (Fig. B.1.6), 5-methyl and 5-bromoisatins as the active 
hydrogen component and dimethylamine, diethylamine, morpholine, 
piperidine, N-ethylcyclohexylamine, 3-azabicyclo [3.2.2] nonane and 3-aza-
bicyclo [3.2.1] octane as the secondary amine moiety.  
 
Fig. B.1.4 
Fig. B.1.5 
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R = 5-H, 5-CH3, 5-Br and R1 & R2 = Different Secondary Amines 
 
The products of Mannich reaction, the N-aminomethylisatins (Mannich 
bases), can also be obtained from the N-hydroxymethyl derivatives by 
reaction with an amine 232 or by reaction with acetyl chloride to yield N-
chloromethylisatin which can be further treated with potassium phthalimide or 
an alcohol to give the corresponding N-phthalimidomethyl or N-alkoxymethyl 
isatins. 233 The Mannich reaction can also be performed with isatin 
derivatives, such as isatin-3-hydrazones 234 and isatin-3-thiosemicarbazones. 
235 
Jozef 236 prepared a series of twenty Mannich bases by treating cyclic 
imides and hydrazides with formaldehyde and secondary amines.  Thus, 
phthalic hydrazide yielded (1) (R = R1 = cyclohexyl, CH2CH2OH, Ph; R = Ph, 
R1 = CH3).  (2) (R = R1 = cyclohexyl, Ph, Et, CH2CH2OH), (3) (R = R1 = Ph, 
cyclohexyl, CH2CH (CH3)2, CH2CHOHCH3; R = Ph, R1 = CH3), (4) (R = R1 = 
CH2CHOHCH3; R = Ph, R1 = cyclohexyl), and (5) (R = R1 = Ph, CH2CH 
(CH3)2, CH2CHOHCH3; R = Ph, R1 = cyclohexyl, R = Ph, R1 = PhCH2) were 
similarly prepared  bis(aminomethyl) compounds were obtained from maleic 
and phthalic hydrazides and from isatin when the piperazine was used. (Fig. 
B.1.7) 
 
Varma and Khan 237 treated (hydroxymethyl) indolinone (1) with 4-
chloroaniline in refluxing ethanol gave the indolinone (2) (R = H). Then they 
carried out Mannich reaction of (2) to give (2) (R = piperidinomethyl, 
morpholinomethyl). Treatment of (1) with 4-nitroaniline, 4-
methylaniline, or methyl-4aminobenzoate gave indolinone (3). (Fig. 
B.1.8) 
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They 238 further carried out condensation of (1) (R = CH2OH, R1 = H) 
with 4-iodoaniline gave (1) (R = H, R1 = p-IC6H4) and not the expected product 
(1) (R = p-IC6H4NHCH2, R1 = H). (Fig. B.1.9) 
 
 
 
 
 
 
 
 
Joshi et. al. 239 prepared fluorotriazinoindoles (1) (R = 7-F, 8-F; N(R1)2 
= Et2N, piperidino, pyrrolidino, morpholino) and fluorodiazoindolones (2) (R2 = 
Ph, 4-FC6H4, 4-Me2NC6H4, 4-ClC6H4, 2-furyl, 4-O2NC6H4) from 
fluoroindolediones (3) (R = 5-F, 6-F). (Fig. B.1.10) 
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The same group 240 also prepared aminoacetylindolediones (1) (R = 5-
F, 6-F; NR1R2 = NMe2, NEt2, morpholino, piperidino) by cyclizing 
fluoroisonitrosoacetanilides with acid, chloroacetylating the 
fluoroindolediones, and aminating the chloroacetyl derivatives.  (2) [R3 = 4-F, 
4-Cl, 4-NO2, 2, 4-(NO2)2] were obtained by Mannich reaction of the 
fluoroindolediones with morpholine and reaction with phenyl hydrazines. 
(R3C6H4NHNH2) (Fig. B.1.11) 
  
They 241 further reported that Mannich reaction of indolediones (1) (R = 
H; R1 = 4-CF3, 5-F, 6-F; X = O) and amines (R2H = morpholine, piperidine) 
gave 46-73 % (1) (R = CH2R2).  Treating (1) (R = H; R1 = 4-CF3, 5-F, 6-F; X = 
O) with R3NH2 (R3 = 4-FC6H4, 3-CF3C6H4) gave 71-82 % (1) (X = NR3), which 
underwent Mannich reaction with R2H to give 50-64 % (1) (R = CH2R2).  
Refluxing thiosemicarbazide with (1) (R =H, X = O) in K2CO3-H2O gave 78-82 
% 1, 2, 3-triazino [5, 6-b] indole-3-thiones (2). Successive treatment of (2) with 
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NaOH and R2CH2CH2Cl.HCl gave 61-73 % (3) (R2 = morpholino, piperidino, 
pyrrolidino). (Fig. B.1.12) 
 
Collino and Volpe 242 prepared Mannich bases from benzimidazoles, 
benzotriazoles, indolones, or benzoxazolones and N-phenylpiperazine, 4-
anilinopiperidine, 4-benzylpiperidine, or N-bezylpiperazine. 
 
 
 
 
 
 
 
 
 
 
 
The same authors 243 further prepared Mannich bases of N 
heterocycles or aromatic amines with trimethylenedipiperidine, dipiperidine, 
and hydroxyethyldipiperidine as well as the isatin derivatives (where, n = 6, 7). 
(Fig. B.1.13) 
 
Jancevska-Nikolovska 244 converted the hexylbenzene into 4-
hexylaniline which underwent cyclization reactions to give acridines, 
benzacridines, isatins, carbazoles, indoles, benzindoles, quinolines, and 
benzoquinolines. (all substituted with the hexyl group) Further they carried out 
Mannich reaction to give N-substituted derivatives. (Fig. B.1.14) 
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Popp and Rajopadhye 245 prepared the title compounds by the 
cyclocondensation of thiolactic acid with isatin-3-imines. 5'-methyl-3'-phenyl-
spiro [3H-indole-3, 2'-thiazolidine]-2, 4' (1H)-dione has been subjected to the 
Mannich condensation to give 1-substituted derivatives. (Fig. B.1.15) 
 
 
 
 
 
 
 
 
 
 
 
Further they 246 synthesized Mannich base of 3'-(4-chlorophenyl)-5, 5'-
dimethyl-4'H-spiro[indole-3, 2'-[1, 3]thiazolidine]-2, 4'(1H)-dione using 
formaldehyde and morpholine along with differently substituted isatin 
derivatives. (Fig. B.1.16) 
 
 
 
 
 
 
 
 
Varma and Singh 247 prepared differently substiuted isatins and then 
they reported Mannich bases of afore mentioned isatins. (Fig. B.1.17) 
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Pandeya et. al. 248 synthesized Mannich bases of norfloxacin by 
reacting them with formaldehyde and several isatin derivatives. The starting 
materials 3-[4-sulfadiazinimino] isatin, 3-[4(-sulfadoximino] isatin and 3-[4'-
amino, 5'-(3'', 4'', 5''-trimethoxybenzyl)pyrimidin-2'-yl]imino isatin and their 5-
substituted derivatives were prepared by reacting isatin and its derivatives 
with sulfadiazine, sulfadoxine and trimethoprim in the presence of glacial 
acetic acid. Mannich bases of norfloxacin were prepared by condensing the 
active hydrogen atom of isatin and the secondary amino function (piperazino 
moiety) of norfloxacin. (Fig. B.1.18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Korepin et. al. 249 reported Mannich reactions of amino alchohols 3-
aminopropan-1-ol or 2-aminoethanol with formaldehyde and C-H or N-H acids 
gave N-substituted tetrahydro-1, 3-oxazines or oxazolidines.  Thus, reaction 
Fig. B.1.17
Fig. B.1.18
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of 3-aminopropanol (1) with formaldehyde and 1, 1-dinitroethane or 2-bromo-
2, 2-dinitroethanol gave the 1, 3-oxazines (2) (R = Me, Br).  Similar reaction of 
(1) with oxalamide and succinamide gave the bis (oxazinyl) diamides (3) (X = 
bond, CH2CH2) and reaction of 2-aminoethanol with formaldehyde and 
benzotriazole gave the oxazolylmethylbenzotriazole. (Fig. B.1.19) 
 
 
 
 
 
 
 
Furthermore they 250 reported that the reactions of RH (RH = isatin, 
benzotriazole, and succinimide) with formaldehyde and methylamine yield 
monoamines (RCH2N(Me)CH2R) and methylenediamines. 
(RCH2N(Me)CH2N(Me)CH2R)  The use of ethylenediamine as the amino 
component affords N, N'-disubstituted imidazolidines, while the reactions with 
3-aminopropanol give N-substituted tetrahydro-1, 3-oxazines.  RCH2NBui2 
was obtained from succinimide, formaldehyde, and diisobutylamine.  
Nitrosative cleavage of the amines obtained was studied: monoamines and 
methylenediamines give N-nitrosoamines. (RCH2N(NO)Me) RCH2NBui2 
affords diisobutylnitrosamine, while imidazolidines transform into dinitroso 
compounds. (RCH2N(NO)CH2CH2N(NO)CH2R) (Fig. B.1.20) 
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Mesropyan et. al. 251 synthesized new N-derivatives of isatin by treating 
ethyl- chloroacetate, N-(2-chloroethyl) morpholine, and 1, 4-
bis(chloromethyl)benzene with isatin sodium salt.  N-derivatives of isatin and 
5-bromoisatin were also prepared by Mannich reaction. (Fig. B.1.21) 
 
 
 
 
 
 
 
Mogilaiah et. al. 252 disclosed a conventional method for the 
preparation of the Mannich base of 3-[3-(p-chlorophenyl)-1, 8-naphthyridin-2-
ylhydrazono]-2-indolinones using formaldehyde and piperidine. The starting 
material was prepared by the condensation of 2-hydrazino-3-(p-chlorophenyl)-
1, 8-naphthyridine and 3-phenylimino-2-indolinones. (Fig. B.1.22) 
 
 
 
 
 
 
 
 
 
 
Yogeeswari et. al. 253 synthesized Mannich bases of gatifloxacin by 
reacting them with formaldehyde and several isatin derivatives. (Fig. B.1.23) 
 
Sriram et. al. 254 reported the synthesis of various aminopyrimidinimino 
isatin derivatives which was achieved in two steps. First step consists 
condensation of 5-bromo isatin and 5-(3, 4, 5-trimethoxybenzyl) pyrimidine-
2,4-diamine followed by Mannich reaction using formaldehyde and various 
secondary amines (R'). (Fig. B.1.24) 
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A new class of 4-aminoquinoline derivatives based on the natural 
product isatin scaffold were designed and synthesized using Mannich reaction 
on isatin and isatin thiosemicarbozones by Chiyanzu et. al. 215 (Fig. B.1.25) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. B.1.23
Fig. B.1.24
Fig. B.1.25
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Sriram et. al. 255 synthesized some 7-substituted ciprofloxacin 
derivatives by Mannich reaction using ciprofloxacin, formaldehyde and 
differently substituted isatin and its derivatives. (Fig. B.1.26) 
 
 
 
 
 
 
 
 
 
Mohamed et. al. 256 prepared N-Mannich bases of phthalimide, isatin, 
5-fluoroisatin, 5-chloroisatin, diphenylamine and succinimide using 
formaldehyde and 8-Hydroxyquinoline to give title compounds. (Fig. B.1.27) 
 
 
  
 
 
 
 
 
Ravichandran et. al. 257 prepared a series of 2, 3-dihydro-2-oxo-1, 3-
disubstituted indoles by the reaction of 2, 3-dihydro-2-oxo-3-substituted 
indoles with 2-[(2, 6-dichlorophenyl) amino] phenylacetic acid in the presence 
of formaldehyde. The title compounds were synthesized in two steps. First 
step consists condensation of substituted amine and isatin while second step 
involves Mannich reaction using formaldehyde and 2-[(2, 6-dichlorophenyl) 
amino] phenylacetic acid. (Fig. B.1.28) 
 
Where, R = 4-chloroaniline, 4-amino benzene sulphonamide, 4-amino 
benzoic acid, 2-amino benzoic acid, Phenyl hydrazine. 
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Esmaeili et. al. 258 prepared N-Mannich bases of isatin by refluxing 
isatin, formaldehyde and secondary amine in tetrahydrofuran. 
 
Tiwari et. al. 259 synthesized 5-substituted-3-{4'-(3''-chlorobenzyloxy)-
benzoyl hydrazono}-2-indolinones by the condensation of 4-(3'-
chlorobenzyloxy)-benzoylhydrazine and 5-substituted isatins. Mannich 
reaction in the presence of formaldehyde and heterocyclic secondary amines 
on indolinones furnished 1-aminomethyl-5-substituted-3-{4'-(3''-
chlorobenzyloxy)-benzoyl hydrazono}-2-indolinones. (Fig. B.1.29) 
 
Where, R1 = H, Me, Br, Cl 
R2 = Morpholine, Piperidine, Pyrrolidine, N-Me-Piperazine 
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Bekircan and Bektas 260 reported preparation of Schiff base of 
substituted isatins and substituted 4-amino-4, 5-dihydro-1H-1, 2, 4-triazole-5-
ones which afterwards underwent Mannich reaction using piperidine and 
formaldehyde to give title compounds. (Fig. B.1.30) (R = 2-fluoro aniline and 
4-fluoro aniline, X = H, Cl) 
 
 
 
 
 
 
 
 
 
 
 
B.7   BIOLOGICAL ACTIVITIES ASSOCIATED WITH ISATINS 
 
Several isatin derivatives are showing excellent pharmacological 
profiles. Following biological activities are reported for isatins developed by 
various research groups and explored. 
 
1 CNS depressant activities 261-263 
2 Anticonvulsant activity 264-295             
3 Anxiogenic and other CNS activities 296-302             
4 Antimicrobial activity 303-329               
5 Anticancer activity 330-340               
6 Antiplasmodial activity 341, 342               
7 Antitubercular activity 343-345               
8 Inhibitor of glucose, aminoacid uptake 346, 347             
9 Isatin derivatives as serine protease inhibitors 348            
10 Isatin derivatives as SARS (Severe Acute Respiratory Syndrome) 
coronavirus 3CL protease inhibitors 349             
11 Isatin derivatives as oxytosin receptor antagonists 350           
Fig. B.1.30
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12 Isatin analogs with potent galanin GAL3 receptor binding affinity 351     
13 Isatin derivatives as ADAMTS-5 (Aggrecanase-2) inhibitors 352          
14 Antileshmanial activity 353 
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3.1   AIM OF CURRENT WORK 
 
Isatin has been known for about 150 years and their derivatives 
constitute a class of biologically active heterocycles which have been found 
associated with antiviral, antibacterial, anthelmintic, amoebicidal, antifungal, 
anti-HIV, anticonvulsant, antileukemic, antifertility, herbicidal, antiinflammatory 
and CNS depressant derivatives. In addition to these cysticidal and 
hypotensive responses have also been reported in certain isatin derivatives. 
  
A large number of C-Mannich bases have been prepared and tested 
for analgesic, antispasmodic, anesthetic and antibacterial activity. Certain 
Mannich bases with complex amine moieties have shown pronounced 
antibacterial activity. Though considerable work has been reported on the 
synthesis and pharmacological activity of Mannich bases derived from 
compounds containing acidic hydrogen on carbon, only few examples of the 
Mannich reaction of compounds containing acidic hydrogen on a nitrogen 
atom are known and even fewer have been evaluated for their 
pharmacological action. 
  
Schiff bases and Mannich bases of isatin are known to possess a wide 
range of pharmacological properties including antibacterial, anti-HIV, 
anticonvulsant, antifungal and antiviral activity. This led us to synthesize some 
of the hitherto unreported N-Mannich bases of isatin along with their Schiff 
bases and to report their anticancer activity. Total reported synthesis is 
consisting of two steps where first step includes synthesis of isatin N-Mannich 
bases using secondary amines viz. morpholine, piperidine, 1-methyl 
piperazine, 1-ethyl piperazine and 1-benzyl piperazine while second step 
includes Schiff bases of these N-Mannich bases using 2-
propylpentanohydrazide and 2-amino-6-methoxy benzothiazole. Looking to 
the diversified biological profile shown by benzothiazoles one more scheme 
has been included in this chapter where Schiff bases of N-acetyl isatin have 
been prepared. 
 
Preparation of unreported and novel isatin derivatives and their 
biological evaluation was the rational behind the built up of this chapter. 
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3.2   REACTION SCHEMES 
 
3.2.1 PREPARATION OF METHYL-2-PROPYLPENTANOATE 
 
Reagents / Reaction Condition (a): Methanol, Con. H2SO4 / Reflux, 12-14 
hours. 
 
3.2.2 PREPARATION OF 2-PROPYLPENTANOHYDRAZIDE 
 
Reagents / Reaction Condition (b): Hydrazine hydrate / Reflux, 12-14 hours. 
 
3.2.3 PREPARATION OF ISATIN-N-MANNICH BASES 
 
 
 
 
 
 
 
 
 
Reagents / Reaction Condition (c): Isatin, 50% Ethanol, Formaldehyde (37-
41%) / 0-5°C. 
O
OH
CH3
CH3
CH3
CH3
O
O CH3
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CH3
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3.2.4 PREPARATION OF 2-AMINO BENZOTHIAZOLE 
 
Reagents / Reaction Condition (d): KSCN, Br2, Glacial acetic acid / 0-5°C. 
 
3.2.5 PREPARATION OF 3-((UN) SUBSTITUTED 1, 3-BENZOTHIAZOL-2-
YL IMINO)-1, 3-DIHYDRO-2H-INDOL-2-ONE 
 
Reagents / Reaction Condition (e): Isatin, Ethanol, Con. H2SO4 / Reflux, 4 
hours. 
 
3.2.6   SCHEME - 1 
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Reagents / Reaction Condition (f): 2-propylpentanohydrazide, Glacial acetic 
acid, Ethanol / Reflux, 5 hours. 
 
3.2.7   SCHEME - 2 
 
 
Reagents / Reaction Condition (g): 2-amino benzothiazole, Con. H2SO4, 
Ethanol / Reflux, 4 hours. 
 
3.2.8   SCHEME - 3 
  
 
Reagents / Reaction Condition (h): Acetic anhydride / Reflux, 5 hours. 
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3.3   REACTION MECHANISM 
 
3.3.1   SCHEME - 1 
 
 
3.3.2   SCHEME - 2 
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3.3.3   SCHEME - 3 
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LG = Leaving Group
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3.4   EXPERIMENTAL 
 
3.4.1 PREPARATION OF METHYL 2-PROPYLPENTANOATE 
 
0.01 mole of 2-propyl pentanoic acid was charged into 250 ml round 
bottom flask. 15 ml of methanol was added into above flask. 3-4 drops of Con. 
Sulphuric acid was added as a catalyst. The reaction mixture was refluxed for 
12-14 hours on water bath. The progress and the completion of the reaction 
were checked by silica gel-G F254 thin layer chromatography using hexane : 
ethyl acetate (4 : 6) as a mobile phase. After the reaction to be completed 
excess of methanol was removed under reduced pressure. The separated 
product was extracted using ethyl acetate (30 ml X 3), the combined organic 
layer was washed using 5% sodium bicarbonate solution (20 ml X 2) followed 
by water (20 ml X 2). The organic layer was dried on anhydrous sodium 
sulphate and the solvent was removed under reduced pressure to acquire the 
product in a viscous liquid form. Yield - 90 %, B. P. - 190-195°C. 
 
3.4.2 PREPARATION OF 2-PROPYLPENTANOHYDRAZIDE 
 
0.01 mole of methyl 2-propylpentanoate was charged into 250 ml round 
bottom flask. 15 ml of hydrazine hydrate was added into above flask. The 
reaction mixture was refluxed on water bath for 12-14 hours. The progress 
and the completion of the reaction were checked by silica gel-G F254 thin layer 
chromatography using hexane : ethyl acetate (4 : 6) as a mobile phase. After 
the reaction to be completed, the mixture was cooled to room temperature to 
give 2-propylpentanohydrazide as a white coloured shining fluffy product. 
Yield - 60 %, M. P. - 120-122°C. 
 
3.4.3 PREPARATION OF ISATIN-N-MANNICH BASES 
 
It was prepared according to the method described by Varma and 
Nobles. a To slurry consisting of 0.04 mole of isatin, 5 ml 50% ethanol and 5 
ml formaldehyde solution (37-41%) was added 0.04 mole of the desired 
                                                 
a R. S. Varma and W. L. Nobles; J. Het. Chem., 1966, 3(4), 462. 
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secondary amine, drop wise, with cooling and shaking. The reaction mixture 
was allowed to stand at room temperature for one hour with occasional 
shaking after which it was warmed on a steam bath for 15 minutes. At the end 
of this period the contents were cooled and the product thus separated was 
filtered and recrystallized from ethanol. 
 
Code Substitution R1 & R2 
MF MW  (g/m) 
MP  
(°C) 
%  
Yield 
IMB-01 Morpholine C13H14N2O3 246 202-204 b 70 
IMB-02 Piperidine C14H16N2O2 244 146-148 c 65 
IMB-03 1-Methyl Piperazine C14H17N3O2 259  178-180 67 
IMB-04 1-Ethyl Piperazine C15H19N3O2 273  192-194 63 
IMB-05 1-Benzyl Piperazine C20H21N3O2 335 128-130 d 60 
 
3.4.4 PREPARATION OF 2-AMINO BENZOTHIAZOLES 
 
It was prepared according to the method described by Stuckwisch. e To 
a solution of 0.2 mole of an appropriate amine and 0.8 mole of potassium 
thiocyanate in 360 ml of glacial acetic acid was added drop wise, with stirring, 
0.2 mole of bromine dissolved in 150 ml of glacial acetic acid while the 
temperature was kept below 35 °C. After all the bromine solution had been 
added, the mixture was stirred for ten hours and was then filtered and the 
residue washed with water. The combined filtrate and washings were 
neutralized with ammonium hydroxide. The precipitate was collected on a 
filter and dried. This material was pure enough for subsequent reactions. 
Further purification was most readily carried out by recrystallization from a 
mixture composed of equal volumes of concentrated hydrochloric acid and 
95% ethanol. The hydrochloride thus obtained was dissolved in water and the 
free base was precipitated with sodium carbonate. The recovery of 2-amino 
benzothiazole was nearly quantitative. 
 
                                                 
b Reported : 203-205°C; A. A. Esmaeili, S. Amini and A. Bodaghi; Synlett,  2007, 9, 1452. 
c Reported : 147-148°C; R. S. Varma and I. A. Khan; Nat. Acad. Sci. Lett., 1979, 2(4), 137. 
d Reported : 128-129°C; F. Collino and S. Volpe; Boll. Chim. Farmace., 1982, 121(5), 221. 
e C. G. Stuckwisch; J. Am. Chem. Soc., 1949, 71, 3417. 
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Code Substitution R MF 
MW 
(g/m) 
MP 
(°C) 
%  
Yield 
ABT-01 4-H C7H6N2S 150 126-128 79 
ABT-02 4-OCH3 C8H8N2OS 180 166-168 83 
ABT-03 4-Cl C7H5ClN2S 184 200-202 80 
ABT-04 4-F C7H5FN2S 168 182-184 81 
ABT-05 4-NO2 C7H5N3O2S 195 248-250 77 
 
3.4.5 PREPARATION OF 3-((UN) SUBSTITUTED 1, 3-BENZOTHIAZOL-2-
YL IMINO)-1, 3-DIHYDRO-2H-INDOL-2-ONE 
 
It was prepared according to the method reported by Chohan et. al. f 
To a stirred solution of 0.01 mole of an appropriately substituted 2-amino 
benzothiazole in 50 ml warm ethanol was added 0.01 mole 1H-indole-2, 3-
dione in 60 ml ethanol. Then 2–3 drops of conc. sulphuric acid were added 
and the reaction mixture was refluxed for 4 hours. The progress and the 
completion of the reaction were checked by silica gel-G F254 thin layer 
chromatography using hexane : ethyl acetate (6 : 4) as a mobile phase. After 
the reaction to be completed, the flask was cooled to afford a solid product. 
The solid residue was filtered, washed with cold ethanol, then with ether and 
dried. Recrystallization was carried out from hot ethanol. 
 
Code No. SubstitutionR MF 
MW  
(g/m) 
MP  
(°C) 
%  
Yield 
DNJ-1500-A 4-H C15H9N3OS 279 164-166 55 
DNJ-1500-B 4-OCH3 C16H11N3O2S 309 188-190 57 
DNJ-1500-C 4-Cl C15H8ClN3OS 313 194-198 51 
DNJ-1500-D 4-F C15H8FN3OS 297 190-192 56 
DNJ-1500-E 4-NO2 C15H8N4O3S 324 208-210 50 
 
                                                 
f Z. H. Chohan, H. Pervez, A. Rauf, K. M. Khan, C. T. Supuran; J. Enz. Inhib. and Med. 
Chem., 2004, 19 (5), 417. 
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3.4.6 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-1301 
TO DNJ-1305 
 
To a stirred solution of 0.01 mole of 2-propylpentanohydrazide in 50 ml 
warm ethanol was added 0.01 mole of an appropriate N-Mannich base of 
isatin in 60 ml ethanol. Then 2–3 drops of glacial acetic acid were added and 
the reaction mixture was refluxed for 5 hours. The progress and the 
completion of the reaction were checked by silica gel-G F254 thin layer 
chromatography using toluene : ethyl acetate (7 : 3) as a mobile phase. After 
the reaction to be completed, the flask was cooled to afford a solid product. 
The solid residue was filtered, washed with cold ethanol and dried. 
Recrystallization was carried out from hot ethanol. (Physical data of the 
synthesized end products are summarized in the table 3.5.1) 
 
3.4.7 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-1401 
TO DNJ-1405 
 
It was again prepared by the method described by Chohan et. al. f To a 
stirred solution of 0.01 mole of 2-amino benzothiazole in 50 ml warm ethanol 
was added 0.01 mole an appropriate Mannich base of isatin in 60 ml ethanol. 
Then 2–3 drops of concentrated sulphuric acid were added and the reaction 
mixture was refluxed for 4 hours. The progress and the completion of the 
reaction were checked by silica gel-G F254 thin layer chromatography using 
hexane : ethyl acetate (6 : 4) as a mobile phase. After the reaction to be 
completed, the flask was cooled to afford a solid product. The solid residue 
was filtered, washed with cold ethanol, then with ether and dried. 
Recrystallization was carried out from hot ethanol. (Physical data of the 
synthesized end products are summarized in the table 3.5.2) 
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3.4.8 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-1501 
TO DNJ-1505 
 
It was prepared according to the method described by Jacobs et. al. g 
0.01 mole of an appropriate Schiff base of isatin was charged into 50 ml round 
bottom flask. 3.5 ml acetic anhydride was added into it and the reaction 
mixture was refluxed for 4 hour with constant stirring. The progress and the 
completion of the reaction were checked by silica gel-G F254 thin layer 
chromatography using toluene : ethyl acetate (7 : 3) as a mobile phase. After 
the reaction to be completed, the flask was cooled to give desired product, 
which was washed with diethyl ether and dried. Recrystallization was carried 
out from methanol. (Physical data of the synthesized end products are 
summarized in the table 3.5.3) 
 
 
 
                                                 
g T. L. Jacobs, S. Winstein, G. B. Linden, J. H. Robson, E. F. Levy and D. Seymour; Org. 
Synth., 1948, 28, 70. 
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3.5   PHYSICAL DATA TABLES  
 
3.5.1 Physical data of N'-{1-[(substituted-1-yl) methyl]-2-oxo-1, 2-
dihydro-3H-indol-3-ylidene}-2-propylpentanohydrazide (DNJ-1301 
to DNJ-1305) 
 
 
 
 
 
 
 
 
 
 
Code Substitution R1 & R2 
MF MW (g/m) 
MP 
(°C) Rf 
% 
Yield 
DNJ-1301 Morpholine C21H30N4O3 386 180-182 0.43 71 
DNJ-1302 Piperidine C22H32N4O2 384 176-178 0.41 69 
DNJ-1303 1-Methyl Piperazine C22H33N5O2 399 204-206 0.44 67 
DNJ-1304 1-Ethyl Piperazine C23H35N5O2 413 222-224 0.48 70 
DNJ-1305 1-Benzyl Piperazine C28H37N5O2 475 190-192 0.55 65 
 
Rf value was calculated using solvent system = Toluene : Ethyl Acetate 
(7 : 3) 
 
N
N
O
N
R2
R1
NH
O
C3H7
C3H7
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3.5.2 Physical data of 3-(1, 3-benzothiazol-2-ylimino)-1-(substituted-4-
ylmethyl)-1, 3-dihydro-2H-indol-2-one (DNJ-1401 to DNJ-1405) 
 
 
 
 
 
 
 
 
 
 
Code SubstitutionR1 & R2 
MF MW (g/m) 
MP 
(°C) Rf 
% 
Yield 
DNJ-1401 Morpholine C20H18N4O2S 378 230-232 0.40 60 
DNJ-1402 Piperidine C21H20N4OS 376 210-212 0.43 58 
DNJ-1403 1-Methyl Piperazine C21H21N5OS 391 196-198 0.45 63 
DNJ-1404 1-Ethyl Piperazine C22H23N5OS 405 234-236 0.49 65 
DNJ-1405 1-Benzyl Piperazine C27H25N5OS 467 200-202 0.56 57 
 
Rf value was calculated using solvent system = Hexane : Ethyl Acetate (6 
: 4) 
 
N
N
O
N
R2
R1
N
S
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3.5.3 Physical data of 1-acetyl-3-[((un)substituted-1, 3-benzothiazol-2-
yl)imino]-1, 3-dihydro-2H-indol-2-one (DNJ-1501 to DNJ-1505) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code SubstitutionR MF 
MW 
(g/m) 
MP 
(°C) Rf 
% 
Yield 
DNJ-1501 4-H C17H11N3O2S 321 178-180 0.36 57 
DNJ-1502 4-OCH3 C18H13N3O3S 351 172-174 0.39 65 
DNJ-1503 4-Cl C17H10ClN3O2S 355 216-218 0.37 63 
DNJ-1504 4-F C17H10FN3O2S 339 198-200 0.34 58 
DNJ-1505 4-NO2 C17H10N4O4S 366 204-206 0.38 60 
 
Rf value was calculated using solvent system = Toluene : Ethyl Acetate 
(7 : 3) 
 
N
N
O
CH3
N
S
O
R
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3.6   SPECTRAL DISCUSSION 
 
3.6.1   MASS SPECTRAL STUDY 
 
Mass spectra of the synthesized compounds were recorded on 
Shimadzu GC-MS QP-2010 model using direct injection probe technique. 
The molecular ion peak was found in agreement with molecular weight of the 
respective compound. Characteristic M+2 ion peaks with one-third intensity of 
molecular ion peak were observed in case of compounds having chlorine 
atom. Fragmentation pattern can be observed to be particular for these 
compounds and the characteristic peaks obtained for each compound. 
Probable fragmentation pattern for DNJ-1301, DNJ-1401 and DNJ-1501 can 
be discussed as under. 
 
N'-1-(morpholin-4-ylmethyl)-2-oxo-1, 2-dihydro-3H-indol-3-ylidene]-2-
propylpentanohydrazide (DNJ-1301) 
 
1. The target compound showed characteristic molecular ion peak. 
2. C7-N4 bond cleavage gave characteristic peak at 299 m/e. [1] 
3. C7-N8 bond cleavage gave two characteristic peaks at 287 m/e and 100 
m/e (base peak). [2] 
4. After C7-N8 bond cleavage, C27-C28 bond cleavage and subsequently 
C24-C25 bond cleavage gave characteristic peaks at 272 m/e and 259 
m/e respectively. [3] & [4] 
5. After C27-C28 and C24-C25 bond cleavages, C26-C27 bond cleavage and 
subsequently C23-C24 bond cleavage gave two characteristic peaks at 
245 m/e and 216 m/e respectively. [5] & [6] 
6. After C26-C27 and C23-C24 bond cleavages, C20-C22 bond cleavage and 
subsequently C20-C21 bond cleavage gave two characteristic peaks at 
188 m/e and 175 m/e respectively. [7] & [8] 
7. After C20-C22 and C20-C21 bond cleavages, N19-C20 bond cleavage gave 
characteristic peak at 160 m/e. [9] 
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8. After N19-C20 bond cleavage, N18-N19 bond cleavage gave 
characteristic peak at 147 m/e. [10] 
9. After N18-N19 bond cleavage, C10-N18 bond cleavage gave 
characteristic peak at 132 m/e. [11] 
10. After C10-N18 bond cleavage, C9-O17 bond cleavage gave characteristic 
peak at 119 m/e. [12] 
 
 
3.6.1.1   FRAGMENTATION PATTERN FOR DNJ-1301 
 
 
 
 
3-(1, 3-benzothiazol-2-ylimino)-1-(morpholin-4-ylmethyl)-1, 3-dihydro-2H-
indol-2-one (DNJ-1401) 
 
1. The target compound showed characteristic molecular ion peak. 
2. C21-N13 bond cleavage gave two characteristic peaks at 279 m/e and 
104 m/e. [1] 
3. O25-C24 and O25-C26 bond cleavages gave characteristic peak at 365 
m/e. [2] 
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4. After O25-C24 and O25-C26 bond cleavages, C23-C24 bond cleavage gave 
characteristic peak at 353 m/e. [3] 
5. After C23-C24 bond cleavage, C26-C27 bond cleavage gave 
characteristic peak at 333 m/e. [4] 
6. After C26-C27 bond cleavage, N22-C23 bond cleavage gave 
characteristic peak at 318 m/e. [5] 
7. After N22-C23 bond cleavage, N22-C27 bond cleavage gave 
characteristic peak at 307 m/e. [6] 
8. After N22-C27 bond cleavage, C21-N22 bond cleavage gave 
characteristic peak at 290 m/e (base peak). [7] 
9. After C21-N22 bond cleavage, N13-C21 bond cleavage gave 
characteristic peak at 279 m/e. [8] 
10. C2-N10 bond cleavage gave two characteristic peaks at 249 m/e and 
132 m/e. [9] 
11. After C2-N10 bond cleavage, N10-C11 bond cleavage gave characteristic 
peak at 234 m/e. [10] 
12. After N10-C11 bond cleavage, O25-C24 and O25-C26 bond cleavages gave 
characteristic peak at 213 m/e. [11] 
13. After O25-C24 and O25-C26 bond cleavages, C23-C24 bond cleavage gave 
characteristic peak at 205 m/e. [12] 
14. After C23-C24 bond cleavage, C26-C27 bond cleavage gave 
characteristic peak at 186 m/e. [13] 
15. After C26-C27 bond cleavage, N13-C21 bond cleavage gave 
characteristic peak at 132 m/e. [14] 
16. After N13-C21 bond cleavage, C12-O20 bond cleavage gave 
characteristic peak at 121 m/e. [15] 
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3.6.1.2   FRAGMENTATION PATTERN FOR DNJ-1401 
 
 
 
 
1-acetyl-3-(1, 3-benzothiazol-2-ylimino)-1, 3-dihydro-2H-indol-2-one 
(DNJ-1501) 
 
1. The target compound showed characteristic molecular ion peak. 
2. C21-N13 bond cleavage gave characteristic peak at 278 m/e. [1] 
3. C2-N10 bond cleavage gave two characteristic peaks at 189 m/e (base 
peak) and 134 m/e. [2] 
4. After C2-N10 bond cleavage, C11-N10 bond cleavage gave characteristic 
peak at 176 m/e. [3] 
5. After C11-N10 bond cleavage, C21-C23 bond cleavage gave 
characteristic peak at 161 m/e. [4] 
6. After C21-C23 bond cleavage, C21-C22 bond cleavage gave 
characteristic peak at 146 m/e. [5] 
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7. After C21-C22 bond cleavage, N13-C21 bond cleavage gave 
characteristic peak at 134 m/e. [6] 
8. After N13-C21 bond cleavage, C12-O20 bond cleavage gave 
characteristic peak at 119 m/e. [7] 
 
3.6.1.3   FRAGMENTATION PATTERN FOR DNJ-1401 
 
 
 
3.6.2   IR SPECTRAL STUDY 
 
IR spectra of the synthesized compounds were recorded on Shimadzu 
FT IR 8400 spectrophotometer using Diffused Reflectance Attachment (DRA) 
System using Potassium Bromide.  
 
N-H stretching frequency was observed near 3430 cm-1 in case of DNJ-
1301 to DNJ-1305. There are two carbonyl groups present in all the 
compounds but due to the same environment, the peaks merged in the region 
of 1680 cm-1. C=N stretching frequency was observed near 1610 cm-1 in all 
the compounds. C-N stretching (2° & 3°) frequency was found DNJ-1301 to 
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DNJ-1305 while rests of the compounds showed only C-N stretching (3°) 
frequency. C-H stretching frequencies were observed between 2810 cm-1 and 
2970 cm-1, while ring skeleton frequencies were observed near 1460 cm-1 in 
all the compounds. 
  
Characteristic frequencies for p-di substitution were observed in DNJ-
1502, DNJ-1503, DNJ-1504 and DNJ-1505. C-X (X = Cl, F) stretching 
frequencies were obtained in DNJ-1503 and DNJ-1504 while DNJ-1502 
showed characteristic C-O-C stretching frequency. DNJ-1301 and DNJ-1401 
also showed C-O-C stretching frequency. 
 
 
3.6.3   1H & 13C NMR SPECTRAL STUDY 
 
1H & 13C NMR spectra of the synthesized compounds were recorded 
on Bruker Avance II 400 spectrometer. Sample solutions were made in 
CDCl3 solvent using tetramethylsilane (TMS) as the internal standard unless 
otherwise mentioned. Numbers of protons and numbers of carbons identified 
from proton NMR & carbon NMR spectrum and their chemical shift (δ ppm) 
were in the agreement of the structure of the molecule. J values were 
calculated to identify o, m and p coupling. In some cases, aromatic protons 
were obtained as multiplet. 1H & 13C NMR spectral interpretation can be 
discussed as under. 
 
1H NMR spectral interpretation of N'-[1-(morpholin-4-ylmethyl)-2-oxo-1, 
2-dihydro-3H-indol-3-ylidene]-2-propylpentanohydrazide (DNJ-1301) 
 
1. Four protons of C23 and C26 in the hydrazide linkage gave multiplet at 
1.79 δ ppm. While another four protons of C24 and C27gave quartet at 
1.53 δ ppm. Six protons of two methyl groups C25 and C28 should 
showed triplet at 1.37 δ ppm. 
2. Another four protons of morpholinyl methylene groups (C3 & C5) and 
one proton of C22 gave multiplet at 2.90 δ ppm. Due to the nitrogen 
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atmosphere, four protons of methylene groups flipped individually and 
peaks got merged. 
3. Four protons of two morpholinyl methylene groups (C2 & C6) gave 
quintet at 3.69 δ ppm. 
4. Two protons of methylene group (C7) attached to two nitrogen atoms of 
indolinone and morpholine ring gave singlet at 4.48 δ ppm. 
5. There are four aromatic protons in the molecule. One proton of C13 
gave quintet (triplet-doublet) at 7.15 δ ppm. One proton of C15 gave 
quartet at 7.39 δ ppm while one proton of C14 gave doublet at 7.62 δ 
ppm. Rest of the proton of C16 gave doublet at 7.80 δ ppm. 
6. One most deshielded proton of secondary amine in hydrazide linkage 
(-NH) gave singlet in the down field at 12.52 δ ppm. 
 
13C NMR spectral interpretation of N'-[1-(morpholin-4-ylmethyl)-2-oxo-1, 
2-dihydro-3H-indol-3-ylidene]-2-propylpentanohydrazide (DNJ-1301) 
 
1. Two most shielded methyl carbons of n-propyl chain (C25 & C28) 
showed peak at 14.07 δ ppm. 
2. Two methylene carbons of n-propyl chain (C24 & C27) showed peak at 
20.68 δ ppm. 
3. Another two methylene carbons (C23 & C26) showed peak at 34.58 δ 
ppm. 
4. Methine carbon of hydrazide linkage (C22) showed peak at 51.00 δ 
ppm. 
5. Two methylene carbons (C3 & C5) of morpholinyl ring gave peak at 
51.94 δ ppm. While another two methylene carbons of morpholinyl ring 
(C2 & C6) showed peak at 66.92 δ ppm. 
6. Methylene carbon (C7) attached to both the nitrogen of indole nucleus 
and morpholine nucleus gave peak at 66.59 δ ppm. 
7. Peaks obtained at 76.89, 77.21, 77.53 δ ppm are due to the solvent 
CDCl3. 
8. Peaks obtained at 110.44, 119.53, 119.95, 120.33, 136.04 and 143.19 
δ ppm are due to the aromatic carbons C13, C15, C16, C11, C14 and C12 
respectively. 
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9. Peak obtained at 161.61 δ ppm is due to the azomethine carbon C10. 
10. Carbonyl carbon (C9) of indolinone ring became deshielded due to the 
adjacent nitrogen atom and showed peak in down field at 173.69 δ 
ppm. 
11. Carbonyl carbon of amide group in hydrazide linkage (C20) became 
most deshielded and showed peak in down field at 179.30 δ ppm. 
 
 
1H NMR spectral interpretation of 3-(1, 3-benzothiazol-2-ylimino)-1-
(morpholin-4-ylmethyl)-1, 3-dihydro-2H-indol-2-one (DNJ-1401) 
 
1. Four protons of two methylene groups (C23 & C27) of morpholine ring 
gave triplet at 2.36 δ ppm. 
2. Another four protons of two methylene groups (C24 & C26) of 
morpholine ring gave triplet at 2.60 δ ppm. 
3. Two protons of methylene group (C21) gave singlet at 3.76 δ ppm. 
4. Rests of the peaks are due to the aromatic protons which are obtained 
as multiplet and are in the agreement of the structure of the molecule. 
Two protons of C7 and C19 gave quintet at 6.97 δ ppm. Two protons of 
C8 and C18 gave triplet at 7.11 δ ppm, while one proton of C16 gave 
multiplet at 7.33 δ ppm. Rests of the three protons of C6, C9 and C17 
gave multiplet at 7.43 δ ppm. 
 
13C NMR spectral interpretation of 3-(1, 3-benzothiazol-2-ylimino)-1-
(morpholin-4-ylmethyl)-1, 3-dihydro-2H-indol-2-one (DNJ-1401) 
 
1. Two methylene carbons (C23 & C27) of morpholinyl ring gave peak at 
46.55 δ ppm. While another two methylene carbons of morpholinyl ring 
(C24 & C26) showed peak at 66.89 δ ppm. 
2. Methylene carbon (C21) attached to both the nitrogen of indole nucleus 
and morpholine nucleus gave peak at 66.66 δ ppm. 
3. Peaks obtained at 76.89, 77.21, 77.53 δ ppm are due to the solvent 
CDCl3. 
Chapter – 3                                                                    Preparation of small library….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                        170 
 
4. Peaks obtained at 110.50, 119.55, 119.94, 120.30, 121.71, 123.28, 
123.61, 132.01, 136.04, 143.22 and 162.32 δ ppm are due to the 
aromatic carbons C19, C16, C15, C9, C17, C6, C7, C8, C5, C18, C14 and C4 
respectively. 
5. Azomethine carbon (C11) gave peak at 161.61 δ ppm. 
6. Carbonyl carbon (C12) of indolinone ring became deshielded due to the 
adjacent nitrogen atom and showed peak in the down field at 173.69 δ 
ppm. 
7. C2 carbon of thiazole ring became most deshielded due to the 
neighboring two nitrogen atoms and showed peak in the down field at 
179.32 δ ppm. 
 
 
1H NMR spectral interpretation of 1-acetyl-3-(1, 3-benzothiazol-2-
ylimino)-1, 3-dihydro-2H-indol-2-one (DNJ-1501) 
 
1. Three shielded protons of methyl group (C23) gave singlet in the up 
field at 3.77 δ ppm. 
2. Rests of the peaks are due to the aromatic protons which are obtained 
as multiplet and are in the agreement of the structure of the molecule. 
Two protons of C7 and C17 gave quintet at 6.97 δ ppm. Two protons of 
C8 and C18 gave triplet at 7.11 δ ppm, while another two protons of C6 
and C9 gave multiplet at 7.33 δ ppm. Rests of the two protons of C16 
and C19 gave multiplet at 7.43 δ ppm. 
 
13C NMR spectral interpretation of 1-acetyl-3-(1, 3-benzothiazol-2-
ylimino)-1, 3-dihydro-2H-indol-2-one (DNJ-1501) 
 
1. Methyl group (C23) attached to the carbonyl group (C21) became most 
shielded and showed peak at 20.68 δ ppm in the up field. 
2. Peaks obtained at 76.91, 77.23, 77.51 δ ppm are due to the solvent 
CDCl3. 
3. Peaks obtained at 119.95, 120.33, 121.71, 123.28, 123.61, 130.80, 
131.36, 132.01, 136.08, 140.04, 146.08 and 146.58 δ ppm are due to 
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the aromatic carbons C9, C6, C16, C19, C7, C8, C17, C15, C18, C5, C14 and 
C4 respectively. 
4. Azomethine carbon (C11) gave peak at 152.69 δ ppm. 
5. Two carbonyl carbons (C12 & C21) of indolinone ring became 
deshielded due to the neighboring nitrogen atom and showed peak in 
the down field at 161.59 and 162.30 δ ppm respectively. 
6. C2 carbon of thiazole ring became most deshielded due to the 
neighboring two nitrogen atoms and showed peak in the down field at 
179.34 δ ppm. 
 
 
 
3.6.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on 
Vario EL Carlo Erba 1108 which showed calculated and found percentage 
values of Carbon, Hydrogen and Nitrogen in support of the structure of 
synthesized compounds. The spectral and elemental analysis data are given 
for individual compounds. 
Chapter – 3                                                                    Preparation of small library….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                        172 
 
 
3.7   ANALYTICAL DATA 
 
N'-[1-(MORPHOLIN-4-YL METHYL)-2-OXO-1, 2-DIHYDRO-3H-INDOL-3-
YLIDENE]-2-PROPYLPENTANOHYDRAZIDE (DNJ-1301): IR (KBr, cm-1): 
3432 (-NH), 2955 (-CH3), 2862 (-CH2), 1680 (>CO), 1610 (-C=N), 1458 (Ar-H, 
ben), 1311 (C-N, Ar, 2°), 1213 (C-N, Aliphatic, 3°), 1050 (C-O-C); 1H NMR 
(400 MHz, CDCl3): δ (ppm) 1.37 (6H, t), 1.53 (4H, qt), 1.79 (4H, m), 2.90 (4H, 
m), 3.69 (4H, q), 4.48 (2H, s), 7.15 (1H, q, J = 7.92 Hz), 7.39 (1H, qt), 7.62 
(1H, d, J = 7.28 Hz), 7.80 (1H, d, J = 7.36 Hz), 12.52 (1H, s); 13C NMR (400 
MHz, CDCl3): δ (ppm) 179.30, 173.69, 161.61, 143.19, 136.04, 120.33, 
119.95, 119.53, 110.44, 66.92, 66.59, 51.94, 51.00, 34.58, 20.68, 14.07; MS 
m/z = 386 (M+); Anal. Calcd. for C21H30N4O3: C, 65.26; H, 7.82; N, 14.50. 
Found: C, 65.21; H, 7.85; N, 14.47. 
 
N'-[2-OXO-1-(PIPERIDIN-1-YL METHYL)-1, 2-DIHYDRO-3H-INDOL-3-
YLIDENE]-2-PROPYLPENTANOHYDRAZIDE (DNJ-1302): IR (KBr, cm-1): 
3430 (-NH), 2957 (-CH3), 2859 (-CH2), 1682 (>CO), 1608 (-C=N), 1460 (Ar-H, 
ben), 1309 (C-N, Ar, 2°), 1210 (C-N, Aliphatic, 3°), 1055 (C-O-C); MS m/z = 
384 (M+); Anal. Calcd. for C22H32N4O2: C, 68.72; H, 8.39; N, 14.57. Found: C, 
68.76; H, 8.43; N, 14.53. 
 
N'-{1-[(4-METHYL PIPERAZIN-1-YL) METHYL]-2-OXO-1, 2-DIHYDRO-3H-
INDOL-3-YLIDENE}-2-PROPYLPENTANOHYDRAZIDE (DNJ-1303): IR 
(KBr, cm-1): 3428 (-NH), 2962 (-CH3), 2854 (-CH2), 1679 (>CO), 1605 (-C=N), 
1464 (Ar-H, ben), 1311 (C-N, Ar, 2°), 1214 (C-N, Aliphatic, 3°), 1053 (C-O-C); 
MS m/z = 399 (M+); Anal. Calcd. for C22H33N5O2: C, 66.14; H, 8.33; N, 17.53. 
Found: C, 66.10; H, 8.37; N, 17.50. 
 
N'-{1-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-2-OXO-1, 2-DIHYDRO-3H-
INDOL-3-YLIDENE}-2-PROPYLPENTANOHYDRAZIDE (DNJ-1304): IR 
(KBr, cm-1): 3431 (-NH), 2960 (-CH3), 2856 (-CH2), 1682 (>CO), 1607 (-C=N), 
1462 (Ar-H, ben), 1310 (C-N, Ar, 2°), 1212 (C-N, Aliphatic, 3°), 1051 (C-O-C); 
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MS m/z = 413 (M+); Anal. Calcd. for C23H35N5O2: C, 66.80; H, 8.53; N, 16.93. 
Found: C, 66.85; H, 8.57; N, 16.89. 
 
N'-{1-[(4-BENZYL PIPERAZIN-1-YL) METHYL]-2-OXO-1, 2-DIHYDRO-3H-
INDOL-3-YLIDENE}-2-PROPYLPENTANOHYDRAZIDE (DNJ-1305): IR 
(KBr, cm-1): 3429 (-NH), 2965 (-CH3), 2861 (-CH2), 1683 (>CO), 1610 (-C=N), 
1463 (Ar-H, ben), 1313 (C-N, Ar, 2°), 1210 (C-N, Aliphatic, 3°), 1050 (C-O-C); 
MS m/z = 475 (M+); Anal. Calcd. for C28H37N5O2: C, 70.71; H, 7.84; N, 14.72. 
Found: C, 70.66; H, 7.88; N, 14.76. 
 
3-[(6-METHOXY-1, 3-BENZOTHIAZOL-2-YL) IMINO]-1-(MORPHOLIN-4-YL 
METHYL)-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-1401): IR (KBr, cm-1): 
2956 (-CH3), 2859 (-CH2), 1683 (>CO), 1613 (-C=N), 1464 (Ar-H, ben), 1344 
(C-N, Ar, 3°), 1250, (C-S-C), 1212 (C-N, Aliphatic, 3°), 1049 (C-O-C); 1H NMR 
(400 MHz, CDCl3): δ (ppm) 2.36 (4H, t), 2.60 (4H, t), 3.76 (2H, s), 6.97 (2H, q, 
J = 0.6 Hz, J = 1.16 Hz), 7.11 (2H, t), 7.33 (1H, m, J = 1.68 Hz, J = 1.08 Hz, J 
= 1.92 Hz, J = 0.52 Hz), 7.43 (3H, m, J = 1.48 Hz, J = 2.24 Hz); 13C NMR (400 
MHz, CDCl3): δ (ppm) 179.32, 173.69, 162.32, 161.61, 143.22, 136.04, 
132.01, 123.61, 123.28, 121.71, 120.30, 119.94, 119.55, 110.50, 66.89, 
66.66, 46.55; MS m/z = 408 (M+); Anal. Calcd. for C21H20N4O3S: C, 61.75; H, 
4.94; N, 13.72. Found: C, 61.70; H, 4.90; N, 13.68. 
 
3-[(6-METHOXY-1, 3-BENZOTHIAZOL-2-YL) IMINO]-1-(PIPERIDIN-1-YL 
METHYL)-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-1402): IR (KBr, cm-1): 
2958 (-CH3), 2860 (-CH2), 1680 (>CO), 1610 (-C=N), 1466 (Ar-H, ben), 1340 
(C-N, Ar, 3°), 1248, (C-S-C), 1210 (C-N, Aliphatic, 3°); MS m/z = 406 (M+); 
Anal. Calcd. for C22H22N4O2S: C, 65.00; H, 5.46; N, 13.78. Found: C, 64.95; 
H, 5.50; N, 13.82. 
 
3-[(6-METHOXY-1, 3-BENZOTHIAZOL-2-YL) IMINO]-1-[(4-METHYL 
PIPERAZIN-1-YL) METHYL]-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-1403): 
IR (KBr, cm-1): 2962 (-CH3), 2856 (-CH2), 1681 (>CO), 1615 (-C=N), 1467 (Ar-
H, ben), 1341 (C-N, Ar, 3°), 1252, (C-S-C), 1214 (C-N, Aliphatic, 3°); MS m/z 
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= 421 (M+); Anal. Calcd. for C22H23N5O2S: C, 62.69; H, 5.50; N, 16.61. Found: 
C, 62.73; H, 5.44; N, 16.65. 
 
1-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-3-[(6-METHOXY-1, 3-
BENZOTHIAZOL-2-YL) IMINO]-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-
1404): IR (KBr, cm-1): 2959 (-CH3), 2854 (-CH2), 1685 (>CO), 1610 (-C=N), 
1466 (Ar-H, ben), 1342 (C-N, Ar, 3°), 1253, (C-S-C), 1214 (C-N, Aliphatic, 3°); 
MS m/z = 435 (M+); Anal. Calcd. for C23H25N5O2S: C, 63.43; H, 5.79; N, 16.08. 
Found: C, 63.40; H, 5.74; N, 16.03. 
 
1-[(4-BENZYL PIPERAZIN-1-YL) METHYL]-3-[(6-METHOXY-1, 3-
BENZOTHIAZOL-2-YL) IMINO]-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-
1405): IR (KBr, cm-1): 2961 (-CH3), 2856 (-CH2), 1683 (>CO), 1610 (-C=N), 
1466 (Ar-H, ben), 1344 (C-N, Ar, 3°), 1251, (C-S-C), 1214 (C-N, Aliphatic, 3°); 
MS m/z = 497 (M+); Anal. Calcd. for C28H27N5O2S: C, 67.58; H, 5.47; N, 14.07. 
Found: C, 67.54; H, 5.44; N, 14.10. 
 
1-ACETYL-3-(1, 3-BENZOTHIAZOL-2-YL IMINO)-1, 3-DIHYDRO-2H-INDOL-
2-ONE (DNJ-1501): IR (KBr, cm-1): 2956 (-CH3), 2858 (-CH2), 1683 (>CO), 
1609 (-C=N), 1464 (Ar-H, ben), 1342 (C-N, Ar, 3°), 1252, (C-S-C), 1213 (C-N, 
Aliphatic, 3°); 1H NMR (400 MHz, CDCl3): δ (ppm) 3.77 (3H, s), 6.97 (2H, m, J 
= 1.12 Hz, J = 0.80 Hz), 7.11 (2H, t), 7.33 (2H, m, J = 0.44 Hz, J = 1.28 Hz), 
7.43 (2H, m, J = 1.52 Hz, J = 1.44 Hz); 13C NMR (400 MHz, CDCl3): δ (ppm) 
179.34, 162.30, 161.59, 152.69, 146.58, 146.08, 140.04, 136.08, 132.01, 
131.36, 130.80, 123.61, 123.28, 121.71, 120.33, 119.95, 20.68; MS m/z = 321 
(M+); Anal. Calcd. for C17H11N3O2S: C, 63.54; H, 3.45; N, 13.08. Found: C, 
63.50; H, 3.41; N, 13.02. 
 
1-ACETYL-3-[(6-METHOXY-1, 3-BENZOTHIAZOL-2-YL) IMINO]-1, 3-
DIHYDRO-2H-INDOL-2-ONE (DNJ-1502): IR (KBr, cm-1): 2962 (-CH3), 2859 
(-CH2), 1681 (>CO), 1613 (-C=N), 1471 (Ar-H, ben), 1341 (C-N, Ar, 3°), 1252, 
(C-S-C), 1217 (C-N, Aliphatic, 3°), 1055 (C-O-C); MS m/z = 351 (M+); Anal. 
Calcd. for C18H13N3O3S: C, 61.53; H, 3.73; N, 11.96. Found: C, 61.57; H, 
3.77; N, 12.00. 
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1-ACETYL-3-[(6-CHLORO-1, 3-BENZOTHIAZOL-2-YL) IMINO]-1, 3-
DIHYDRO-2H-INDOL-2-ONE (DNJ-1503): IR (KBr, cm-1): 2960 (-CH3), 2856 
(-CH2), 1691 (>CO), 1612 (-C=N), 1467 (Ar-H, ben), 1339 (C-N, Ar, 3°), 1246, 
(C-S-C), 1209 (C-N, Aliphatic, 3°), 870 (C-Cl), 815 (1,4-di sub); MS m/z = 355 
(M+); Anal. Calcd. for C17H10ClN3O2S: C, 57.39; H, 2.83; N, 11.81. Found: C, 
57.43; H, 2.86; N, 11.86. 
 
1-ACETYL-3-[(6-FLUORO-1, 3-BENZOTHIAZOL-2-YL) IMINO]-1, 3-
DIHYDRO-2H-INDOL-2-ONE (DNJ-1504): IR (KBr, cm-1): 2958 (-CH3), 2860 
(-CH2), 1689 (>CO), 1610 (-C=N), 1470 (Ar-H, ben), 1340 (C-N, Ar, 3°), 1250, 
(C-S-C), 1215 (C-N, Aliphatic, 3°), 992 (C-F), 810 (1,4-di sub); MS m/z = 339 
(M+); Anal. Calcd. for C17H10FN3O2S: C, 60.17; H, 2.97; N, 12.38. Found: C, 
60.13; H, 2.93; N, 12.33. 
 
1-ACETYL-3-[(6-NITRO-1, 3-BENZOTHIAZOL-2-YL) IMINO]-1, 3-DIHYDRO-
2H-INDOL-2-ONE (DNJ-1505): IR (KBr, cm-1): 2955 (-CH3), 2850 (-CH2), 
1685 (>CO), 1613 (-C=N), 1463 (Ar-H, ben), 1339 (C-N, Ar, 3°), 1248, (C-S-
C), 1211 (C-N, Aliphatic, 3°), 812 (1,4-di sub); MS m/z = 366 (M+); Anal. 
Calcd. for C17H10N4O4S: C, 55.73; H, 2.75; N, 15.29. Found: C, 55.77; H, 
2.80; N, 15.33. 
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3.8   RESULTS AND DISCUSSION 
 
Mannich bases and Schiff bases of isatin were prepared in this 
chapter. Isatin is known to produce N-Mannich bases using formaldehyde and 
secondary amines while it is known to give 3-substiuted Schiff bases when 
reacted with primary amine.  
 
Isatin-N-Mannich bases were prepared using the known methodology 
and their Schiff bases were prepared using two different primary amine 
functional groups, one is 2-propylpentanohydrazide and another is 2-
aminobenzothiazole. 2-propylpentanohydrazide was prepared by reacting 
hydrazine hydrate with Methyl-2-propylpentanoate and 2-propylpentanoate 
was prepared by the esterification of 2-propylpentanoic acid which is also 
known as very well known anticonvulsant drug “Valproic acid”. 2-
aminobenzothiazoles also possess varied biological profile. Thus two 
biologically active components were substituted on isatin to study the 
biological activity profile of title compounds.  
 
Schiff base of isatin using 2-propylpenanohydrazide is not reported so 
far while Schiff base of isatin and 2-aminobenzothiazole is not much explored. 
Moreover Mannich bases of these Schiff bases are not reported so far. 
Furthermore acetylation was carried out on isatin-Schiff bases. Thus it is first 
attempt to prepare three different types of indolinone derivatives and their 
anticancer evaluation.  
 
The compounds prepared in this chapter possess indole nucleus and 
are basically indolinone derivatives. Indoles and indolinones are very well 
known for their anticancer activity. Thus all the compounds were screened for 
their anticancer activity against three different cancer cell lines. (viz. breast, 
lung and stomach) All the compounds found to be good to moderate active 
against all the three cancer cell lines. 
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3.9   CONCLUSION 
 
Indole nucleus is much known for its anticancer activity. Many naturally 
occurring indole alkaloids as well as synthetic indole molecules have shown 
pronounced anticancer activity as well as other biological profile too. 
Exploration of unreported chemistry and their biological activity was the aim 
behind the work done in this chapter.  
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3.10  SPECTRAL REPRESENTATION OF SYNTHESIZED 
COMPOUNDS 
 
3.10.1   Mass Spectrum of DNJ-1301 
 
 
3.10.2   IR Spectrum of DNJ-1301 
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3.10.3   1H NMR Spectrums of DNJ-1301 
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3.10.4   13C NMR Spectrum of DNJ-1301 
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3.10.5   Mass Spectrum of DNJ-1401 
 
 
 
 
3.10.6   IR Spectrum of DNJ-1401 
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3.10.7   1H NMR Spectrum of DNJ-1401 
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3.10.8   13C NMR Spectrum of DNJ-1401 
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3.10.9   Mass Spectrum of DNJ-1501 
 
 
3.10.10   IR Spectrum of DNJ-1501 
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3.10.11   1H NMR Spectrums of DNJ-1501 
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3.10.12   13C NMR Spectrum of DNJ-1501 
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4.1   INRODUCTION TO PYRAZOLE ALDEHYDES 
 
Pyrazole refers both to the class of simple aromatic ring organic 
compounds of the heterocyclic series characterized by a five-membered ring 
structure composed of three carbon atoms and two nitrogen atoms in adjacent 
positions and to the unsubstituted parent compound. Being so composed and 
having pharmacological effects on humans, they are classified as alkaloids, 
although they are rare in nature. 
 
The synthesis of pyrazoles remains of great interest owing to the wide 
applications in pharmaceutical and agrochemical industry due to their 
herbicidal, fungicidal, insecticidal, analgesic, antipyretic and anti-inflammatory 
properties. 1, 2 Some methods have been developed in recent years, though 
the most important method is the reaction between hydrazines and β-
dicarbonyl compounds. 3 This reaction involves the double condensation of 1, 
3-diketones or α, β-unsaturated ketones with hydrazine or its derivatives. 4, 5 
However, the appealing generality of this method is somewhat vitiated by the 
severe reaction conditions or the multistep sequences usually required to 
access the starting materials. 6 Thus, continuous efforts have been devoted to 
the development of more general and versatile synthetic methodologies for 
this class of compounds. 7 
 
The application of Vilsmeier–Haack (VH) reagent (POCl3 / DMF) for 
formylation of a variety of both aromatic and heteroaromatic substrates is well 
documented. 8 Besides this, the reagent has also been extensively used for 
effecting various chemical transformations from other classes of compounds. 
Many of these reactions have led to novel and convenient routes for the 
synthesis of various heterocyclic compounds. 9 A notable example that finds 
significant application in heterocyclic chemistry is the synthesis of 4-
formylpyrazoles from the double formylation of hydrazones with Vilsmeier-
Haack (VH) reagent. 10, 11 These observations, coupled with the recent 
developments on the simple synthesis of pyrazole derivatives, 1, 2 especially 
4-functionalized 1, 3-diphenylpyrazoles as antibacterial, [12] anti-
inflammatory, 13, 14 antiparasitic, 15 and antidiabetic 16 drugs, prompted 
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chemistry research to undertake the synthesis of pyrazole-4-carboxldehyde 
derivatives using Vilsmeier-Haack (VH). 17-19 The study is particularly aimed at 
developing a one-pot synthesis of pyrazole-4-carboxaldehyde oximes starting 
from acetophenone phenylhydrazones. 
 
Chapter – 4                                                   Studies on different types of reactions….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                        190 
 
 
4.2   INTRODUCTION TO OXINDOLE 
 
Oxindole (1, 3-dihydro-2H-indol-2-one; C8H7NO) is an aromatic 
heterocyclic organic compound. It has a bicyclic structure, consisting of a six-
membered benzene ring fused to a five-membered nitrogen-containing ring. 
The compound's structure is based on the indoline structure but where a 
carbonyl is situated at the 2-position of the five-membered ring. 
 
 
 
 
 
 
 
 
 
4.2.1   PHYSICAL PROPERTIES OF OXINDOLE 
 
Oxindole crystallizes from water in colourless needles melting at 126-
127°C. The substance boils at 195°C at 17 mm a and at 227°C at 73 mm. 21 It 
is soluble in hot water, alchohol, benzene, ether and acetic acid. It is more 
soluble in alkaline solutions than in water. The heat of combustion at constant 
volume has been found to be about 950.5 kg.-cal./mole. b  
 
The chemistry of indoles especially that of oxindole derivatives dates 
back to 134 years old when first Baeyer 20 published the results of his 
researches on the reaction of isatin. In addition to isatide, which had been 
obtained previously by Laurent 21-23 and by Erdmann, 24 Baeyer obtained 
dioxindole (C8H7NO2) by the further reduction of which oxindole was 
prepared. Baeyer established the constitution of oxindole as the lactam of 2-
aminophenylaceticacid through its synthesis by the reduction of 2-
                                                 
a A. Waul and P. Bagard; Compt. rend., 1910, 149, 132. 
b M. Berthelomt and G. Andre; Compt. rend., 1899, 128, 970. 
 
N
H
O
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nitrophenylaceticacid with tin and hydrochloric acid. Current practice in 
oxindole nomenclature is to number the positions as shown in the Fig. 4.1. 
Oxindole is frequently called indolinone which is now well accepted 
everywhere. 25, 26 
 
4.2.2   SYNTHESIS OF OXINDOLES 
 
Synthesis of oxindole and its derivatives are also a part of known 
chemistry where many methods are reported. 
 
Baeyer and Knop 27 found that when isatin isreduced with sodium 
amalgam in alkaline medium 3-hydroxy oxindole (dioxindal) is obtained. 
Further reduction of dioxindole with tin and mineral acids or by sodium 
amalgam in acid medium gave oxindole. 
 
One convenient method for preparing oxindole is that of Marschalle. 28, 
29 In this procedure isatin is reduced to dioxindole through the agency of 
sodium hydrosulphite. Dioxindale is then reduced to oxindole by the action of 
sodium amalgam in a solution saturated with carbon dioxide. 
 
Isatin was also reduced to oxindole through the agency of hydrazide by 
Curtius and Thun. 30 
 
The first synthesis of oxindole (other than the reduction of isatin) and 
the one who established its constitution with certainly was by Baeyer 31 
through the reduction of 2-nitrophenylaceticacid with tin and hydrochloric acid. 
 
Reduction of 2-nitro phenylacetic acid with Zn and hydrochloric acid 
gives both oxindole and 1-hydroxyoxindole (1, 2-dioxindole) 32-34 
 
Baeyer and Comstok 35 prepared oxindole from the barium salt of 2-
aminophenyl acetic acid by acidifying and then heating. 
 
Substituted oxindoles have been prepared by the reduction of 
substituted derivatives of 2-nitrophenylacetic acid by Wispec, 36 Smith and 
Macmullen 37 and many other workers. 
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Oxindole was also prepared by Suida 38 through the reduction of 2-
acetaminomandelic acid by either hydroiodic acid and phosphorous or sodium 
amalgam. 
 
A procedure developed by Hinsberg 39, 40 serves for the preparation of 
N-alkyloxindoles. A secondary aromatic amine is condenced with the 
sodiumbisulphite addition compound of glyoxal; the resulting product gives an 
N-alkyl oxindole on treatment with aqueous hydrochloric acid. 
 
Oxindole was obtained by Mazzaro and Borgo 41 by steam distillation in 
the presence of hydrochloric acid of the product obtained when oxindole is 
treated with sulfuryl chloride. 
 
N-alkylindoles and N-substituted indole-α-carboxylicacids have been 
converted into the corresponding oxindoles by Colman 42 and Michaelis. 43 
 
Brunner 44-46 prepared oxindole by heating β-derivative of many 
substituted oxindoles especially 3, 3-acetylphenylhydrazine with lime at 200-
220°C this procedure has been extended by Brunner 47 and by others 48-52 to 
the preparation dialkylderivatives of oxindole. 
 
Another convenient and general method for the preparation of oxindole 
and of N-substituted oxindoles is that of Stolle. 53-57 An α-halogenated acid 
chloride or bromide is condensed with an aromatic amine. Subsequent ring 
closure with aluminiumchloride yields the corresponding oxindole. 
 
In the course of the investigation of the structure of physostigmine 
(esertine) Stedman and Barger 58 obtained the oxindole derivatives as a 
degradation product. Catalytic reduction of oxindole derivative gives 
physostigmine. 
 
6-aminooxindole was prepared by Gabrial and Meyer 59 by the 
reduction of 2, 4-dinitrophenylaceticacid with tin and hydrochloric acid. 
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o-aminophenylaceticacid condensed with o-nitrobenzaldehyde to give 
what Neber thought was quinoline derivative, but the product was shown by 
Kliegl and Schmalenback 60 to be 3-(o-nitrobenzal) oxindole. 
 
Recently many workers have reported direct or indirect synthesis of 
oxindole 61-100 and 2, 6-dichlorophenyl-2-indolinone 101-105 using different 
methodologies. 
 
4.2.3   SYNTHETIC OXINDOLES AS ENZYME INHIBITORS 
 
A new series of isatin derivatives was designed, by utilizing a 
combination of protein structure based drug design, molecular modelling, and 
structure activity relationship (SAR). These compounds were subsequently 
synthesized and evaluated as inhibitors of human coronavirus 3C-like and 
rhinovirus proteases. 106 Modelling studies of these protein-inhibitor 
complexes lead to some interesting conclusions about placing specific groups 
at N1 and C5 position. The C2 carbonyl of isatin was envisioned to react in the 
active site of human rhinovirus (HRV) 3C protease with the cysteine 
responsible for catalytic proteolysis, thus forming a stabilized transition state 
mimic. (Fig. 4.2) 
 
 
 
 
 
 
 
 
More recently, a series of novel oxindoles were discovered as efficient 
HIV (human immunodeficiency virus) non-nucleoside reverse transcriptase 
inhibitors. Systematic structural modifications of the lead molecule defined its 
SAR, and permitted the identification of increased antiviral activity at the early 
stages in infection. 107 These studies suggested that both the NH and the 
carbonyl oxygen moieties are crucial for the antiviral activities, and also 
Fig. 4.2
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demonstrated that the cyclopropane moiety is critical in optimizing effective 
molecular interactions. (Fig. 4.3) 
 
  
 
 
 
 
 
 
 
 
2-Indolinone derivatives have recently been established as anti cancer 
compounds 108 and more specifically as tyrosine kinase inhibitors (SU5416, 
SU5614, SU6668, SU6597, SU6663 and SU6561-Fig. 4.4) that block kit 
activation and growth of small cell in lung cancer. 109 Targeting receptor 
kinase by novel indolinone derivatives like BIBF1000 in multiple myeloma 
abrogration of stroma derived interleukin-6 secretion and induction of 
apoptosis in cytogenetically with definite subgroups has been identified. 110 
Various other analogs have been evaluated as kinase inhibitors, anticancer 
and antiangiogenic agents with encouraging results. 111 
 
After the first report of fibroblast growth factor receptor (FGFr-1) co-
crystallization with SU4984 and SU5402, the crystal structure of a receptor 
tyrosine kinase (RTK) bound to a competitive inhibitor of ATP was identified. 
112 These compounds are also inhibitors of both the vascular endothelial 
growth factor receptor (TK flk-1) and vascular endothelial growth factor 
(VEGF). SU4984 and SU5402 inhibit the autophosphorylation of FGFr with 
IC50 values of 10-40 µM. 113 
 
Fig. 4.3
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SU11248 is designed to bind in particular, VEGF receptor, PDGF 
receptors α and β, Flt3 and C-KIT tyrosine kinases. 114, 115 The other 
derivatives studied are SU6577 and SU6663.  
 
All molecules of SU series are indolines, unsubstituted at the nitrogen 
of the indole ring, while the molecules developed by Boehringer Ingelheim 
Pharma, Ingelheim (DE) are oncolytic and various tyrosine kinase receptor 
inhibitors and similar to the Sugen molecules, but substituted in the 6-position 
of the indolinone nucleus. 116 Recently Andreani et al. 117 extensively studied 
several E isomers of 3-(3, 4, 5-trimethoxybenzylidene)-1, 3-dihydroindol-2-
ones as anticancer agents. Moreover, (2-chloroindolyl) methylene-2-
indolinone derivatives were studied as CDK1/cyclinB inhibitors by the same 
author. 118 The closely structurally related compounds 3-(((4-phenyl)-
piperazine-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2H-indol-2-one derivatives and 
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related compounds have shown as CNS antagonists which bind 5-HT2C and 
a1 receptors. 119 
 
Further, these indolinone-derivatives were prepared by attaching 
different chemical substituents to an oxindole-core, and were observed to act 
as efficient inhibitors of protein tyrosinase kinases (PTKs). 112 These protein 
kinases are critical components of signaling pathways in the control of cell 
proliferation and differentiation, and enhanced PTK activity has been 
implicated in many human cancers. 120 Thus, selective inhibitors of this class 
of proteins can have considerable therapeutic value, as compounds SU4984 
and SU5402. Some oxindole and aza-oxindoles were synthesized and 
described as potent inhibitors of TrkA tyrosine kinases, a subclass in this 
family of enzymes, such as compounds A and B. Some substituents with 
similar scaffold in these compounds can increase the selectivity for TrkA 
inhibition over CDK2, another class of kinase proteins. As an example, 
compound A showed IC50 = 0.008 μmol L-1 for TrkA, and 10.4 μmol L-1 for 
CDK2. 121 (Fig. 4.5) 
 
Another compound with similar structure, SU9516, a novel 3-
substituted indolinone compound, had effects on colon cancer cell kinase 
activity, cell proliferation, cell cycle progression, and apoptosis examined. 122 
In this case, the studies aimed at the so called cyclin-dependent kinases 
(CDK), which are key-regulators of the cell cycle. Protein kinases constitute a 
large class of proteins that catalyze the phosphorylation of target proteins and 
enzymes. They can regulate a wide range of processes including 
carbohydrate and lipid metabolism, neurotransmitter biosynthesis, DNA 
transcription and replication, organelle trafficking, smooth muscle contraction, 
and cell differentiation. 123 These proteins are specific for each phase of the 
cell cycle, and determine the progression of distinctive and well ordered 
phosphorylation events occurring. Therefore, they constitute promising target 
for anticancer drug development. 124 It was demonstrated that the oxindole 
SU9516 is a potent and selective inhibitor of the CDK2 kinase catalytic 
activity; it also decreases ligand -dependent and -independent cell cycle 
progression, and increases apoptosis in a cell line-specific manner. 
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On the other hand, some oxindole-derivative compounds have been 
reported as potent inhibitors of vascular endothelial growth factor (VEGF) that 
stimulated angiogenesis. 125 Angiogenesis, the development of the 
microvasculature, is a complex multistep event, described as a crucial aspect 
of tumor growth and spread. Tumors with greatest vasculature are often 
associated with poorer prognosis and higher metastatic potential. 
Angiogenesis inhibitors prevent the growth of blood vessels from surrounding 
tissue of a solid tumor, and those VEGF exert their effect in tumor growth by 
binding to cell surface receptors which have intrinsic tyrosinase kinase 
activity. 126 The oxindole derivatives named SU5416 and SU6668 inhibited 
angiogenesis in vitro by >86% at 10 μmol L-1 concentration, and this inhibition 
was already significant at 1 μmol L-1. Both compounds are now a days in 
clinical trial for cancer treatment. 127 (Fig. 4.6) 
 
 
 
 
 
 
 
Fig. 4.5
Fig. 4.6
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Novel oxime-derivatives of indirubin, a metabolite of isatin oxidation 
and an active ingredient of a traditional Chinese medicine containing a bis-
oxindole skeleton have been recently developed, based on structure-activity 
relationship studies, as potent cancer cell growth inhibitors for different cell 
lines. Recent investigations indicated that these oxindoles display high 
inhibition of some cyclin-dependent kinases (CDK2). 128 (Fig. 4.7) 
 
 
 
 
 
 
 
 
 
 
 
Moreover recently Virsodia et. al. 129 reported in vitro anticancer 
evaluation of 1-(2, 6-dichlorophenyl)-3-methylene-1, 3-dihydro indole-2-one 
derivatives against SW 620 colon cancer cell line. (Fig. 4.8) 
 
 
 
 
 
 
 
 
Where R = Differently substituted benzaldehydes 
 
Fig. 4.7
Fig. 4.8
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4.3   INTRODUCTION TO COUMARIN 
 
Coumarin is a chemical compound (2H-chromen-2-one, 1-benzopyran-
2-one, benzopyrone; C9H6O2); a toxin found in many plants, notably in high 
concentration in the tonka bean, vanilla grass, woodruff, mullein, and bison 
grass. It has a sweet scent, readily recognised as the scent of newly-mown 
hay, and has been used in perfumes since 1882. It has clinical medical value 
as the precursor for several anticoagulants, notably warfarin, and is used as a 
gain medium in some dye lasers. 
 
 
 
 
 
 
 
 
 
 
The isolation of coumarin was first reported by Vogel 130 in 1820. He 
isolated coumarin from tonka beans, bearing the characteristic aroma of 
cutted grass. The name of coumarin originates 131 from a Caribbean word 
“coumarou” for the tonka tree, which was known botanically at one time as 
Coumarouna odorta Aubl, coumarin is now the accepted trival name. 
Coumarin was first synthesized in 1868 on treatment of sodium salt of o-
hyroxy benzaldehyde with acetic anhydride. 132a, 132b Compounds containing 
coumarin subunit possess a wide range of activities and show an interesting 
reactivity. 133-136 This is consequence of the rich electronic structure of 
coumarin which offers abundant possibilities for diversified activity and 
reactivity of the system. 
 
4.3.1   SYNTHESIS OF 4-HYDROXY COUMARIN 
 
Perkin 132 synthesized coumarin and then several methods are 
reported for the synthesis of 4-hydroxy coumarins and their 4-hydroxy 
substituted derivatives namely: 
O O
1
2
3
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1 Anschutz method 137 
2 Pauli Lockemann synthesis 138 
3 Sonn's synthesis 139 
4 Mentzer's synthesis 140 
5 Robertson synthesis 141 
6 Ziegler and Junek method 142 
7 Garden's method 143 
8 Shah, Bose and Shah's method 144 
9 Kaneyuki method 145 
10 Resplandy's method 146 
11 Jain, Rohatagi and Sheshadri's method 147 
12 Shah, Bhatt and Thakor's method 148 
 
Shah and co-workers 144, 148 have prepared 4-hydroxy coumarin 
derivatives in good yield by condentation of different phenols with malonic 
acid in the presence of zinc chloride and phosphorous oxychloride. The 
method is useful as single step preparation of 4-hydroxy coumarin derivatives 
substituted in benzenoid part. 
 
Recently many researchers 149-180 have reported synthetic strategies 
for 4-hydroxy coumarin. 
 
4.3.2   BIOLOGICAL ACTIVITIES ASSOCIATED WITH 4-
HYDROXYCOUMARIN DERIVATIVES 
 
Numerous biological activities have been associated with simple 
coumarins and its analogues. Among them, antimicrobial, antiviral, anticancer, 
enzyme inhibition, anti-inflammatory, antioxidant, anticoagulant and effect on 
central nervous system are most prominent. Coumarin nucleus possesses 
diversified biological activities that can be briefly summarized as under: 
 
1 Antimicrobial and Molluscicidal 181-202 
2 Antiviral 203-207 
3 Anticancer 208-218 
4 As Enzyme Inhibition 219-224 
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5 Antioxidant 225-228 
6 Anti-inflammatory 229-233 
7 Anticoagulant and Cardiovascular 234-237 
8 Effect on Central Nervous System 238-240 
 
 4-hydroxycoumarin is a versatile scaffold and is being consistently 
used as a building block in organic chemistry as well as in heterocyclic 
chemistry for the synthesis of different heterocycles. The synthetic versatility 
of 4-hydroxycoumarin has led to the extensive use of this compound in 
organic synthesis. 4-hydroxy coumarin shows diversified chemical reactivity. 
Preparation of 3-acetyl-4-hydroxycoumarinyl chalcones, condensation 
reaction of 4-hydroxycoumarin with aldehydes and use of 4-hydroxycoumarin 
as a β-keto ester in dihydropyrimidine synthesis have been discussed herein.  
 
4.3.3   INTRODUCTION TO COUMARINYL CHALCONES 
   
The compound 1, 3–diphenyl-2-propene-1-one is known by its trivial 
name chalcone. Many naturally occurring flavonoids share structural features 
with chalcone and are referred by the generic term “chalcones”. This is well 
illustrated by benzal-acetophenone or phenyl styryl ketone or phenyl 
acreloacetophenone named first time as chalcones by Kostanecki and 
Tambor. 241 Certain flavonoids also include chalcone subunit and found to 
have anticancer activity and chemopreventive activity in some tumors. 
 
Additionally, some natural or synthetic chalcones are proved to have 
significant antiproliferation activity on different cell lines. Though the 
mechanism of antiproliferative activity of flavonoids and chalcones is still 
unknown, it is believed to be linked with the interaction of type II estrogen 
receptors. 
 
The in vivo action of these polyphenol substances is certainly much 
more complicated. All these compounds are generally characterized by an 
almost complete solubility in water and, in vivo, by a very poor bioavailability 
linked to a rapid metabolism of phenols and a marked affinity for lipids and 
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proteins. It has now been found that certain novel chalcones, chalcone 
derivatives and chalcone analogues, in particular ones in which the phenyl 
ring at the 1st position is substituted or replaced by the rings containing one or 
more heteroatoms, possess greater antiproliferation activity both on sensitive 
cancer cells or on cells which are resistant to common chemotherapeutic 
drugs, including the latest generation of anti-neoplastic agents, pacitaxel and 
docetaxel. 
 
In recent patent literature, compounds of the general formula shown in 
Fig. 4.10 are a pharmaceutically acceptable salt or solvate there of wherein Ar 
represents a substituted or unsubstituted, (preferably aromatic), carbocycilc or 
heterocyclic group, said carbocyclic or heterocyclic group containing from 5 to 
10 ring atoms, said ring atoms forming one or two rings, wherein each ring 
contains 5 or 6 ring atoms, any heteroatoms being selected from N, O and S, 
any substituents on the Ar group being independently selected from the group 
consisting of: (a) Cl, (b) Br, (c) F, (d) OH, (e) NO2, (f) CF3, (g) C1-4 lower alkyl 
(in particular CH3), (h) SCH3, (i) NHCOCH3, (j) N(R)(R1) wherein R and R1 are 
the same or different and each represents H or lower C1-4 alkyl. (Fig. 4.10, 
4.11, 4.12 and 4.13) 
 
 
 
 
 
 
 
 
 
 
 
 
OO
R1
R
COCH=CHAr
Fig. 4.10 
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Several 2'-hydroxy chalcones are found to exist as pigments. The 
natural chalcones are found to contain phloroglucinol, pyraogallol, catechol 
and hydroquinone nuclei. 242-246 
 
Chalcones contain keto-ethylenic linkage and therefore reactive 
towards reagents like phenyl hydrazine, hydrazine hydrate and ethyl 
acetoacetate to produce heterocyclic derivatives. Chalcones have close 
relationship to flavones, flavanones, flavanols and dihydroflavanols. They are 
useful as intermediates in the synthesis of certain heterocyclic compounds 
like flavones, anthocyanins and benzal coumarones. 247-250 Butein, phloretin 
and hissopin are found to be naturally occurring chalcones. Sometimes, 
chalcones are found to occur in nature as glycosides like carthamin and 
isocarthamin present in Carthamus tinctorious. 251 
 
2'-Hydroxy chalcones are used as starting material to synthesize 
naturally occurring flavanones, flavones, flavonols, etc. The chalcones are 
also natural biocides 252-254 and are well known intermediates in the synthesis 
of heterocyclic compounds exhibiting various biological activities like 
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antimalarial, 255 antiviral, 256 antitumor, 257 herbicidal 258 and also bactericidal 
259, 260 activities. They are also identified as antioxidants. 261 
 
Curcumin is a yellow pigment isolated from the rhizome of the 
perennial herb Curcuma longa L (turmeric). The chemical structure of 
curcumin was elucidated by Lampe et. al. 262 
 
Curcumin has several biological activities. It possesses anti-
inflammatory, antioxidant, antibacterial, antihepatotoxic, hypotensive and 
hypocholesterolemic properties. 263-266 Tonneses 267 describes curcumin as a 
non-toxic compound even at high dosages. It has a dual effect in oxygen 
radical reactions, thus it can act as a scavenger of hydroxyl radicals or 
catalyse the formation of hydroxyl radicals depending on the experimental 
conditions. 267, 268 
 
  Curcumin inhibits in vitro lipid peroxide formation by liver homogenates 
of oedemic mice. 269 The inflammatory response induced experimentally in 
animals appeared to be corelated with disturbances of the regulation of 
cellular oxidative process, as is evident from the anti-inflammatory action of 
well known antioxidants. There is evidence of a parallel between the inhibition 
of aedema formation in mice induced by carrageenan and the decrease in the 
production of lipid peroxides in liver homogenate. 269 Modification of groups on 
the terminal aromatic rings of curcumin reveals that electron donating groups 
increase anti-inflammatory activity. 270 The structural similarity of chalcone like 
molecules is expected to exhibit either antagonize or potentiate the biological 
activity in question and therefore it was very essential to study further, the 
coumarin derivatives possessing such ethylenic linkages-discussed earlier. 
 
 
4.3.4   CHALCONES OF 3-ACETYL-4-HYDROXYCOUMARIN 
 
4-hydroxycoumarin is known to give 3-substituted-4-hydroxycoumarin 
derivatives on electrophilic or nucleophilic attack; acetylation of 4-
hydroxycoumarin using glacial acetic acid in presence of phosphorous 
oxychloride to yield 3-acetyl-4-hydroxycoumarin is one of it. Subsequent 
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reaction of 3-acetyl-4-hydroxycoumarin with aldehydes forms chalcone at C3 
position with the elimination of water molecule under basic condition. These 
chalcones are excellent intermediates to build different heterocycles by 
means of further cyclization using it. 
 
Recently coumarinyl chalcones have drawn attention of chemistry 
researchers towards it chemistry and antiviral activity. 4-hydroxycoumarinyl 
chalcones were prepared from 3-acetyl-4-hydroxycoumarins via Claisen 
condensation with benzaldehydes by Mulwad et. al., 271 which were further 
cyclized on treatment with 10 % sulfuric acid in ethanol and selenium dioxide 
in amyl alchohol to give 4H, 5H-2, 3-dihydro-2-phenylpyrano [3, 2 - c] – 1 – 
benzopyran - 4, 5 - diones and 4H, 5H – 2 – phenylpyrano [3, 2 - c] – 1 – 
benzopyran - 4, 5 – diones respectively.  The chalcone oximes on refluxing 
with silica gel and dichloroethane gave 2 – oxo – 3 – styryl - 4H – 1 – 
benzopyran [3, 4 - d] isoxazoles. 
 
Due to the exceptional reactivity of 4-hydroxycoumarin and the 
versatile biological activity of coumarin derivatives, the synthesis of 3-
substituted 4-hydroxycoumarin derivatives was carried out and tested for 
antibacterial and antifungal activity by Zavrsnik et. al. 272 Microbiological 
activity of synthesized compounds was executed using diffusion method on 
the species of bacteria Escherichia coli 113-1, Pseudomonas aeruginosa 
ATCC 9027, Staphylococcus aureus SG 511, and fungi Candida albicans 
ATCC 10231. The antibacterial activity of currently used antibiotics was also 
carried out on the same species of bacteria for comparison point of view. The 
synthesis of derivatives of 3-cinnamoyl-4-hydroxycoumarin and azomethines 
of 4-hydroxycoumarin was also carried out. Both the groups of compounds 
showed significant microbiological activity. All synthesized compounds 
showed antimycotic and antibacterial activity. Derivatives of 3-cinnamoyl-4-
hydroxycoumarin in relation to azomethines of 4-hydroxycoumarin showed 
better activity in case of all the bacteria and fungi species. The best 
antibacterial activity was shown by the species which had -Cl or -OCH3 as 
substituents, and the best antimycotic activity was shown by the species 
which contained Cl. 
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Preparation of 4-hydroxycoumarin, its 3-acetyl derivative was carried 
out by Mohamed et. al. 273 Further this 3-acetyl-4-hydroxycoumarin was 
condensed with aryl aldehydes to afford respective α-hydroxychalcones. They 
have also reported further cyclization of chalcones into different heterocyclic 
moieties. 
 
3-acetyl-4-hydroxylcoumarin was synthesized by acetylation and acyl 
chlorination of salicylic acid followed by the cyclocondensation of acetoacetic 
ester, then condensation with aldehydes to obtain the three title product by 
Ding et. al. 274 The three derivatives have high extinction coefficients in UV-vis 
absorption, which were 5.25 x 104 L/(mol-cm), 3.39 x 104 L/(mol-cm), and 
3.24 x 104 L/(mol-cm), respectively, and intensive luminescence in both the 
THF solution and solid state.  Derivatives TM1 and TM2 emit intensive orange 
red luminescence with the same absorption peak at 500 nm and the identical 
small Stoke shift of 85 nm in the emission spectra in THF. The 
photoluminescence peaks of the three derivatives in solid state are at 705, 
643, and 660 nm, respectively.  Derivative TM3 displays intensive red 
luminescence with the peak at 486 nm and a large Stoke shift of 152 nm in 
the emission spectrum in THF, which makes it a novel red luminescent 
material that may be used in OLEDs.  
 
Title compounds (1) [R1 = H, OH; R2 = H, OH, OMe, F, Cl; R3 = H, OH, 
OMe, F, CF3, Cl; R4 = H, OMe; n = 1, 2] were prepared for use as HIV-1 
protease inhibitors by Kulkarni et. al. 275 Thus, 4-hydroxycoumarin was treated 
with PhCH=CHCOCl to give (1) [R1-R4 = H, n = 1] which had ki for HIV-1 
protease inhibition of 10 µM. (2Z, 4E)-5-phenylpenta-2, 4-dienoic acid was 
prepared by treating 3-phenylacrylaldehyde and acetic anhydride which were 
treated with 4-hydroxycoumarin to give (1) [R1-R4 = H, n =2]. (Fig. 4.14) 
 
 
 
 
 
 Fig. 4.14
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A simple synthesis and biological properties of 1, 3-diphenyl-2-propen-
1-ones are described by Jang et. al. 276 The key synthetic strategies involve 
Grignard reaction of aldehyde and oxidation reaction in high yields. The 
prepared compounds were evaluated for free-radical scavenging, suppression 
of LPS-induced NO generation, and anti-excitotoxicity in vitro.  It was found 
that a couple of compounds were potent suppressors of NO generation and 
demonstrated anti-excitotoxicity with the concentration range 10-20 µM in 
vitro. 
 
Trivedi et. al. 277 synthesized differently substituted 4-hydroxy 
coumarins and its 3-acetyl derivatives. Further they condensed 3-acetyl-4-
hydroxy coumarin with differently substituted aromatic benzaldehydes to 
afford coumarinyl chalcones. They not only improved the synthetic 
methodology of chalcones from strong alkali and alchohol to piperidine and 
chloroform but they reported their antiviral activity too. 
 
4.4   INTRODUCTION ON CHROMANE DIONES 
 
Tautomeric form of 4-hydroxycoumarin was first established by J. 
Kolsa. 278 He proposed that if 4-hydroxy coumarin is a 2, 4-dioxochroman than 
its –COCH2CO group should be reactive and easily condense with ester but 
show no reaction with diethylcarbonate, ethylcyanoacetate, 
methylacetoacetate, ethylacetoacetate and benzylacetoacetate in presence of 
sodium and sodium ethoxide. Thus it was concluded that 4-hydroxycoumarin 
enolises at the lactone carbonyl and exists mainly in coumarin tautomerism in 
which the enol form of coumarin is favored. (Fig. 4.15) 
 
 
 
 
 
 
 
 
 
 
O O
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O
Fig. 4.15
Chapter – 4                                                   Studies on different types of reactions….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                        209 
 
Various methods are utilized to prepare 2, 4-chromandiones and 2, 3, 
4-chromantriones shows ketonic nature of 4-hydroxycoumarin and therefore 
they were thought of interest to investigate their chemical reactivity and other 
properties. So far, 2, 4-chromandiones have been isolated as crystalline 
solids. Solid derivatives of 2, 3, 4-chromantriones have been reported usually 
as derivatives of the 3-keto group. 
 
Extensive work has been reported on 2, 4-chromandiones and 2, 3, 4-
chromanetriones. They are regarded as analogues of 4-chromanones and 3, 
4-chromanediones respectively. 279 (Fig. 4.16) 
 
 
 
 
 
 
 
 
 
 
A brief survey of literature on some 2, 4-chromandione and 2, 3, 4-
chromantrione derivatives is summarized. 
 
4-hydroxycoumarins frequently react with aromatic aldehydes to give 3-
benzylidene-2, 4-chromandiones. 280-283 (Fig. 4.17) 
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However, reactions using salicylaldehyde or its analogues multicyclic 
compounds were obtained either solely or in addition to salicylidene 
derivatives of type as shown in Fig. 4.18. 284 
 
 
The proportions of the products were dependent on reaction conditions 
used e.g. when salicylaldehyde and 4-hydroxycoumarin refluxed in ethanol; a 
dimeric type of structure in addition to benzylidene derivative was obtained. 
285 
When two moles of salicylaldehyde were reacted with 4-
hydroxycoumarins, it gave appropriate benzylidene derivative only (Fig. 4.19). 
However, one mole of salicylaldehyde with two moles of 4-hydroxycoumarin 
gave the dicoumarinyl structure. 286 (Fig. 4.20) 
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Similarly, reaction of 4-hydroxycoumarin with acetylated 
aldehydohexoses in ethanol for 24 hours gave substance shown in Fig. 4.21. 
287 
 
 
 
 
 
 
Reaction between 4-hydroxycoumarin and hydroxylamine 
hydrochloride gave corresponding 2, 4-chromadione-4-oximes. 288 (Fig. 4.22) 
 
Reaction of chlorine with 4-hydroxycoumarins in suitable solvent or 
sulfuryl chloride led to the formation 3, 3-dichloro-2, 4-chromandiones. 289-293 
Halogenations of 3-substituted 4-hydroxycoumarin afforded 3-chloro-2, 4-
chromandiones. When 3, 3' methylenebis (4-hydroxycoumarin) was treated 
with sufuryl chloride, 3, 3' methylenebis (3-chloro-2, 4-chromandione) was 
isolated. (Fig. 4.23) 
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When 3-amino-4-hydroxycoumarin was reacted with nitrous acid, it 
gave 3-diazo-2, 4-chromandiones. The same product was also obtained in 
72% yield when sodium nitrite in dilute hydrochloric acid was added to 3-
amino-4-hydroxycoumarin. 294 (Fig. 4.24) 
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However, reaction of 4-hydroxycoumarin with aqueous sodium nitrite 
afforded 2, 3, 4-chromantrione-3-oxime which forms a silver salt. 295 (Fig. 
4.25)  
 
 
 
 
 
 
 
 
 
 
4.5  USE OF 4-HYDROXYCOUMARIN IN DIHYDROPYRIMIDINE 
SYNTHESIS 
 
Three component Biginelli reaction is very well known for the synthesis 
of dihydropyrimidine derivatives. P. Biginelli reported the synthesis of 
functionalized 3, 4-dihydropyrimidine-(1H)-ones (DHPMs) via three 
component condensation reaction of an aromatic aldehydes, urea and ethyl 
acetoacetate. In the past decade, this long-neglected multicomponent 
reaction has experienced a remarkable revival, mainly due to the interesting 
pharmacological properties associated with this dihydropyrimidine scaffold. 296 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reaction was carried out by simply heating a mixture of the three 
components dissolved in ethanol with a catalytic amount of concentrated 
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hydrochloric acid at reflux temperature (Fig. 4.26). The product of this novel 
one-pot, three-component synthesis that precipitated on cooling of the 
reaction mixture was identified correctly by Biginelli as 3, 4-dihydropyrimidine-
2(1H)-one. Apart from a series of publications by the late Karl Folkers in the 
mid 1930s, the “Biginelli reaction” or “Biginelli condensation” as it was 
henceforth called was largely ignored in the early part of the 20th century. The 
synthetic potential of this new heterocycle synthesis therefore remained 
unexplored for quite some time. In the 1970s and 1980s, interest slowly 
increased and the scope of the original cyclocondensation reaction was 
gradually extended by variation of all three building blocks, allowing access to 
a large number of multifunctionalized dihydropyrimidines. 297-299 
 
Dihydropyrimidinone derivatives are of considerable interest in industry 
as well as in academia because of their promising biological activities as 
calcium channel blockers, antihypertensive agents, and anticancer drugs. 298, 
299 They also show anti fungal activity, 300 antibacterial activity, 300 antiviral 
activity 301 and antitumor 301 activity. They are also known as analgesics 302 
and antidepressants. 303 Thus, synthesis of this heterocyclic nucleus is of 
much importance, and quite a number of synthetic procedures based on the 
modifications of the century-old Biginelli’s reaction involving acid-catalyzed 
three-component condensation of 1,3-dicarbonyl compound, aldehyde, and 
urea, have been developed during past few years. 298, 299 Basically, these 
methods are all similar, using different Lewis acid catalysts such as BF3, 304a 
FeCl3, 304b InCl3, 304c BiCl3, 304d LaCl3, 304e LiClO4, 304f Mn-(OAc)3, 304g CAN, 
304h and VCl3 304i in a solvent such as CH3CN, CH2Cl2, or THF. Recently, a 
number of procedures under solvent-free conditions using Yb(OTf)3, 304j 
montmorillonite 304k and ionic liquid 304l as catalysts have also been reported.  
 
Biginelli reaction consists three components i.e. aldehyde functional 
group, urea or thiourea and β-keto ester. Many reactions have been reported 
using differently substituted aromatic as well as aliphatic aldehydes. 
Substituted ureas and thioureas have also been used in the synthesis of N-
substituted dihydropyrimidine derivatives as well. Simple β-keto esters viz. 
ethylacetoacetate, methylacetoacetate and acetylacetone have been widely 
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used while differently substituted β-keto esters have also been used for the 
synthesis of diversified dihydropyrimidine derivatives via Biginelli reaction. 
 
Use of 4-hydroxycoumarin in the synthesis of dihydropyrimidine 
synthesis is not much reported. The tautomeric form (1) of 4-hydroxy-
coumarin acts as a cyclic β-keto ester (Fig. 4.27) and condenses with 
aldehydes in the presence of urea / thiourea under acidic conditions and gives 
rise to the expected coumarin fused pyrimidines. 
 
 
 
 
  
 
 
 
Brambhatt et. al. 305 reported synthetic method for the fused 
benzopyranopyrimidine derivatives. They reported the poor yielded synthetic 
procedure with the longer time period. 
 
Microwave assisted green chemical approach was applied to the 
synthesis of benzopyranopyrimidines by Kidwai et. al. 306 This method not 
only gave better yield with reduced reaction time but also eliminated the need 
of an external acid due to the usage of acidic solid support. Since the reaction 
takes place under acidic conditions, the effect of three different acidic 
inorganic support viz. acidic alumina, montmorillonite K10 clay and silica gel 
was explored. The same reaction was also carried out in solution phase under 
MW. A conventional method with basic alumina in oil bath maintained at 110–
120°C was also attempted, but the reaction took from 4 to 6 h to give the 
required product in about 39–60 % yield. This clearly indicates that the 
coupling of microwaves with the solid supported reagent is more than simple 
thermal effects. Furthermore They 307 eliminated the use of inorganic solid 
support and condensed all the three components i.e. 4-hydroxycoumarin, 
aromatic aldehydes and urea / thiourea, neat under microwave irradiation. 
Fig. 4.27
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4.6   AIM OF CURRENT WORK  
 
This chapter contains four different schemes. Different types of 
reactions have been carried out on pyrazole aldehydes in each and every 
scheme. The synthesis of pyrazoles remain of great interest owing to the wide 
applications in pharmaceutical and agrochemical industry due to their 
herbicidal, fungicidal, insecticidal, analgesic, antipyretic, anti inflammatory, 
anti bacterial, anti parasitic and anti diabetic properties. Earlier, from this 
laboratory, some indolinone derivatives were prepared and tested for anti 
cancer activity on colon cancer cell line (SW 620), which showed good 
results. c In continuation of our previous work, few differently substituted 
pyrazole aldehydes were developed and new indolinone derivatives to 
observe their anti cancer activity. 
 
Similarly, chalcones of 3-acetyl-4-hydroxycoumarin with differently 
substituted benzaldehydes were prepared and tested for anti viral activity 
which showed good results. In continuation, new chalcones of 3-acetyl-4-
hydroxycoumarin with pyrazole aldehydes were synthesized and evaluated for 
their antiviral activity. 
 
Recently much attention has been devoted towards dihydropyrimidine 
derivatives due to their significant therapeutic and medicinal properties. 
Literature survey revealed that differently substituted benzaldehydes are 
fused with 4-hydroxycoumarin and urea / thiourea to synthesize coumarin 
fused pyrimidines but in place of substituted benzaldehydes, pyrazole 
aldehydes are not approached, which inspired us to synthesize some new 
coumarin fused pyrimidines. In the present work, the keto tautomeric form of 
4-hydroxy-coumarin acts as a cyclic β-keto ester and condenses with pyrazole 
aldehydes in the presence of urea / thiourea under acidic conditions and gives 
rise to the expected coumarin fused pyrimidines.  
 
                                                 
c V. Virsodia, A. Manvar, K. Upadhyay, R. Loriya, D. Karia, M. Jaggi, A. Singh, R. Mukherjee, 
M. S. Shaikh, E. C. Coutinho and A. Shah; Eur. J. Med. Chem., 2008, 1-8 (In press)  
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4-hydroxycoumarins and aromatic aldehydes are known to produce 2, 
4-chromane diones (arylidine at C3 position) and coumarin dimers under 
reflux, with or without base. Thus, few new chromane diones were prepared 
using pyrazole aldehydes. 
 
Though the chemistry of the synthesized compounds is known, the 
compounds are reported herein for the first time. Biological importance of 
such important compounds is the rational behind the current work done in this 
chapter.  
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4.7   REACTION SCHEMES 
 
4.7.1 PREPARATION OF PYRAZOLE ALDEHYDE 
 
STEP – 1 
 
 
Reagents / Reaction Condition (a): Phenyl hydrazine, Substituted 
acetophenone, Glacial acetic acid, Ethanol / Reflux, 5-6 hours. 
 
STEP – 2 
 
 
Reagents / Reaction Condition (b): DMF – POCl3 / 70-80°C, 5-6 hours. 
Where, R = 4-H, 4-Cl, 4-F, 4-NO2, 3-NO2 
 
4.7.2 PREPARATION OF 3-ACETYL-4-HYDROXYCOUMARIN 
 
STEP – 1 
 
 
Reagents / Reaction Condition (c): Anhydrous ZnCl2, POCl3 / 70°C, 12 hours. 
NH
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STEP – 2 
 
 
Reagents / Reaction Condition (d): POCl3, Glacial acetic acid / Reflux, 30 min. 
 
4.7.3 PREPARATION OF 1-(2, 6-DICHLOROPHENYL)-2-INDOLINONE 
 
STEP – 1 
 
 
 
 
 
 
 
 
Reagents / Reaction Condition (e): ClCH2COCl / Reflux, 5 hours. 
 
STEP – 2 
 
 
 
 
 
 
 
 
 
Reagents / Reaction Condition (f): Anhydrous AlCl3 / 160°C, 2 hours. 
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4.7.4   SCHEME - 1 
 
 
Reagents / Reaction Condition (g): 1-(2, 6-dichloro phenyl)-indolinone, 
Piperidine, Ethanol / Reflux, 5-7 hours. OR MW method: 1-(2, 6-dichloro 
phenyl)-indolinone, Piperidine, DMF / MW, 400 Watt. 
 
4.7.5   SCHEME - 2 
 
 
Reagents / Reaction Condition (h): 3-acetyl-4-hydroxycoumarin, Piperidine, 
Chloroform / Reflux, 4 hours. 
 
Where, R = 4-H, 4-Cl, 4-F, 4-NO2, 3-NO2 
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4.7.6   SCHEME - 3 
 
 
Reagents / Reaction Condition (i): 4-hydroxycoumarin, Piperidine, Methanol / 
Reflux, 4-5 hours. OR MW method: 4-hydroxycoumarin, Piperidine, DMF / 
MW, 400 Watt. 
 
4.7.7   SCHEME - 4 
 
 
Reagents / Reaction Condition (j): 4-hydroxycoumarin, Urea or Thiourea, Con. 
HCl, Methanol / Reflux, 5-6 hours. 
 
Where, X = O or S, R = 4-H, 4-Cl, 4-F, 4-NO2, 3-NO2 
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4.8   PLAUSIBLE REACTION MECHANISM 
 
4.8.1   SCHEME - 1 
 
 
4.8.2   SCHEME - 2 
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4.8.3   SCHEME - 3 
 
 
 
 
4.8.4   SCHEME - 4 
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4.9   EXPERIMENTAL 
 
4.9.1 PREPARATION OF PYRAZOLE ALDEHYDE 
 
STEP – 1 PREPARATION OF ACETOPHENONE PHENYL HYDRAZONE 
 
0.1 mole of appropriately substituted acetophenone was dissolved in 
50 ml of ethanol into 250 ml round bottom flask. 0.1 mole of Phenyl hydrazine 
was added to above flask along with 3-4 drops of glacial acetic acid. The 
reaction mixture was refluxed for 5-6 hours. The progress and the completion 
of the reaction were checked by silica gel-G F254 thin layer chromatography 
using toluene : ethyl acetate (7 : 3) as a mobile phase. After the reaction to be 
completed, the reaction mixture was cooled to room temperature and the 
crystalline product was separated by filtration. The product was washed with 
ethanol and dried to give substituted acetone phenyl hydrazone in good yield 
which was pure enough to use as such for the next step. 
 
Code No. MF MW (g/m) MP (°C) % Yield 
APH-01 C14H13N3O2 255 106-108 85 
APH-02 C14H13N3O2 255 134-136 80 
APH-03 C14H14N2 210 126-128 78 
APH-04 C14H13ClN2 244 ----- 79 
APH-05 C14H13FN2 228 ----- 72 
 
STEP – 2 PREPARATION OF PYRAZOLE ALDEHYDE 
 
25 ml of dry dimethylformamide was transferred into 250 ml flat bottom 
flask. 3 ml of phosphorous oxychloride was added drop wise to above flask 
under stirring at 0-5°C. After completion of the addition, the mixture was 
stirred at this temperature for 10-15 min. 0.03 mole of freshly prepared 
acetophenone phenyl hydrazone was added to above mixture and the content 
was heated on water bath for 5-6 hours. The progress and the completion of 
the reaction were checked by silica gel-G F254 thin layer chromatography 
using toluene : ethyl acetate (7 : 3) as a mobile phase. After the reaction to be 
completed, the reaction mixture was cooled to room temperature and the 
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content of the flask was poured on crushed ice to isolate the product. The 
separated product was filtered off and it was washed with cold water to 
remove acidity. It was dried at 65°C and recrystallized from the mixture of 
DMF-Methanol to give crystalline pyrazole aldehyde in good yield. 
 
Code No. MF MW (g/m) MP (°C) % Yield 
PA-01 C16H11N3O3 293 162-164 75 
PA-02 C16H11N3O3 293 176-178 70 
PA-03 C16H12N2O 248 144-146 68 
PA-04 C16H11ClN2O 282 142-144 71 
PA-05 C16H11FN2O 266 148-150 70 
 
4.9.2 PREPARATION OF 3-ACETYL-4-HYDROXYCOUMARIN 
 
STEP – 1 PREPARATION OF 4-HYDROXYCOUMARIN 
 
It was prepared according to the method reported by Shah et. al. d Yield 
- 55 %, MP - 210-212°C. (210-212°C b) 
 
STEP – 2 PREPARATION OF 3-ACETYL-4-HYDROXYCOUMARIN 
 
It was prepared according to the method reported by Dholakia et. al. e 
Yield - 60 %, MP - 120-122°C. (121-122°C c) 
 
4.9.3 PREPARATION OF 1-(2, 6-DICHLOROPHENYL)-2-INDOLINONE 
 
It was prepared according to the literature method. f, g, h, i Yield - 60 %, 
MP - 126-128°C. (124°C-126°C e) 
 
                                                 
d A. K. Shah, N. S. Bhatt and V. M. Thakor; Curr. Sci., 1984, 53(24), 1289. 
e V N. Dholakia, M. G. Parekh and K. N. Trivedi; Aust. J. Chem., 1968, 21, 2345. 
f G. S. Predvoditeleva, T. V. Kartseva, O. N. Oleshko, V. I. Shvedov, R. D. Syubaev, G. Ya. 
Shvarts, L. M. Alekseeva, O. S. Shvedov, V. V. Chistyakov and Yu. N. Sheinker; Khim.-Farm. 
Zh., 1987, 21, 441. 
g P. Moser, A. Sallmann and I. Wiesenberg; J. Med. Chem., 1990, 33, 2358. 
h A. Sallmann and R. Pfister; British Patatent 1,132,318, 1968. (CA 70:57455b) 
i A. Sallmann and R. Pfister; Ger. Offen. 1,815,802, 1969. (CA 72:12385d) 
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4.9.4 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-701 TO 
DNJ-705 
 
METHOD – (A) CONVENTIONAL APPROACH 
 
0.01 mole of 1-(2, 6-dichlorophenyl)-2-indolinone was dissolved into 30 
ml of methanol into 100 ml round bottom flask. 0.01 mole of an appropriately 
substituted pyrazole-4-carboxaldehyde was added to the above flask along 
with catalytic amount of piperidine. The reaction mixture was refluxed on 
water bath for 5-7 hours. The progress and the completion of the reaction 
were checked by silica gel-G F254 thin layer chromatography using hexane : 
ethyl acetate (6 : 4) as a mobile phase. After the reaction to be completed, the 
reaction mixture was cooled to room temperature and the product was 
separated by filtration. The product was washed with methanol and dried to 
give desired product in moderate yield which was recrystallized by DMF. 
(Physical data of the synthesized end products are summarized in the table 
4.10.1)  
 
METHOD – (B) MICROWAVE APPROACH 
 
0.01 mole of 1-(2, 6-dichlorophenyl)-2-indolinone was dissolved into 20 
ml of dimethylformamide into 100 ml microwave flask. 0.01 mole of an 
appropriately substituted pyrazole-4-carboxaldehyde was added to the above 
flask along with catalytic amount of piperidine. The reaction mixture was 
irradiated under microwave irradiation using Qpro-M microwave synthesizer 
for the desired time at 400 W. The progress and the completion of the 
reaction were checked at the interval of every one min. by silica gel-G F254 
thin layer chromatography using hexane : ethyl acetate (6 : 4) as a mobile 
phase. After the reaction to be completed, the reaction mixture was cooled 
and scratched into 30 ml of methanol. The separated product was filtered off 
and washed with methanol and it was dried to give desired product in good 
yield which was recrystallized by DMF. (Physical data of the synthesized end 
products are summarized in the table 4.10.1)  
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Comparative results of method (A) and method (B) are summarized as under. 
 
Reaction Condition % Yield 
Method (A) Method (B) Code 
No. 
Temp. 
(°C) 
Time 
(hrs.) 
Watt 
(W) 
Temp.
(°C) 
Time 
(min.)
Method 
(A) 
Method 
(B) 
DNJ-701 90-95 5.0 400 110 3.0 48 81 
DNJ-702 90-95 5.5 400 110 3.1 50 80 
DNJ-703 90-95 6.0 400 110 3.3 52 85 
DNJ-704 90-95 7.0 400 110 3.0 49 79 
DNJ-705 90-95 4.0 400 110 3.2 55 83 
 
4.9.5 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-801 TO 
DNJ-805 
 
0.01 mole of 3-acetyl-4-hydroxycoumarin and 0.01 mole of an 
appropriately substituted pyrazole-4-carboxaldehyde were dissolved in 30 ml 
of chloroform. A catalytic amount of piperidine was added and the reaction 
mixture was refluxed for 4 hours. The progress and the completion of the 
reaction were checked by silica gel-G F254 thin layer chromatography using 
hexane : ethyl acetate (6 : 4) as a mobile phase. The chloroform was distilled 
out and the residue was washed with methanol and dried to give desired 
product in moderate yield which was recrystallized by DMF. (Physical data of 
the synthesized end products are summarized in the table 4.10.2)  
 
4.9.6 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-901 TO 
DNJ-905 
 
METHOD – (A) CONVENTIONAL APPROACH 
 
0.01 mole of 4-hydroxycoumarin was dissolved in 30 ml of methanol 
into 100 ml round bottom flask. 0.01 mole of an appropriately substituted 
pyrazole-4-carboxaldehyde was added to the above flask along with few 
drops of piperidine. The reaction mixture was heated on water bath for 4-5 
hours. The progress and the completion of the reaction were checked by silica 
gel-G F254 thin layer chromatography using hexane : ethyl acetate (6 : 4) as a 
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mobile phase. After the reaction to be completed, the reaction mixture was 
cooled to room temperature and the product was separated by filtration. The 
product was washed with methanol and dried to give desired product in good 
yield which was recrystallized by DMF. (Physical data of the synthesized end 
products are summarized in the table 4.10.3) 
 
METHOD – (B) MICROWAVE APPROACH 
 
0.01 mole of 4-hydroxycoumarin was dissolved into 20 ml of 
dimethylformamide into 100 ml microwave flask. 0.01 mole of an appropriately 
substituted pyrazole-4-carboxaldehyde was added to the above flask along 
with few drops of piperidine. The reaction mixture was irradiated under 
microwave irradiation using Qpro-M microwave synthesizer for the desired 
time at 400 W. The progress and the completion of the reaction were checked 
at interval of every one min. by silica gel-G F254 thin layer chromatography 
using hexane : ethyl acetate (6 : 4) as a mobile phase. After the reaction to be 
completed, the reaction mixture was scratched into 30 ml of methanol. The 
separated product was filtered off and washed with methanol and it was dried 
to give desired product in good yield which was recrystallized by DMF. 
(Physical data of the synthesized end products are summarized in the table 
4.10.3)  
 
Comparative results of method (A) and method (B) are summarized as under. 
 
Reaction Condition % Yield 
Method (A) Method (B) Code No. 
Temp.  
(°C) 
Time 
(hrs.) 
Watt 
(W) 
Temp. 
(°C) 
Time 
(min.) 
Method 
(A) 
Method 
(B) 
DNJ-901 90-95  4.5  400 110  3.0  68 85 
DNJ-902 90-95  5.0  400 110  3.3 64 80 
DNJ-903 90-95  4.8  400 110  3.1 70 83 
DNJ-904 90-95  5.5  400 110  3.2 72 81 
DNJ-905 90-95  5.3  400 110  3.0 66 79 
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4.9.7 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-1601 
TO DNJ-1605 AND DNJ-1701 TO DNJ-1705 
 
0.015 mole of urea / thiourea was dissolved into 20 ml of methanol. 
0.01 mole of an appropriately substituted pyrazole-4-carboxaldehyde was 
added to above reaction mixture and additional 20 ml of methanol was added 
along with few drops of concentrated hydrochloric acid. This reaction mixture 
was transferred to 250 ml round bottom flask containing 0.01 mole of 4-
hydroxycoumarin into 10 ml of methanol. The content of the flask was heated 
on water bath for 5-6 hours. The progress and the completion of the reaction 
were checked by silica gel-G F254 thin layer chromatography using toluene : 
ethyl acetate (7 : 3) as a mobile phase. After the reaction to be completed, the 
reaction mixture was cooled to room temperature and the product was 
separated by filtration. The product was washed with methanol and dried to 
give desired product in moderate yield which was recrystallized by DMF. 
(Physical data of the synthesized end products are summarized in the table 
4.10.4 & 4.10.5)  
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4.10   PHYSICAL DATA TABLES  
 
4.10.1 Physical data of 1-(2, 6-dichlorophenyl)-3-{[3-(substituted phenyl)-
1-phenyl-1H-pyrazol-4-yl] methylene}-1, 3-dihydro-2H-indol-2-one 
(DNJ-701 to DNJ-705) 
 
 
 
 
 
 
 
 
 
 
 
 
Code Substitution R MF 
MW 
(g/m) 
MP 
(°C) Rf 
DNJ-701 4-NO2 C30H18Cl2N4O3 553 250-252 0.62 
DNJ-702 3-NO2 C30H18Cl2N4O3 553 268-270 0.61 
DNJ-703 H C30H19Cl2N3O 508 224-226 0.55 
DNJ-704 4-F C30H18Cl2FN3O 526 240-242 0.57 
DNJ-705 4-Cl C30H18Cl3N3O 542 256-258 0.60 
 
Rf value was calculated using solvent system = Hexane : Ethyl Acetate (6 
: 4) 
N
O
N
N
Cl
Cl
R
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4.10.2 Physical Data of 3-{(2E)-3-[3-(substituted phenyl)-1-phenyl-1H-
pyrazol-4-yl] prop-2-enoyl}-4-hydroxy-2H-chromen-2-one (DNJ-801 
to DNJ-805) 
 
 
 
 
 
 
 
 
 
 
 
Code Substitution R MF 
MW 
(g/m) 
MP 
(°C) Rf 
% 
Yield 
DNJ-801 H C27H18N2O4 434 270-272 0.46 50 
DNJ-802 4-NO2 C27H17N3O6 479 262-264 0.52 52 
DNJ-803 3-NO2 C27H17N3O6 479 222-224 0.50 48 
DNJ-804 4-Cl C27H17ClN2O4 468 250-252 0.44 54 
DNJ-805 4-F C27H17FN2O4 452 264-266 0.49 51 
 
Rf value was calculated using solvent system = Hexane : Ethyl Acetate (6 
: 4) 
 
 
 
 
O O
OH O
NN
R
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4.10.3 Physical data of (3E)-3-{[3-(substituted phenyl)-1-phenyl-1H-
pyrazol-4-yl] methylene}-2H-chromene-2, 4(3H)-dione (DNJ-901 to 
DNJ-905) 
 
 
 
 
 
 
 
 
 
 
 
 
Code Substitution R MF 
MW 
(g/m) 
MP 
(°C) Rf 
DNJ-901 4-NO2 C25H15N3O5 437 162-164 0.45
DNJ-902 3-NO2 C25H15N3O5 437 170-172 0.47
DNJ-903 H C25H16N2O3 392 158-160 0.40
DNJ-904 4-Cl C25H15ClN2O3 426 178-180 0.50
DNJ-905 4-F C25H15FN2O3 410 184-186 0.42
 
Rf value was calculated using solvent system = Hexane : Ethyl Acetate (6 
: 4) 
 
O O
O
NN
R
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4.10.4 Physical data of 4-[3-(substituted phenyl)-1-phenyl-1H-pyrazol-4-
yl]-3, 4-dihydro-2H-chromeno [4, 3-d] pyrimidine-2, 5(1H)-dione 
(DNJ-1601 to DNJ-1605) 
 
 
 
 
 
 
 
 
 
Code Substitution R MF 
MW 
(g/m) 
MP 
(°C) Rf 
% 
Yield 
DNJ 
1601 H C26H18N4O3 434 278-280 0.50 48 
DNJ 
1602 4-NO2 C26H17N5O5 479 
288-290 
(dec.) 0.53 51 
DNJ 
1603 3-NO2 C26H17N5O5 479 
294-296 
(dec.) 0.51 54 
DNJ 
1604 4-Cl C26H17ClN4O3 468 286-288 0.48 44 
DNJ 
1605 4-F C26H17FN4O3 452 282-284 0.46 56 
 
Rf value was calculated using Solvent System = Toluene : Ethyl Acetate 
(7 : 3) 
 
O
NHNH
N
N
O
O
R
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4.10.5 Physical data of 4-[3-(substituted phenyl)-1-phenyl-1H-pyrazol-4-
yl]-5-thioxo-1, 3, 4, 5-tetrahydro-2H-chromeno [4, 3-d] pyrimidin-2-
one (DNJ-1701 to DNJ-1705) 
 
 
 
 
 
 
 
 
 
 
 
Code Substitution R MF 
MW 
(g/m) 
MP 
(°C) Rf 
% 
Yield 
DNJ 
1701 H C26H18N4O2S 450 288-290 0.51 50 
DNJ 
1702 4-NO2 C26H17N5O4S 495 
298-300 
(dec.) 0.59 54 
DNJ 
1703 3-NO2 C26H17N5O4S 495 >300 0.57 48 
DNJ 
1704 4-Cl C26H17ClN4O2S 484 292-294 0.55 48 
DNJ 
1705 4-F C26H17FN4O2S 468 296-298 0.52 52 
 
Rf value was calculated using Solvent System = Toluene : Ethyl Acetate 
(7 : 3) 
O
NHNH
N
N
S
O
R
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4.11   SPECTRAL DISCUSSION 
 
4.11.1   MASS SPECTRAL STUDY 
 
Mass spectra of the synthesized compounds were recorded on 
Shimadzu GC-MS QP-2010 model using direct injection probe technique. 
The molecular ion peak was found in agreement with molecular weight of the 
respective compound. Characteristic M+2 ion peaks with one-third intensity of 
molecular ion peak were observed in case of compounds having chlorine 
atom. Fragmentation pattern can be observed to be particular for these 
compounds and the characteristic peaks obtained for each compound. 
Probable fragmentation pattern for DNJ-705, DNJ-804, DNJ-905, DNJ-1605 
and DNJ-1705 can be discussed as under. 
 
3-{[3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl] methylene}-1-(2, 6-
dichlorophenyl)-1, 3-dihydro-2H-indol-2-one (DNJ-705) 
 
1. The target compound showed characteristic molecular ion peak. 
2. C2-C16 bond cleavage gave characteristic peak at 524 m/e. [1] 
3. Loss of one chlorine atom (C28-Cl37 bond cleavage) from title 
compound gave characteristic peak at 506 m/e. [2] 
4. Loss of two chlorine atoms (C11-Cl23 and C15-Cl24 bond cleavages) 
gave characteristic peak at 478 m/e. [3] 
5. N21-C31 bond cleavage gave characteristic peak at 464 m/e. (loss of 
one phenyl ring) [4] 
6. Loss of all the three chlorine atoms, from the title compound gave 
characteristic peak at 442 m/e. (C28-Cl37, C11-Cl23 and C15-Cl24 bond 
cleavages) [5] 
7. C17-C18 bond cleavage gave two characteristic peaks at 290 m/e and 
253 m/e respectively. [6]  
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4.11.1.1   FRAGMENTATION PATTERN FOR DNJ-705 
 
 
3-{(2Z)-3-[3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl] prop-2-enoyl}-4-
hydroxy-2H-chromen-2-one (DNJ-804) 
 
1. The target compound showed characteristic molecular ion peak. 
2. Loss of hydroxyl group, substituted at C4 position, gave characteristic 
peak at 449 m/e. [1] 
3. C3-C12 bond cleavage gave two characteristic peaks at 307 m/e and 
162 m/e respectively. [2] 
4. C12-C15 bond cleavage gave two characteristic peaks at 279 m/e and 
189 m/e. [3] 
5.  C15-C16 bond cleavage gave characteristic peak at 265 m/e. [4] 
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6. C16-C17 bond cleavage gave characteristic peak at 215 m/e. [5]  
 
 
4.11.1.2   FRAGMENTATION PATTERN FOR DNJ-804 
 
 
3-{[3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl] methylene}-2H-
chromene-2, 4(3H)-dione (DNJ-905) 
 
1. The target compound showed characteristic molecular ion peak (BASE 
PEAK. 
2. Loss of fluorine atom gave characteristic peak at 393 m/e. [1] 
3. Loss of two carbonyl groups, substituted at C2 and C4 position gave 
characteristic peak at 381 m/e (C2-C11 and C4-C18 bond cleavages). [2] 
4. After C2-C11 and C4-C18 bond cleavages, loss of flurorine atom gave 
characteristic peak at 365 m/e (C22-F31 bond cleavage). [3] 
5. N16-C25 bond cleavage gave characteristic peak at 333 m/e. [4] 
6. C14-C19 bond cleavage gave characteristic peak at 318 m/e. [5] 
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7. C3-C12 bond cleavage gave two characteristic peaks at 249 m/e and 
158 m/e respectively. [6] 
8. After C3-C12 bond cleavage, from 249 m/e fragment loss of fluorine 
atom gave characteristic peak at 234 m/e. [7]  
 
4.11.1.3   FRAGMENTATION PATTERN FOR DNJ-905 
 
 
4-[3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl]-3, 4-dihydro-2H-chromeno 
[4, 3-d] pyrimidine-2, 5(1H)-dione (DNJ-1603) 
 
1. The target compound showed characteristic molecular ion peak. 
2. N5-C6 and N7-C8 bond cleavages gave characteristic peak at 438 m/e. 
[1] 
3 After N5-C6 and N7-C8 bond cleavages, C4-N5 bond cleavage with 
subsequent loss of nitro group gave characteristic peak at 374 m/e. [2] 
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4. After C4-N5 bond cleavage and loss of nitro group, C18-C22 bond 
cleavage gave characteristic peak at 291 m/e. [3] 
5. After C18-C22 bond cleavage, N20-C28 bond cleavage gave 
characteristic peak at 223 m/e. [4] 
6. From title molecule, N20-C28 bond cleavage gave characteristic peak at 
409 m/e. [5] 
7. After N20-C28 bond cleavage, loss of nitro group or C18-C22 bond 
cleavage from title molecule gave characteristic peak at 355 m/e. [6 & 
7] 
  
4.11.1.4   FRAGMENTATION PATTERN FOR DNJ-1603 
 
 
4-[3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl]-2-thioxo-1,2,3,4-tetrahydro-
5H-chromeno [4, 3-d] pyrimidin-5-one (DNJ-1703) 
 
1. The target compound showed characteristic molecular ion peak. 
2. N5-C6 and N7-C8 bond cleavages gave characteristic peak at 438 m/e. 
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3 After N5-C6 and N7-C8 bond cleavages, C4-N5 bond cleavage with 
subsequent loss of nitro group gave characteristic peak at 374 m/e. [2] 
4. After C4-N5 bond cleavage and loss of nitro group, C18-C22 bond 
cleavage gave characteristic peak at 291 m/e. [3] 
5. After C18-C22 bond cleavage, N20-C28 bond cleavage gave 
characteristic peak at 223 m/e. [4] 
 
4.11.1.5   FRAGMENTATION PATTERN FOR DNJ-1703 
 
 
 
4.11.2   IR SPECTRAL STUDY 
 
IR spectra of the synthesized compounds were recorded on Shimadzu 
FT IR 8400 spectrophotometer using Diffused Reflectance Attachment (DRA) 
System using Potassium Bromide. 
 
In case of DNJ-701 to DNJ-705 series of compounds, stretching and 
bending frequency for aromatic and stretching frequencies for methyl, 
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methylene groups were found near 3050 cm-1, 1400-1640 cm-1, 2950 cm-1 
and 2850 cm-1 respectively in all the compounds. Characteristic frequencies 
for carbonyl group (near 1700 cm-1), C-Cl (near 870 cm-1), C-N (3°) (near 
1350 cm-1) and 1, 2-disubstitution (near 750 cm-1) in all the compounds. 
Characteristic frequency for 1, 4-disubstitution (near 820 cm-1) was found in 
DNJ-701, DNJ-704 and DNJ-705 while for 1, 3-disubstitution (near 770 cm-1) 
was found in DNJ-702. Characteristic frequencies for C-F (near 990 cm-1), C-
Cl (near 870 cm-1) were found in DNJ-704 and DNJ-705 respectively. 
 
In case of DNJ-801 to DNJ-805 series of compounds, stretching and 
bending frequency for aromatic and stretching frequencies for methyl, 
methylene groups were found near 3050 cm-1, 1400-1640 cm-1, 2950 cm-1 
and 2850 cm-1 respectively in all the compounds. Characteristic frequency for 
hydroxyl group was obtained near 3600 cm-1 in all the compounds. Two 
Carbonyl stretching frequencies were obtained near 1700 cm-1 in all the 
compounds. Frequencies for ether linkage and C-N (3°) were obtained near 
1050 cm-1 and 1350 cm-1 respectively in all the compounds. Characteristic 
frequency for 1, 4-disubstitution (near 820 cm-1) was found in DNJ-802, DNJ-
804 and DNJ-805 while for 1, 3-disubstitution (near 770 cm-1) was found in 
DNJ-803. Characteristic frequencies for C-Cl (near 870 cm-1), C-F (near 990 
cm-1) were found in DNJ-804 and DNJ-805 respectively. 
 
In case of DNJ-901 to DNJ-905 series of compounds, stretching and 
bending frequency for aromatic and stretching frequencies for methyl, 
methylene groups were found near 3050 cm-1, 1400-1640 cm-1, 2950 cm-1 
and 2850 cm-1 respectively in all the compounds. Two Carbonyl stretching 
frequencies were obtained near 1700 cm-1 and 1670 cm-1 in all the 
compounds. Frequencies for ether linkage and C-N (3°) were obtained near 
1050 cm-1 and 1350 cm-1 respectively in all the compounds. Characteristic 
frequency for 1, 4-disubstitution (near 820 cm-1) was found in DNJ-901, DNJ-
904 and DNJ-905 while for 1, 3-disubstitution (near 770 cm-1) was found in 
DNJ-802. Characteristic frequencies for C-Cl (near 870 cm-1), C-F (near 990 
cm-1) were found in DNJ-904 and DNJ-905 respectively. 
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DNJ-1601 to DNJ-1605 and DNJ-1701 to DNJ-1705 serieses of 
compounds, almost similar kind of frequencies were observed. Stretching 
frequency for secondary amine group (-NH) was obtained near 3150 cm-1 in 
all the compounds. Stretching and bending frequency for aromatic and 
stretching frequencies for methyl, methylene groups were found near 3050 
cm-1, 1400-1640 cm-1, 2950 cm-1 and 2850 cm-1 respectively in all the 
compounds. Two Carbonyl stretching frequencies were obtained near 1700 
cm-1 and 1670 cm-1 in all the compounds while frequency for thioamide group 
(>CS) was obtained near 1150 cm-1 in DNJ-1701 to DNJ-1705. Frequencies 
for ether linkage, C-N (3°) and C-N (2°) were obtained near 1050 cm-1, 1350 
cm-1 and 1320 cm-1 respectively in all the compounds. Characteristic 
frequency for 1, 4-disubstitution (near 820 cm-1) was found in DNJ-1602, DNJ-
1604, DNJ-1605, DNJ-1702, DNJ-1704 and DNJ-1705 while for 1, 3-
disubstitution (near 770 cm-1) was found in DNJ-1603 and DNJ-1703. 
Characteristic frequencies for C-Cl (near 870 cm-1), C-F (near 990 cm-1) were 
found in DNJ-1604, DNJ-1704 and DNJ-1605, DNJ-1705 respectively. 
 
4.11.3   1H NMR SPECTRAL STUDY 
 
1H & 13C NMR spectra of the synthesized compounds were recorded 
on Bruker Avance II 400 spectrometer. Sample solutions were made in 
CDCl3 solvent using tetramethylsilane (TMS) as the internal standard unless 
otherwise mentioned. Numbers of protons and numbers of carbons identified 
from H NMR & C NMR spectrum and their chemical shift (δ ppm) were in the 
agreement of the structure of the molecule. J values were calculated to 
identify o, m and p coupling. In some cases, aromatic protons were obtained 
as multiplet. 1H & 13C NMR spectral interpretation can be discussed as under. 
 
1H NMR spectral interpretation of 3-{[3-(4-chlorophenyl)-1-phenyl-1H-
pyrazol-4-yl] methylene}-1-(2, 6-dichlorophenyl)-1, 3-dihydro-2H-indol-2-
one (DNJ-705) 
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1. Due to the two chlorine atoms substituted in meta position and nitrogen 
atom substituted to the para position, one aromatic proton of C13 
became shielded and gave doublet at 6.45 δ ppm. Due to the same 
environment of chlorine groups, two protons present at C12 and C14 
became identical and proton of C13 gave doublet instead of double 
doublet. 
2. Arylidine proton of C17 became deshielded and gave singlet in aromatic 
region at 7.61 δ ppm. 
3. One most deshielded proton of pyrazole ring gave singlet in down field 
at 9.92 δ ppm. 
4. Rests of the peaks are due to the aromatic protons of two phenyl rings 
substituted in pyrazole ring and two aromatic rings, one substituted at 
the nitrogen atom of indolinone nucleus and another fused to the 
nitrogen containing five membered ring. 
 
1H NMR spectral interpretation of 3-{(2Z)-3-[3-(4-chlorophenyl)-1-phenyl-
1H-pyrazol-4-yl] prop-2-enoyl}-4-hydroxy-2H-chromen-2-one (DNJ-804) 
 
1. Two protons of C15 and C16 gave double doublet in upfield at 5.70 δ 
ppm and 5.60 δ ppm respectively. J value of both the double doublet 
was come to 3.6 Hz which proved to be the compound-cis isomer. 
2. One proton of hydroxyl group became highest deshielded and did not 
appear till 10 δ ppm. 
3. One proton of pyrazole ring became most deshielded and gave singlet 
at 7.95 δ ppm. 
4. Rests of the peaks are due to the aromatic protons of two phenyl rings 
substituted in pyrazole ring and one phenyl ring fused to the pyran ring. 
 
1H NMR spectral interpretation of 3-{[3-(4-fluorophenyl)-1-phenyl-1H-
pyrazol-4-yl] methylene}-2H-chromene-2, 4(3H)-dione (DNJ-905) 
 
1. Arylidine proton of C12 became deshielded and gave single in aromatic 
region at 7.95 δ ppm. 
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2. One most deshielded proton of pyrazole ring gave singlet in the down 
field at 8.24 δ ppm. 
3. Rests of the peaks are due to the aromatic protons of two phenyl rings 
substituted in pyrazole ring and one phenyl ring fused to the pyran ring. 
 
1H NMR spectral interpretation of 4-[3-(3-nitrophenyl)-1-phenyl-1H-
pyrazol-4-yl]-3, 4-dihydro-2H-chromeno [4, 3-d] pyrimidine-2, 5(1H)-dione 
(DNJ-1603) 
 
1. Two most deshielded protons of secondary amine groups of pyrimidine 
ring gave singlet at 9.71 δ ppm and 9.97 δ ppm for C7 and C5 
respectively. 
2. One deshielded proton of pyrazole ring gave singlet in the down field at 
8.24 δ ppm. 
3. One shielded proton of pyrimidine ring (C8) gave singlet at 6.53 δ ppm. 
4. Rests of the peaks are due to the aromatic protons of two phenyl rings 
substituted in pyrazole ring and one phenyl ring fused to the pyran ring. 
 
1H NMR spectral interpretation of 4-[3-(3-nitrophenyl)-1-phenyl-1H-
pyrazol-4-yl]-2-thioxo-1,2,3,4-tetrahydro-5H-chromeno [4, 3-d] pyrimidin-
5-one (DNJ-1703) 
 
1. Two most deshielded protons of secondary amine groups of pyrimidine 
ring gave singlet at 9.79 δ ppm and 10.00 δ ppm for C7 and C5 
respectively. 
2. One deshielded proton of pyrazole ring gave singlet in the down field at 
8.24 δ ppm. 
3. One shielded proton of pyrimidine ring (C8) gave singlet at 6.53 δ ppm. 
4. Rests of the peaks are due to the aromatic protons of two phenyl rings 
substituted in pyrazole ring and one phenyl ring fused to the pyran ring. 
Chapter – 4                                                   Studies on different types of reactions….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                        245 
 
 
4.11.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on 
Vario EL Carlo Erba 1108 which showed calculated and found percentage 
values of Carbon, Hydrogen and Nitrogen in support of the structure of 
synthesized compounds. The spectral and elemental analysis data are given 
for individual compounds. 
 
4.12   ANALYTICAL DATA 
 
1-(2, 6-DICHLORO PHENYL)-3-{[3-(4-NITRO PHENYL)-1-PHENYL-1H-
PYRAZOL-4-YL] METHYLENE}-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-
701): IR (KBr, cm-1): 3063 (Ar-H, str), 1702 (>CO), 1602, 1564, 1523, 1493 
(Ar-H, ben), 1334 (C-N, Ar, 3°), 885 (C-Cl), 830 (1,4-di sub), 748 (1,2-di sub); 
MS m/z = 553 (M+); Anal. Calcd. for C30H18Cl2N4O3: C, 65.11; H, 3.28; N, 
10.12. Found: C, 65.15; H, 3.26; N, 10.15. 
 
1-(2, 6-DICHLORO PHENYL)-3-{[3-(3-NITRO PHENYL)-1-PHENYL-1H-
PYRAZOL-4-YL] METHYLENE}-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-
702): IR (KBr, cm-1): 3060 (Ar-H, str), 2962 (-CH2), 2856 (-CH3), 1703 (>CO), 
1605, 1560, 1521, 1493 (Ar-H, ben), 1333 (C-N, Ar, 3°), 890 (C-Cl), 775 (1,3-
di sub), 750 (1,2-di sub); MS m/z = 553 (M+); Anal. Calcd. for C30H18Cl2N4O3: 
C, 65.11; H, 3.28; N, 10.12. Found: C, 65.08; H, 3.24; N, 10.10. 
 
1-(2, 6-DICHLORO PHENYL)-3-[(1, 3-DIPHENYL-1H-PYRAZOL-4-YL) 
METHYLENE]-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-703): IR (KBr, cm-1): 
3066 (Ar-H, str), 2962 (-CH2), 2856 (-CH3), 1705 (>CO), 1605, 1564, 1523, 
1493 (Ar-H, ben), 1335 (C-N, Ar, 3°), 892 (C-Cl), 748 (1,2-di sub); MS m/z = 
508 (M+); Anal. Calcd. for C30H19Cl2N3O: C, 70.87; H, 3.77; N, 8.27. Found: C, 
70.90; H, 3.80; N, 8.30.  
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1-(2, 6-DICHLORO PHENYL)-3-{[3-(4-FLUORO PHENYL)-1-PHENYL-1H-
PYRAZOL-4-YL] METHYLENE}-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-
704): IR (KBr, cm-1): 3067 (Ar-H, str), 2966 (-CH2), 2860 (-CH3), 1700 (>CO), 
1600, 1565, 1525, 1491 (Ar-H, ben), 1335 (C-N, Ar, 3°), 990 (C-F), 890 (C-
Cl), 831 (1,4-di sub), 752 (1,2-di sub); MS m/z = 526 (M+); Anal. Calcd. for 
C30H18Cl2FN3O: C, 68.45; H, 3.45; N, 7.98. Found: C, 68.50; H, 3.50; N, 8.01.  
 
3-{[3-(4-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL] METHYLENE}-
1-(2, 6-DICHLORO PHENYL)-1, 3-DIHYDRO-2H-INDOL-2-ONE (DNJ-705): 
IR (KBr, cm-1): 3057 (Ar-H, str), 1700 (>CO), 1602, 1564, 1523, 1493 (Ar-H, 
ben), 1330 (C-N, Ar, 3°), 888 (C-Cl), 834 (1,4-di sub), 746 (1,2-di sub); 1H 
NMR (400 MHz, CDCl3): δ (ppm) 6.45 (1H, d, J = 7.72 Hz), 7.12 (1H, m, J = 
0.84 Hz, J = 0.64 Hz, J = 0.80 Hz), 7.22 (1H, m, J = 0.88 Hz, J = 0.88 Hz, J = 
0.92 Hz), 7.33 (1H, t), 7.46 (3H, m, J = 1.0 Hz, J = 1.88 Hz), 7.55 (5H, m, J = 
3.16 Hz, J = 1.92 Hz), 7.61 (1H, s), 7.69 (1H, m, J = 1.84 Hz), 7.87 (2H, t, J = 
1.16 Hz), 9.92 (1H, s); MS m/z = 542 (M+); Anal. Calcd. for C30H18Cl3N3O: C, 
66.38; H, 3.34; N, 7.74. Found: C, 66.33; H, 3.30; N, 7.70. 
 
3-[(2Z)-3-(1, 3-DIPHENYL-1H-PYRAZOL-4-YL) PROP-2-ENOYL]-4-
HYDROXY-2H-CHROMEN-2-ONE (DNJ-801): IR (KBr, cm-1): 3551 (-OH), 
3077 (Ar-H, str), 2971 (-CH3), 2858 (-CH2), 1727 (>CO), 1700 (>CO), 1621, 
1575, 1500, 1435 (Ar-H, ben), 1317 (C-N, Ar, 3°), 1088 (C-O-C); MS m/z = 
434 (M+); Anal. Calcd. for C27H18N2O4: C, 74.64; H, 4.18; N, 6.45. Found: C, 
74.69; H, 4.22; N, 6.50. 
 
4-HYDROXY-3-{(2Z)-3-[3-(4-NITRO PHENYL)-1-PHENYL-1H-PYRAZOL-4-
YL] PROP-2-ENOYL}-2H-CHROMEN-2-ONE (DNJ-802): 3567 (-OH), 3070 
(Ar-H, str), 2969 (-CH3), 2863 (-CH2), 1720 (>CO), 1703 (>CO), 1617, 1571, 
1495, 1420 (Ar-H, ben), 1320 (C-N, Ar, 3°), 1081 (C-O-C), 831 (1,4-di sub); 
MS m/z = 479 (M+); Anal. Calcd. for C27H17N3O6: C, 67.64; H, 3.57; N, 8.76. 
Found: C, 67.67; H, 3.60; N, 8.72.  
 
4-HYDROXY-3-{(2Z)-3-[3-(3-NITRO PHENYL)-1-PHENYL-1H-PYRAZOL-4-
YL] PROP-2-ENOYL}-2H-CHROMEN-2-ONE (DNJ-803): 3577 (-OH), 3066 
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(Ar-H, str), 2971 (-CH3), 2853 (-CH2), 1724 (>CO), 1708 (>CO), 1625, 1580, 
1535, 1440 (Ar-H, ben), 1327 (C-N, Ar, 3°), 1092 (C-O-C), 787 (1,3-di sub); 
MS m/z = 479 (M+); Anal. Calcd. for C27H17N3O6: C, 67.64; H, 3.57; N, 8.76. 
Found: C, 67.69; H, 3.53; N, 8.80.  
 
3-{(2Z)-3-[3-(4-CHLORO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL] PROP-
2-ENOYL}-4-HYDROXY-2H-CHROMEN-2-ONE (DNJ-804): IR (KBr, cm-1): 
3539 (-OH), 1722 (>CO), 1708 (>CO), 1610, 1505, 1429 (Ar-H, ben), 1305 
(C-N, Ar, 3°), 1095 (C-O-C), 876 (C-Cl), 842 (1,4-di sub); 1H NMR (400 MHz, 
CDCl3): δ (ppm) 5.60 (1H, d, J = 3.6 Hz), 5.70 (1H, d, J = 3.6 Hz), 7.28 (4H, 
q), 7.45 (2H, t), 7.53 (2H, q, J = 0.88 Hz, J = 0.92 Hz), 7.68 (2H, d, J = 9.52 
Hz), 7.86 (3H, qt, J = 1.92 Hz), 7.95 (1H, s); MS m/z = 468 (M+); Anal. Calcd. 
for C27H17ClN2O4: C, 69.16; H, 3.65; N, 5.97. Found: C, 69.20; H, 3.60; N, 
6.00.  
 
3-{(2Z)-3-[3-(4-FLUORO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL] PROP-
2-ENOYL}-4-HYDROXY-2H-CHROMEN-2-ONE (DNJ-805): IR (KBr, cm-1): 
3547 (-OH), 3060 (Ar-H, str), 2958 (-CH3), 2870 (-CH2), 1725 (>CO), 1712 
(>CO), 1605, 1500, 1470, 1429 (Ar-H, ben), 1310 (C-N, Ar, 3°), 1092 (C-O-C), 
995 (C-F), 837 (1,4-di sub); MS m/z = 452 (M+); Anal. Calcd. for C27H17FN2O4: 
C, 71.68; H, 3.79; N, 6.19. Found: C, 71.70; H, 3.80; N, 6.15. 
 
3-[(1, 3-DIPHENYL-1H-PYRAZOL-4-YL) METHYLENE]-2H-CHROMENE-2, 
4(3H)-DIONE (DNJ-901): IR (KBr, cm-1): 2966 (-CH3), 2866 (-CH2), 1732 
(>CO, lactam ring), 1666 (>CO), 1608, 1560, 1508, 1470 (Ar-H, ben), 1380 
(C-N, Ar, 3°), 1115 (C-O-C); MS m/z = 392 (M+); Anal. Calcd. for C25H16N2O3: 
C, 76.52; H, 4.11; N, 7.14. Found: C, 76.57; H, 4.15; N, 7.18. 
 
3-{[3-(4-NITROPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL] METHYLENE}-
2H-CHROMENE-2, 4(3H)-DIONE (DNJ-902): IR (KBr, cm-1): 2959 (-CH3), 
2866 (-CH2), 1730 (>CO, lactam ring), 1670 (>CO), 1610, 1560, 1503, 1455 
(Ar-H, ben), 1385 (C-N, Ar, 3°), 1105 (C-O-C), 840 (1,4-di sub); MS m/z = 437 
(M+); Anal. Calcd. for C25H15N3O5: C, 68.65; H, 3.46; N, 9.61. Found: C, 
68.60; H, 3.50; N, 9.65.  
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3-{[3-(3-NITROPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL] METHYLENE}-
2H-CHROMENE-2,4(3H)-DIONE (DNJ-903): IR (KBr, cm-1): 2967 (-CH3), 
2855 (-CH2), 1725 (>CO, lactam ring), 1665 (>CO), 1603, 1568, 1515, 1460 
(Ar-H, ben), 1381 (C-N, Ar, 3°), 1107 (C-O-C), 781 (1,3-di sub); MS m/z = 437 
(M+); Anal. Calcd. for C25H15N3O5: C, 68.65; H, 3.46; N, 9.61. Found: C, 
68.66; H, 3.42; N, 9.57.  
 
3-{[3-(4-CHLORO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL] 
METHYLENE}-2H-CHROMENE-2, 4(3H)-DIONE (DNJ-904): IR (KBr, cm-1): 
2960 (-CH3), 2866 (-CH2), 1721 (>CO, lactam ring), 1667 (>CO), 1606, 1563, 
1500, 1460 (Ar-H, ben), 1385 (C-N, Ar, 3°), 1110 (C-O-C), 877 (C-Cl), 836 
(1,4-di sub); MS m/z = 426 (M+); Anal. Calcd. for C25H15ClN2O3: C, 70.34; H, 
3.54; N, 6.56. Found: C, 70.30; H, 3.58; N, 6.60.  
 
3-{[3-(4-FLUORO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL] METHYLENE}-
2H-CHROMENE-2, 4(3H)-DIONE (DNJ-905): IR (KBr, cm-1): 1727 (>CO, 
lactam ring), 1660 (>CO), 1612, 1560, 1505, 1464 (Ar-H, ben), 1382 (C-N, Ar, 
3°), 1112 (C-O-C), 998 (C-F), 839 (1,4-di sub); 1H NMR (400 MHz, CDCl3): δ 
(ppm) 7.28 (4H, q), 7.45 (3H, t), 7.53 (3H, q, J = 1.28 Hz, J = 1.24 Hz), 7.86 
(3H, qt, J = 1.92 Hz), 7.95 (1H, s), 8.24 (1H, s); MS m/z = 410 (M+); Anal. 
Calcd. for C25H15FN2O3: C, 73.17; H, 3.68; N, 6.83. Found: C, 73.20; H, 3.72; 
N, 6.87.  
 
4-(1, 3-DIPHENYL-1H-PYRAZOL-4-YL)-3, 4-DIHYDRO-2H-CHROMENO [4, 
3-D] PYRIMIDINE-2, 5(1H)-DIONE (DNJ-1601): IR (KBr, cm-1): 3185 (-NH), 
3095 (Ar-H, str), 2967 (-CH3), 2847 (-CH2), 1727 (>CO, lactam ring), 1655 
(>CO, amide), 1610, 1562, 1544, 1493 (Ar-H, ben), 1347 (C-N, Ar, 3°), 1315 
(C-N, Ar, 2°), 1057 (C-O-C); MS m/z = 434 (M+); Anal. Calcd. for C26H18N4O3: 
C, 71.88; H, 4.18; N, 12.90. Found: C, 71.83; H, 4.22; N, 12.94.  
 
4-[3-(4-NITRO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-3, 4-DIHYDRO-
2H-CHROMENO [4, 3-D] PYRIMIDINE-2, 5(1H)-DIONE (DNJ-1602): IR (KBr, 
cm-1): 3182 (-NH), 3090 (Ar-H, str), 2962 (-CH3), 2850 (-CH2), 1730 (>CO, 
lactam ring), 1660 (>CO, amide), 1604, 1560, 1550, 1500 (Ar-H, ben), 1350 
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(C-N, Ar, 3°), 1320 (C-N, Ar, 2°), 1055 (C-O-C), 820 (1,4-di sub); MS m/z = 
479 (M+); Anal. Calcd. for C26H17N5O5: C, 65.13; H, 3.57; N, 14.61. Found: C, 
65.17; H, 3.60; N, 14.65. 
 
4-[3-(3-NITROPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-3, 4-DIHYDRO-2H-
CHROMENO [4, 3-D] PYRIMIDINE-2, 5(1H)-DIONE (DNJ-1603): IR (KBr, 
cm-1): 3180 (-NH), 3092 (Ar-H, str), 1729 (>CO, lactam ring), 1657 (>CO, 
amide), 1611, 1565, 1548, 1498 (Ar-H, ben), 1351 (C-N, Ar, 3°), 1318 (C-N, 
Ar, 2°), 1050 (C-O-C), 780 (1,3-di sub); 1H NMR (400 MHz, CDCl3): δ (ppm) 
6.53 (1H, s), 7.28 (3H, q), 7.45 (2H, t), 7.53 (2H, q, J = 0.88 Hz, J = 0.68 Hz), 
7.68 (2H, d, J = 8.88 Hz), 7.86 (3H, qt, J = 0.92 Hz), 7.95 (1H, s), 8.24 (1H, s), 
9.71 (1H, s), 9.97 (1H, s); MS m/z = 479 (M+); Anal. Calcd. for C26H17N5O5: C, 
65.13; H, 3.57; N, 14.61. Found: C, 65.10; H, 3.53; N, 14.57. 
 
4-[3-(4-CHLORO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-3, 4-DIHYDRO-
2H-CHROMENO [4, 3-D] PYRIMIDINE-2, 5(1H)-DIONE (DNJ-1604): IR (KBr, 
cm-1): 3189 (-NH), 3087 (Ar-H, str), 2958 (-CH3), 2867 (-CH2), 1725 (>CO, 
lactam ring), 1655 (>CO, amide), 1605, 1560, 1542, 1488 (Ar-H, ben), 1355 
(C-N, Ar, 3°), 1321 (C-N, Ar, 2°), 1047 (C-O-C), 875 (C-Cl), 825 (1,4-di sub); 
MS m/z = 468 (M+); Anal. Calcd. for C26H17ClN4O3: C, 66.60; H, 3.65; N, 
11.95. Found: C, 66.65; H, 3.70; N, 12.00.  
 
4-[3-(4-FLUORO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-3, 4-DIHYDRO-
2H-CHROMENO [4, 3-D] PYRIMIDINE-2, 5(1H)-DIONE (DNJ-1605): IR (KBr, 
cm-1): 3182 (-NH), 3080 (Ar-H, str), 2952 (-CH3), 2861 (-CH2), 1727 (>CO, 
lactam ring), 1659 (>CO, amide), 1601, 1555, 1530, 1480 (Ar-H, ben), 1350 
(C-N, Ar, 3°), 1320 (C-N, Ar, 2°), 1052 (C-O-C), 995 (C-F), 830 (1,4-di sub); 
MS m/z = 452 (M+); Anal. Calcd. for C26H17FN4O3: C, 69.02; H, 3.79; N, 12.38. 
Found: C, 68.98; H, 3.82; N, 12.34.  
 
4-(1, 3-DIPHENYL-1H-PYRAZOL-4-YL)-5-THIOXO-1, 3, 4, 5-
TETRAHYDRO-2H-CHROMENO [4, 3-D] PYRIMIDIN-2-ONE (DNJ-1701): IR 
(KBr, cm-1): 3187 (-NH), 3092 (Ar-H, str), 2965 (-CH3), 2841 (-CH2), 1725 
(>CO, lactam ring), 1608, 1565, 1541, 1490 (Ar-H, ben), 1355 (C-N, Ar, 3°), 
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1315 (C-N, Ar, 2°), 1167 (>CS, thioamide), 1085 (C-O-C); MS m/z = 450 (M+); 
Anal. Calcd. for C26H18N4O2S: C, 69.32; H, 4.03; N, 12.44. Found: C, 69.36; 
H, 4.08; N, 12.48.  
 
4-[3-(4-NITRO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-5-THIOXO-1, 3, 4, 
5-TETRAHYDRO-2H-CHROMENO [4, 3-D] PYRIMIDIN-2-ONE (DNJ-1702): 
IR (KBr, cm-1): 3187 (-NH), 3085 (Ar-H, str), 2964 (-CH3), 2855 (-CH2), 1727 
(>CO, lactam ring), 1615, 1568, 1545, 1494 (Ar-H, ben), 1355 (C-N, Ar, 3°), 
1326 (C-N, Ar, 2°), 1165 (>CS, thioamide), 1085 (C-O-C), 827 (1,4-di sub); 
MS m/z = 495 (M+); Anal. Calcd. for C26H17N5O4S: C, 63.02; H, 3.46; N, 14.13. 
Found: C, 63.06; H, 3.41; N, 14.17.  
 
4-[3-(3-NITRO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-5-THIOXO-1, 3, 4, 
5-TETRAHYDRO-2H-CHROMENO [4, 3-D] PYRIMIDIN-2-ONE (DNJ-1703): 
IR (KBr, cm-1): 3178 (-NH), 3091 (Ar-H, str), 1729 (>CO, lactam ring), 1609, 
1561, 1539, 1501 (Ar-H, ben), 1353 (C-N, Ar, 3°), 1316 (C-N, Ar, 2°), 1162 
(>CS, thioamide), 1088 (C-O-C), 750 (1,3-di sub); 6.53 (1H, s), 7.28 (3H, q), 
7.45 (2H, t), 7.53 (2H, q, J = 0.88 Hz, J = 1.24 Hz), 7.68 (2H, d, J = 9.12 Hz), 
7.86 (3H, qt, J = 1.96 Hz), 7.95 (1H, s), 8.24 (1H, s), 9.79 (1H, s), 10.00 (1H, 
s); MS m/z = 495 (M+); Anal. Calcd. for C26H17N5O4S: C, 63.02; H, 3.46; N, 
14.13. Found: C, 63.04; H, 3.42; N, 14.17.  
 
4-[3-(4-CHLORO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-5-THIOXO-1, 3, 
4, 5-TETRAHYDRO-2H-CHROMENO [4, 3-D] PYRIMIDIN-2-ONE (DNJ-
1704): IR (KBr, cm-1): 3182 (-NH), 3085 (Ar-H, str), 2961 (-CH3), 2865 (-CH2), 
1729 (>CO, lactam ring), 1607, 1565, 1545, 1492 (Ar-H, ben), 1353 (C-N, Ar, 
3°), 1325 (C-N, Ar, 2°), 1160 (>CS, thioamide), 1047 (C-O-C), 877 (C-Cl), 821 
(1,4-di sub); MS m/z = 484 (M+); Anal. Calcd. for C26H17ClN4O2S: C, 64.39; H, 
3.53; N, 11.55. Found: C, 64.35; H, 3.57; N, 11.50.  
 
4-[3-(4-FLUORO PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-5-THIOXO-1, 3, 
4, 5-TETRAHYDRO-2H-CHROMENO [4, 3-D] PYRIMIDIN-2-ONE (DNJ-
1705): IR (KBr, cm-1): 3188 (-NH), 3085 (Ar-H, str), 2951 (-CH3), 2863 (-CH2), 
1730 (>CO, lactam ring), 1613, 1559, 1535, 1487 (Ar-H, ben), 1357 (C-N, Ar, 
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3°), 1328 (C-N, Ar, 2°), 1164 (>CS, thioamide), 1052 (C-O-C), 990 (C-F), 832 
(1,4-di sub); MS m/z = 468 (M+); Anal. Calcd. for C26H17FN4O2S: C, 66.65; H, 
3.66; N, 11.96. Found: C, 66.70; H, 3.70; N, 12.00. 
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4.13   RESULTS AND DISCUSSION 
 
Four different schemes had been adopted to build up this chapter. This 
chapter is mostly related to modification in the previous work done by our 
group as well as others but the scaffolds reported here are new. Earlier 
indolinone derivatives were known to be prepared by conventional method 
using piperidine (base) in refluxing methanol or ethanol. Different 2-indolinone 
derivatives have been prepared by adopting the conventional method. 
Moreover, microwave assisted method was also employed to compare both 
the methods in order to acquire best results. Microwave assisted method 
found much faster than the conventional one and % yield found to be higher 
than conventional but the purity was similar in both the methods.  
 
It is very well known that C3 position of 4-hydroxycoumarin is highly 
reactive. 3-acetyl-4-hydroxycoumarin was synthesized by acetylation on 4-
hydroxycoumarin adopting cited literature method. Chalcones of 3-acetyl-4-
hydroxycoumarin were prepared using substituted benzaldehydes using 
piperidine (base) and chloroform which showed good anti viral activity j. In this 
chapter, continuing previous work chalcones of 3-acetyl-4-hydroxycoumarin 
using differently substituted pyrazole aldehydes were synthesized using the 
same experimental protocol. 
 
4-hydroxycoumarin and different pyrazole aldehydes were refluxed in 
methanol under basic condition in order to prepare coumarin dimers but the 4-
hydroxycoumarin tautomarize into 2H-chromene-2, 4(3H)-dione and due to 
the in situ generation of active methylene group it gave arylidine at C3-
position. 
 
Three component Biginelli reaction was used to prepare the coumarin 
fused pyrimidine derivatives. Mixture of urea / thio urea, pyrazole aldehyde 
                                                 
j J. C. Trivedi, J. B. Bariwal, K. D. Upadhyay, Y. T. Naliapara, S. K. Joshi, C. C. Pannecouque, 
E. De Clercq and A. K. Shah; Tet. Lett., 2007, 48(48), 8472. 
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and 4-hydroxycoumarin was refluxed into methanol under acidic condition to 
give rise to the expected product.  
 
 
4.14   CONCLUSION 
 
2-Indolinone derivatives have recently been established as an anti 
cancer compounds and more specifically as tyrosine kinase inhibitors 
(SU5416, SU5614, SU6668, SU6597, SU6663 and SU6561) that block kit 
activation and growth of small cell in lung cancer. Moreover Virsodia et. al. a 
reported the anticancer evaluation results of the arylidine products of 1-(2, 6-
dichlorophenyl)-2-indolinone. Biological importance of such scaffolds inspired 
us to prepare new indolinone derivatives and to carry out their anticancer 
evaluation. 
 
4-hydroxycoumarin is a versatile scaffold and is being consistently 
used as a building block in organic chemistry as well as in heterocyclic 
chemistry for the synthesis of different heterocycles. The synthetic versatility 
of 4-hydroxycoumarin has led to the extensive use of this compound in 
organic synthesis. 4-hydroxy coumarin shows diversified chemical reactivity 
and biological profile. Thus it was of interest to study the biological activities of 
newly synthesized coumarin derivatives. 
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4.15  SPECTRAL REPRESENTATION OF SYNTHESIZED 
COMPOUNDS 
 
4.15.1   Mass Spectrum of DNJ-705 
 
 
 
4.15.2   IR Spectrum of DNJ-705 
 
 
 
 
500750100012501500175020002500300035004000
1/cm
20
40
60
80
100
120
%T
30
76
.5
6
30
57
.2
7
17
00
.3
1
16
97
.4
1 1
62
0.
26
16
02
.9
0
15
64
.3
2
15
23
.8
2
14
93
.9
2
14
61
.1
3
14
37
.0
2
13
84
.9
4
13
30
.9
3
12
14
.2
3
11
76
.6
2
11
54
.4
3
10
98
.5
0
10
51
.2
4
10
12
.6
6
95
4.
80
88
8.
25
83
4.
24
78
4.
09
74
6.
48
68
5.
72
63
3.
64
55
6.
48
51
6.
94 4
48
.4
6
DNJ-705
N
O
N
N
Cl
Cl
Cl
MW : 542 g/m 
Chapter – 4                                                   Studies on different types of reactions….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                        255 
 
 
4.15.3   1H NMR Spectrums of DNJ-705 
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4.15.4   Mass Spectrum of DNJ-804 
 
 
 
 
4.15.5   IR Spectrum of DNJ-804 
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4.15.6   1H NMR Spectrums of DNJ-804 
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4.15.7   Mass Spectrum of DNJ-905 
 
 
 
 
4.15.8   IR Spectrum of DNJ-905 
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4.15.9   1H NMR Spectrums of DNJ-905 
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4.15.10   Mass Spectrum of DNJ-1603 
 
 
 
 
4.15.11   IR Spectrum of DNJ-1603 
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4.15.12   1H NMR Spectrums of DNJ-1603 
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4.15.13   Mass Spectrum of DNJ-1703 
 
 
 
 
4.15.14   IR Spectrum of DNJ-1703 
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4.15.15   1H NMR Spectrums of DNJ-1703 
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5.1   INTRODUCTION TO ARYLAMINOCOUMARIN 
 
Many coumarin molecules are known in literature but 4-aminocoumarin 
is not much reported. The preparation of 4-aminocoumarin and other 4-
arylaminocoumarins are pioneered by various research workers. 
 
Apparently it is found that 4-aminocourmarin is prepared by direct 
method by removing acidic hydroxyl group (1) with amino group (3) in one 
step only, but alternate route is to convert the hydroxyl group (1) into chloro 
group (2) and then convert it into amino group (3) by appropriate reagent for 
substitution. (Fig. 5.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The conversion of 4-hydroxy coumarin can also be afforded by a direct 
one step method using appropriate arylamine using solvents, without solvents 
under conventional heating or by using microwave assisted synthetic strategy. 
 
A small review of current update is included. 
 
O O
OH
O O
NH
R
O O
Cl
(1)
(2)
(3)
R = H, Alkyl or Aryl
Fig. 5.1
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Anschutz 1 reported the synthesis of 4-anilinocoumarin during his 
pioneering work by heating 4-hydroxycoumarin with aniline. 
 
Checchi and Vettori 2 prepared 4-aminocoumarin-3-sulphonamide and 
its derivatives. Sulphonation of 4-hydroxycoumarin in absence of any solvent, 
with an excess of chlorosulphonic acid yielded 3-sulphonic acid, which was 
converted to its potassium salt and on further chlorination with phosphorous 
oxychloride, afforded 4-chlorocoumarin sulphochloride. The treatment of 
either ammonia or primary aliphatic and aromatic amines led to the formation 
of 4-aminocoumarin-3-sulphonamide and its derivatives. 
 
Zagorevskii 3 reported that the action of liquor ammonia on 4-
chlorocoumarin in the presence of copper powder exclusively afforded the 4-
aminocoumarin. In another method, 4-chlorocoumarin when treated with 
concentrated ammonium hydroxide in dioxane for 40 hours at room 
temperature afforded 4-aminocoumarin in 25% yield and o-
hydroxyphenylpropionamide (52% yield) 4, 5 due to opening of the lactone ring. 
However, only the desired 4-aminocoumarins were obtained in some cases. 6-
9 (Fig. 5.2) 
 
 
 
 
 
 
 
 
 
Mustafa et. al. 10 reported the synthesis for the preparation of 4-
anilinocoumarin in low yield by refluxing 4-hydroxycoumarin with aniline in 
ethanol. 
 
Wolfbeis 11 reported the synthesis of 4-arylaminocoumarin from 4-
hydroxycoumarin by direct condensation with anilines. 
 
O O
NH2
OH
NH2
O
4-aminocoumarin o-hydroxyphenylpropionamide
Fig. 5.2
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4-arylaminocoumarins were prepared by treatment of an ethanolic 
solution of 4-hydroxycoumarin and o-aminobenzaldehyde under reflux 
condition, which on further cyclization afforded 6H-[1] benzopyrano [4, 3-b] 
quinoline. 12 This has proved the way for another clean method for the 
synthesis of 3, 4-fused systems on coumarin nucleus. (Fig. 5.3) 
 
 
 
 
Asherson et. al. 13 heated dicoumarol and 4-hydroxycoumarin with 
aniline to yield 4-arylaminocoumarin. Which was further validated by Conlin 
et. al. 14 while they heated dicoumarol and 4-hydroxycoumarin with aniline, 
benzylamine and cyclohexylamine under reflux to yield corresponding anil of 
4-hydroxycoumarin. 
 
Stunic et. al. 15 synthesized N-substituted-(3-nitrocoumarinyl) 
aminoacids from 4-chloro-3-nitrocoumarin in good yield. (Fig. 5.4) 
 
 
 
O O
OH
+
NH2
OHC
O O
NH
CHO
O
N
O
4 hours
Ethanol Reflux
6 hours Reflux
Fig. 5.3
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Bhatt and Thakor 16 prepared 4-anilinocoumarins by direct 
condensation of 4-hydroxycoumarins with different amines, thus opening the 
single step route of such arylaminocoumarin derivatives. 
 
Joshi 17 and Berghaus 18 have also independently reported the 
synthesis of 4-amino [1] benzopyrans as intermediate products during 
annelation. 
 
Reddy et. al. 19 carried out condensation reaction of 4-hydroxycoumarin 
and 2-aminothiophenol in dimethylsulfoxide. This cyclized product was 
desulfurized with Raney-Nickel to give 4-arylaminocoumarin. 
 
Bardan et. al. 20 have prepared 4-aminocoumarin by condensation of 
primary and secondary amine with 4-chlorocoumarin under reflux in xylene. 
 
In another different approach, during the study of β-ketoenamino 
functionality, the 4-hydroxycoumarins were directly converted to 4-amino / 4-
arylamino coumarins by Ivanov et. al. 21 
 
Kirpichenok et. al. 22 reacted 3-iodo-7(dialkylamino) coumarins with 
different secondary amines (viz. diethylamine, piperidine, morpholine, 
imidazole and benzimidazole) in order to get 4-(substituted amino) coumarin 
derivatives in good yield. 
 
Tabaković et. al. 23 also reported the preparation of 3-nitro-4-
anilinocoumarin by refluxing 3-nitro-4-coumarinyl-N-phenyldithiocarbamate in 
dimethylformamide for 30 minutes. 
O O
Cl
NO2
O O
NO2
NH
R
COOR'
R = R' = H, CH3, C2H5
Fig. 5.4
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Hamdi et. al. 24 reported that heating 1, 2-phenylenediamine with the 4-
hydroxycoumarin in ethanol, two products were obtained, one was N-(2-
aminophenyl)-3-hydroxy-3-(2-hydroxyphenyl) acrylamide and another was 4-
[(2-aminophenyl) amino]-2H-chromen-2-one. While 1, 4-phenylenediamine 
was refluxed in xylene with 4-hydroxycoumarin, it also gave two products, one 
was 4-[(4-aminophenyl) amino]-2H-chromen-2-one and another was the 
dimer. 
 
Papousis et. al. 25 prepared 3-phenyliodonium tosylate from 4-
aminocoumarin using [hydroxyl(tosyloxy)iodo]benzene which upon 
basification converted to its conjugated acid which on refluxing in acetonitrile 
gave 3-iodo-4-anilinocoumarin. Further they reported that treating 3-iodo-4-
anilinocoumarin with PdCl2(PPh3)2 in triethylamine and tetrahydrofuran gave 
4-anilinocoumarin. 
 
Hamdi et. al. 26 further tried to explain different possibilities on reaction 
of 4-hydroxycoumarin with 1, 2-diamino ethane in isopropyl alchohol for 4 
hours. (Fig. 5.5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O O
OH
O O
NHCH2CH2NH2
4 hours
O
NH
NH
O
O
O
NH2CH2CH2NH2
4 hours NH2CH2CH2NH2
4 hours
NH2CH2CH2NH2
OH
ONH
NH2
Fig. 5.5
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Andrea et. al. 27 synthesized 4-(2'-Aminophenyl) amino-3-
coumarincarbaldehyde by condensing 4-chloro-3-coumarin carbaldehyde with 
o-phenylene diamine in presence of triethylamine in refluxing ethanol. 
 
Kováč et. al. 28 synthesized substituted 4-(substituted amino)coumarin 
by reacting coumarin-4-sulphonamide with phenoxy N-(substituted)carbamate 
in presence of DBU (diazabicycloundecene) under reflux, while N-(4-
isopropylphenyl)-4-aminocoumarin was synthesized by reacting coumarin-4-
sulphonamide with 4-isopropylphenyl isocyanate in presence of DBN 
(diazabicyclononene) under reflux in dioxane.  
 
Stoyanov et. al. 29 reported that the reaction of 4-hydroxycoumarin with 
some primary amines and morpholine under microwave irradiation occurred 
without opening of the lactone ring to give N-substituted 4-aminocoumarins in 
excellent yields. Under the same experimental conditions, 4-hydroxy-6-
methyl-2-pyrone reacted with benzylamine or 2-phenylethylamine to give the 
corresponding N, N'-di substituted 4-amino-6-methyl-2-pyridones. The main 
advantages of this procedure are dramatically shortened reaction time, higher 
amine utilization and considerably improved yields.  
 
Soman 30 prepared 4-arylamino derivative of 4-hydroxy-11-methyl-2H-
[1] benzofuro [3, 2-g] chromen-2-one by refluxing them in dimethylformamide 
for shorter time period. 
 
Chavan 31 prepared 4-aryl- and 4-alkylaminocoumarins by reaction of 
4-hydroxycoumarin with amines under microwave irradiation using solvent-
free conditions in good to excellent yields. 
 
Shcherbakov et. al. 32, 33 reported that the 4-hydroxy-5, 6, 7, 8-
tetrafluorocoumarin reacts with the monoamines to form salts under the mild 
conditions or the 4-alkyl (aryl) aminocoumarins on refluxing in o-xylene.  The 
3 – acetyl - 4- hydroxyl - 5, 6, 7, 8 - tetrafluorocoumarin reacts with the strong 
basic amines in the polar solvents to give salts that can be transformed into 
the 3 – alkylaminoethylidene - 5, 6, 7, 8 – tetrafluorobenzopyran - 2, 4 - 
diones.  The later can be obtained by reaction of the 3 - acetylcoumarin with 
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different amines.  By reacting 3 - acetylcoumarin with the strong basic amines 
in dimethylsulfoxide gave 7 – alkylamino – 3 – alkylaminoethylidene - 5, 6, 8 - 
trifluorobenzopyrandiones. The 3 – acetimidoyl – 4 – hydroxyl - 5, 6, 7, 8 - 
tetrafluorocoumarin affords the 3 - alkylaminoethylidenebenzopyrandiones 
with the monoamines, but in dimethylsulfoxide the 7-substituted 3-acetimidoyl-
5, 6, 8-trifluorobenzopyrandiones or the 7-alkylamino-3-alkylaminoethylidene-
5, 6, 8-triflurobenzopyrandiones can be obtained. 
 
Ghosh et. al. 34 converted 2-Aminochromones into 4-chlorocoumarins 
by reacting them with phosphorous oxychloride. Which on subsequent 
treatment with ethylenediamine gave 2, 3, 4, 5-tetrahydro-7-(2'-
hydroxyphenyl)-1, 4-diazepin-5-ones and 4-[(2-aminoethyl) amino] coumarins 
in ethanol. While in dimethylformamide, it gave [4-(2-formamidoethyl) 
aminocoumarins]. 
 
Ganina et. al. 35 synthesized different 4-arylaminocoumarins in high 
yields by reacting 4-hydroxycoumarin trifluoromethanesulfonates with different 
amines in refluxing dioxane with the presence of pyridine. 
 
Strakova et. al. 36 heated 4-hydroxycoumarin with aniline, p-toluidine, 
p-anisidine and benzylamine without solvent at higher temperature to yield the 
corresponding 4-arylaminocoumarins. These compounds were converted to 
N-substituted 4-amino-3-(chloroacetyl) coumarins by treating them with 
excess of chloroacetyl chloride.  The later products while reacted with 
thiourea gave 3-(2-amino-4-thiazolyl)-4-aminocoumarins. 
 
Zhang et. al. 37 generated 4-amino-3-arylcoumarin by consecutive 
Suzuki-Miyaura reaction / nucleophilic substitution of 3-aryl-4-tosyloxy 
coumarin using potassium carbonate and ethanol.  
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5.2   BIOLOGICAL ACTIVITIES ASSOCIATED WITH 4-
ARYLAMINOCOUMARINS AND ITS DERIVATIVES 
 
Spalding et. al. 4 studied 4-morpholino coumarins as analogue of the 
camaqauin (quinoline-antimalarial) for antimalarial activity in the plasmodium 
gallinaceum infection in chicks, but the compounds were found to be inactive, 
while 7-(4-aminosulphonamide) coumarins were found to possess stronger 
tubercular activity. 38 
 
Bechmann 39 studied the antibacterial activity of the compounds for the 
type shown in Fig. 5.6. 3-nitro-4-(2-pyridylamino) coumarins were tested for 
their antimicrobial activity against S. aureus, E. coli and C. alebicans. 40  
 
 
 
 
 
 
 
 
 
 
Leurquin 41 reported orally active 4-piperazinylcoumarin as 
psychotropic compounds. 
 
Zagorevskii et. al. 42, 43 have prepared several 3-nitro-4-
aminocoumarins possessing neutropic activity, generally inhibiting 
spontaneous locomotor activity and decreasing hypersensitivity induced by 
phenamine and prolonging sleep due to a barbiturate drug thiopental. 
Zagorevskii 44 further reported weak psychotropic activity in arylamino 
coumarin derivatives of the type shown in Fig. 5.7.  
O O
NO2
NH
N
O O
NH
N(CH2)3Ph
Fig. 5.6
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Bardan et. al. 45 reported the synthesis of a novel series of substituted-
aminocoumarins (1) (R, R1 = H, OH, N-arylamino) and the preliminary 
evaluation of their in vitro antimicrobial activity was described.  The reaction of 
(1) (R = OH; R1 = H) (Fig. 5.8) with a numbers of primary or cyclic secondary 
amines afforded the corresponding aminocoumarin derivatives. Antimicrobial 
screening showed that some of these novel compounds possess moderate 
activity against Bacillus subtilis and Bacillus pumilus. 
 
 
 
 
 
 
 
 
 
 
In last few years, new structural classes of tyrosine kinase inhibitors 
(anticancer agents) have begun to emerge which exhibit enormous 
improvements in potency and specificity over prior compounds. Most of these 
compounds are directed against either the epidermal growth factor (EGF) or 
platelers derived growth factor (PDGF) receptor tyrosine kinease and have 
O O
NR
O O
NR
R = H, OH, CH3
O O
R
R1
1
Fig. 5.7
Fig. 5.8
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capacity to effectively suppress their targets in cells. Structures types shown 
in Fig. 5.9 were found to be most effective. 46, 47 
 
As structural features of above compounds tallies with the title 
compounds (i.e. 4-aryl aminocoumarins), it induced to study the possible 
alteration in the activity by substituting the benzenoid part either with 
electrone withdrawing group (EWG) or electrone donating group (EDG) and 
also by shifting of the heterocyclic system for 4-anilinoquinazoline to other 
structures like 4-anilinocoumarins. 
 
Shan and coworkers 48-53 have synthesized the following type of 4-
arylaminocoumarins shown in Fig. 5.10 and screened for anti-HIV activity 
against HIV-1 (strain HTLV-IIIB / LAI) 54 and HIV-2 (strain LAV-2ROD) 55 and 
antitubercular activity against M. tuberculosis H37Rv. 
 
 
 
 
 
 
 
 
 
 
 
 
N
N
NH
N
NH
O
CH3
O
CH3
N
H
O O
NH
R
R'
R = H, CH3, di-CH3, Benzo etc...
R' = H, CH3, di-CH3, OCH3, Cl, di-Cl etc...
Fig. 5.9
Fig. 5.10
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Recently Hamdi et. al. 56 reported the reaction of 4-hydroxycoumarin in 
toluene with a variety of aromatic bis (nucleophilic) compounds, where 3-
(dimethylaminomethylene)-2, 4-chromandione was used as a key 
intermediate for the preparation of bis [N-(4-oxocoumarinylmethylene)]-1, 4-
diamines. Alternative synthetic procedures and antibacterial activity data of 
some of the new compounds were given. Compounds thus prepared, i.e., 1, 
3-dihydro-4-(2-hydroxyphenyl)-2H-1, 5-benzodiazepin-2-one, 4-[(2-
mercaptophenyl) amino]-2H-1-benzopyran-2-one and 4-[(2-hydroxyphenyl) 
amino]-2H-1-benzopyran-2-one were evaluated for their antibacterial activity 
against Staphylococcus aureus. 
 
Braccio et. al. 57 obtained the N-substituted tricyclic 2-aminochromone 
derivatives by treating the corresponding (methylthio) or (methylsulfinyl) 
derivatives with an excess of the properly substituted amines.  Compound (1) 
(R = R1 = Ph) was synthesized through the reaction of β-naphthol with the 
base / POCl3 reagent.  The N-substituted 4-aminocoumarin bicyclic and 
tricyclic derivatives such as (2) [X = OCH3, Y = H (3)] were prepared by 
treating the corresponding chloro derivatives with the excess of properly 
substituted amines.  Compounds were tested in vitro for their antiproliferative 
activity (DNA synthesis inhibition in Ehrlich cells) and cytotoxicity (MTT test in 
HeLa cells).  The inhibitory properties of three selected compounds (3), (2) (X 
= Y = OCH2O) and (4) on protein and RNA syntheses in Ehrlich cells were 
also evaluated. Among the twenty seven compounds tested, ten 4-
aminocoumarin derivatives and two 2-aminochromone derivatives, (4) and (1) 
(R = H, R1 = 4-chlorophenyl) showed an appreciable antiproliferative activity 
(IC50 range: 1.74-13.8 µM), whereas only four compounds exhibited a 
comparable cytotoxic activity (IC50 range: 4.95-12.9 µM). (Fig. 5.11) 
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Chavda et. al. 58 replaced the phenolic hydroxyl group of 4-
hydroxycoumarins by different amines in a single step method by direct 
heating to get newly substituted 4-amino derivatives which were screened for 
their antimicrobial activity. 
 
5.3   MANNICH REACTION ON 4-HYDROXYCOUMARIN 
 
Mannich reaction has been reported 20, 46, 59, 60, 61 on 4-
hydroxycoumarin where 3-substituted C-Mannich bases of 4-hydroxycoumarin 
have been obtained using different secondary amines and formaldehyde. 
Where these Mannich bases are associated with antimicrobial activity 46 and 
psychotropic activity. 20 
 
 
5.4   C-MANNICH BASES OF ARYLAMINOCOUMARINS 
 
Literature survey revealed that Mannich reaction has not been carried 
out on 4-arylaminocoumarins yet, but similar kinds of compounds have been 
prepared by Savel'ev et. al. 60 Where, firstly they carried out Mannich reaction 
on 4-hydroxycoumarin to give 3-substituted-4-hydroxycoumarin (i. e. C-
Mannich bases) which consequently converted into 3-substituted-4-chloro 
O
O
NRR1 O O
NHPh
Y
X
O O
NHPh
O
O
NHPhO
O
1 2
3 4
Fig. 5.11
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coumarin and treatment of 4-chloro derivative with primary and secondary 
amines gave title compounds with weak psychotropic activity. (Fig. 5.12) 
 
 
 
 
 
 
 
 
 
 
 
 
Where R = MeNH, BuNH, PhCH2NH, PhNH, Me2N, Et2N, pyrrolidino, 
piperidino, morpholino, 4-methylpiperazino. 
 
O O
NR
O O
NR
1 2
Fig. 5.12
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5.5   AIM OF CURRENT WORK  
 
Our group is involved in the synthesis of aryl amino coumarins since 
last few years, where, aryl amino coumarins showed good antitubercular 
activity. Previously, preparation of differently substituted aryl amino coumarins 
was only the aim. Afterwards, the aryl amino coumarins were further cyclized 
to give fused pyridine as well as fused benzothiazine derivatives, which 
showed good antitubercular as well as anticancer activity. Looking to the 
interesting biological profile showed by coumarin benzothiazine derivatives 
and their unexplored chemistry part and from the literature survey, it was 
decided to modify previously prepared fused benzothiazines derived from aryl 
amino coumarins into N-substituted benzothiazine derivatives so that N-
alkylation was carried out on coumarin benzothiazine derivatives by different 
methods but it failed. Then N-alkylation was carried out on aryl amino 
coumarin derivatives but it also failed. Afterwards, new route was thought by 
which benzothiazine derivatives could be synthesized that is why the Mannich 
reaction was carried out on aryl amino coumarins in order to prepare N-
Mannich bases of aryl amino coumarins and their further cyclization into 
benzothiazine derivatives. But to our surprise, the Mannich reaction on aryl 
amino coumarin resulted into unusual new product formation which has been 
discussed in results and discussion in detail. 
 
Literature revealed that Mannich reaction is not reported on aryl amino 
coumarins but similar kind of scaffold is reported 60. Where Mannich reaction 
was carried out on 4-hydroxy coumarin and the hydroxyl group present at 4th 
position in coumarin nucleus was converted into chloro which was easily 
removed by the treatment of aromatic primary amine. As discussed in chapter 
– 1, Mannich bases can be synthesized by Mannich reaction on nitrogen of 
secondary amine by using simplified methodology and easy work up and this 
inspired us to develop some new aryl amino coumarin derivatives by Mannich 
reaction for our targeted work. Formaldehyde solution (37-41 %) and different 
type of secondary amines were used to acquire Mannich bases under acidic 
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conditions. Thus the chemistry of Mannich reaction on arylaminocoumarins is 
not only interesting but also novel and is reported here for the first time.  
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5.6   REACTION SCHEMES 
 
5.6.1 PREPARATION OF 4-HYDROXY COUMARIN  
 
Reagents / Reaction Condition (a): Anhydrous ZnCl2, POCl3 / 70°C, 12 hours. 
 
5.6.2 PREPARATION OF 4-(SUBSTITUTED ANILINO) COUMARIN 
 
 
Reagents / Reaction Condition (b): Substituted primary amines / MW, 320 
Watt. 
 
5.6.3 PREPARATION OF ARYL AMINO COUMARIN C-MANNICH BASES 
 
Reagents / Reaction Condition (c): Formaldehyde (37-41 % solution), 
Secondary amine, DMF, Con. HCl / Warm→Room Temperature 
OH
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O
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O O
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5.7   PLAUSIBLE REACTION MECHANISM 
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5.8   EXPERIMENTAL 
 
5.8.1 PREPARATION OF 4-HYDROXY COUMARIN 
 
It was prepared according to the method reported by Shah et. al. a Yield 
- 55 %, MP - 210-212°C (210-212°C a). 
   
5.8.2 GENERAL PROCEDURE FOR THE PREPARATION OF 4-
(SUBSTITUTED ANILINO) COUMARIN 
 
Mixture of 0.1 mole of 4-hydroxy coumarin and 0.1 mole of 
appropriately substituted primary amine was irradiated neat under microwave 
irradiation using domestic microwave oven (LG MS-192 W) for desired time at 
320 Watt. The reaction mixture was cooled to room temperature and 
methanol was added to it. The separated solid was filtered and washed with 
methanol. It was dried and recrystallized with dimethylformamide to give 4-
(substituted anilino) coumains. Required reaction time and obtained results 
are summarized as under. 
 
Reaction 
Time (min.) 
Reaction 
Time (min.) Code No. 
320 Watt 
% yield Code No.
320 Watt 
% yield 
AAC-1 6.0 81 AAC-8 6.4 91 
AAC-2 4.1 85 AAC-9 5.3 83 
AAC-3 6.3 79 AAC-10 7.3 80 
AAC-4 5.2 88 AAC-11 7.1 79 
AAC-5 5.5 84 AAC-12 7.0 88 
AAC-6 4.3 90 AAC-13 5.2 84 
AAC-7 6.2 77    
 
 
                                                 
a A. K. Shah, N. S. Bhatt and V. M. Thakor; Curr. Sci., 1984, 53(24), 1289. 
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5.8.3 GENERAL PROCEDURE FOR THE PREPARATION OF DNJ-1001 
TO DNJ-1015 
 
0.01 mole of appropriately substituted aryl amino coumarin was 
dissolved into 30 ml of dimethylformamide. 1 ml of formaldehyde (37-41 % 
solution) and 0.01 mole of an appropriate secondary amine were added into 
above reaction mixture under acidic condition. The content was heated on 
boiling water bath for some time and the reaction mixture was left overnight at 
room temperature to furnish the product. The separated crystals were filtered 
off and it was washed with acetone to give white to pale yellow coloured 
shining crystals. The purity of the compound was checked by silica gel-G F254 
thin layer chromatography using toluene : ethyl acetate (7 : 3) as a mobile 
phase. Recrystallization was not required in any case though it was carried 
out from acetone / methanol. (Physical data of the synthesized end products 
are summarized in the table 5.9.1) 
 
1-methyl piperazine was used in case of DNJ-1001 while 1-benzyl 
piperazine was used in case of DNJ-1003. Rests of the compounds were 
synthesized using 1-ethyl piperazine. 
 
Moreover single crystal of DNJ-1003 was developed in order to prove 
the X-ray crystallographic structure. Acquired crystal structure and related 
data are also given. 
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5.9   PHYSICAL DATA TABLES 
  
5.9.1 Physical data of 4-(substituted aniline) coumarins C-Mannich 
bases (DNJ-1001 to DNJ-1015) 
 
 
 
 
 
 
 
 
 
 
 
Substitution Code R1 & R2 R3, R4 & R5 
MF MW (g/m)
MP 
(°C) Rf 
% 
Yield
DNJ 
1001 
1-methyl 
piperazinyl Anilino C21H23N3O2 349 158 0.40 70 
DNJ 
1002 
1-ethyl 
piperazinyl Anilino C22H25N3O2 363 164 0.43 65 
DNJ 
1003 
1-benzyl 
piperazinyl Anilino C27H27N3O2 425 176 0.50 63 
DNJ 
1004 
1-ethyl 
piperazinyl 
2-chloro 
phenyl amino C22H24ClN3O2 397 170 0.44 59 
DNJ 
1005 
1-ethyl 
piperazinyl 
3-chloro 
phenyl amino C22H24ClN3O2 397 168 0.46 61 
DNJ 
1006 
1-ethyl 
piperazinyl 
4-chloro 
phenyl amino C22H24ClN3O2 397 162 0.48 55 
DNJ 
1007 
1-ethyl 
piperazinyl 
2-fluoro 
phenyl amino C22H24FN3O2 381 184 0.42 46 
DNJ 
1008 
1-ethyl 
piperazinyl 
4-fluoro 
phenyl amino C22H24FN3O2 381 190 0.44 58 
DNJ 
1009 
1-ethyl 
piperazinyl 
2-methyl 
phenyl amino C23H27N3O2 377 180 0.44 67 
DNJ 
1010 
1-ethyl 
piperazinyl 
3-methyl 
phenyl amino C23H27N3O2 377 186 0.46 63 
DNJ 
1011 
1-ethyl 
piperazinyl 
2-methoxy 
phenyl amino C23H27N3O3 393 174 0.45 44 
O
NH
O
N
R2R1
R3
R4
R5
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DNJ 
1012 
1-ethyl 
piperazinyl 
3-methoxy 
phenyl amino C23H27N3O3 393 166 0.47 56 
DNJ 
1013 
1-ethyl 
piperazinyl 
3-
trifluoromethyl 
phenyl amino 
C23H24F3N3O2 431 182 0.43 66 
DNJ 
1014 
1-ethyl 
piperazinyl Octyl amino C24H37N3O2 399 200 0.48 40 
DNJ 
1015 
1-ethyl 
piperazinyl 
2-furyl methyl 
amino C21H25N3O3 367 196 0.41 50 
 
Rf value was calculated using solvent system = Toluene : Ethyl Acetate 
(70% : 30%) 
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5.10   SPECTRAL DISCUSSION 
 
5.10.1   MASS SPECTRAL STUDY 
 
Mass spectra of the synthesized compounds were recorded on 
Shimadzu GC-MS QP-2010 model using direct injection probe technique. 
The molecular ion peak was found in agreement with molecular weight of the 
respective compound. Characteristic M+2 ion peaks with one-third intensity of 
molecular ion peak were observed in case of compounds having chlorine 
atom. Fragmentation pattern can be observed to be particular for these 
compounds and the characteristic peaks obtained for each compound. 
Probable fragmentation pattern for DNJ-1013 can be discussed as under. 
 
4-[(3-chlorophenyl) amino]-3-[(4-ethylpiperazin-1-yl) methyl]-2H-
chromen-2-one (DNJ-1013) 
 
1. The target compound showed characteristic molecular ion peak. 
2. C26-C27 bond cleavage gave characteristic peak at 416 m/e. [1] 
3. N16-C26 bond cleavage gave characteristic peak at 403 m/e. [2] 
4. Cleavage of the bonds C15-N16 and C17-N15 gave characteristic peak at 
389 m/e. [3] 
5. Cleavage of the bond C17-C18 gave characteristic peak at 374 m/e. [4] 
6. C14-C15 bond cleavage gave characteristic peak at 359 m/e. [5] 
7. Cleavage of the bond N13-C18 gave characteristic peak at 346 m/e. [6] 
8. N13-C14 bond cleavage gave characteristic peak at 331 m/e. [7] 
9. Cleavage of the bond C12-N13 gave two characteristic peaks. One at 
316 m/e and second at 113 m/e. [8] 
10. C24-C28 bond cleavage gave characteristic peak at 248 m/e. [9] 
11. Cleavage of the bond C3-C12 gave characteristic peak at 235 m/e. [10] 
12. N19-C20 bond cleavage gave two characteristic peaks. One at 287 m/e 
and second at 145 m/e. [11] 
13. Cleavage of the bond C4-N19 gave characteristic peak at 272 m/e. [12] 
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14. After C4-N19 bond cleavage, cleavage of the bonds C17-C18, C15-N16 
gave characteristic peak at 217 m/e. [13] 
15. C14-C15 bond cleavage gave characteristic peak at 204 m/e. [14] 
 
 
 
 
 
 
 
 
 
  
5.10.1.1   FRAGMENTATION PATTERN FOR DNJ-1013 
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5.10.2   IR SPECTRAL STUDY 
 
IR spectra of the synthesized compounds were recorded on Shimadzu 
FT IR 8400 spectrophotometer using Diffused Reflectance Attachment (DRA) 
System using Potassium Bromide.  
 
All compounds showed the carbonyl stretching frequency near 1700 
cm-1. All compounds showed N-H stretching frequency in the region of 3220-
3395 cm-1. C-N stretching (2° & 3°) frequency was found in each and every 
compound. C-H stretching frequencies were observed at 2810-2970 cm-1, 
while ring skeleton frequencies were observed at 1450-1610 cm-1.  
 
Characteristic frequencies for o, m and p-di substitution were observed 
in each compound. C-X (X = Cl, F) stretching frequencies were obtained in 
DNJ-1004, DNJ-1005, DNJ-1006, DNJ-1007, DNJ-1008 and DNJ-1013. All 
compounds showed C-O-C stretching frequency.  
 
5.10.3   1H & 13C NMR (APT 25) SPECTRAL STUDY 
 
1H & 13C NMR (APT 25) spectra of the synthesized compounds were 
recorded on Bruker Avance II 400 & Bruker Avance II 300 spectrometer. 
Sample solutions were made in CDCl3 solvent using tetramethylsilane (TMS) 
as the internal standard unless otherwise mentioned. Numbers of protons and 
numbers of carbons identified from H NMR & C NMR spectrum and their 
chemical shift (δ ppm) were in the agreement of the structure of the molecule. 
J values were calculated to identify o, m and p coupling. In some cases, 
aromatic protons were obtained as multiplet. 1H & 13C NMR (APT 25) spectral 
interpretation can be discussed as under. 
 
1H NMR spectral interpretation of 3-[(4-ethylpiperazin-1-yl) methyl]-4-{[3-
(trifluoromethyl) phenyl] amino}-2H-chromen-2-one (DNJ-1013) 
 
1. One most deshielded proton of secondary nitrogen introduced at fourth 
position in coumarin nucleus gave singlet at 10.54 δ ppm which is the 
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most identifiable and characteristic peak for these types of compounds 
from which it could be prove that the compounds were the C-Mannich 
bases and were not the N-Mannich bases. 
2. Two protons of methylene group attached at C3 position of coumarin 
nucleus gave a sharp singlet in the up-field at 3.76 δ ppm. 
3. Three most shielded protons of methyl group of ethyl piperazine ring 
gave triplet at 1.12 δ ppm. 
4. Two protons of methylene group attached on nitrogen atom in 
piperazine ring and eight protons of piperazine ring merged in the 
region of 2.15-2.62 δ ppm . 
5. Four protons of coumarinyl phenyl ring and four protons of another 
phenyl ring attached to the secondary nitrogen gave multiplet peaks in 
the region of 7.00-7.48 δ ppm. 
6. J values were calculated which were in the agreement of the m 
substitution. 
 
13C NMR (APT 25) spectral interpretation of 3-[(4-ethylpiperazin-1-yl) 
methyl]-4-{[3-(trifluoromethyl) phenyl] amino}-2H-chromen-2-one (DNJ-
1013) 
 
 In 13C NMR (APT 25), upward directed peaks were due to C and CH2 
while downward directed peaks were due to CH and CH3. 
 
1. Carbonyl group of β keto ester showed upward peak at 162.89 δ ppm. 
2. Coumarinyl C4 carbon showed upward directed peak at 143.29 δ ppm 
chemical shift value. 
3. 132.89 δ ppm chemical shift is due to trifluoromethyl group. 
4. C3 carbon of coumarin nucleus showed peak upward at 105.57 δ ppm 
from which it could be prove that the compounds were the C-Mannich 
bases and were not the N-Mannich bases because if the compounds 
would be N-Mannich bases, they would show peak of C3 carbon 
downward due to CH. 
5. Peaks at 77.03-77.88 δ ppm are due to the solvent CDCl3. 
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6. 54.78 δ ppm chemical shift is due to the peak obtained for bridged 
methylene group (C12) attached between C3 position and piperazine 
ring. 
7. 53.42 δ ppm showed chemical shift for two piperazinyl methylene 
carbon atoms C15 and C17. 
8. 52.72 δ ppm showed chemical shift for two piperazinyl methylene 
carbon atoms C14 and C18. 
9. 12.37 δ ppm showed chemical shift for methyl carbon atom C27. 
10. Rests of the peaks were due to the aromatic carbon atoms.  
 
 
 
5.10.4   ELEMENTAL ANALYSIS 
 
Elemental analysis of the synthesized compounds was carried out on 
Vario EL Carlo Erba 1108 which showed calculated and found percentage 
values of Carbon, Hydrogen and Nitrogen in support of the structure of 
synthesized compounds. The spectral and elemental analysis data are given 
for individual compounds. 
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5.11   X-ray Crystal Structure of DNJ-1003 
 
 
 
Chapter – 5                                                             Synthesis and Characterization….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                        305
 
The compound crystallizes in the Tetragonal crystal class in the space 
group I 41 / a with the cell parameters a = 27.7990(6) A°, b = 27.7990(6) A°, c 
= 12.1800(8) A°, V = 9412.5(7) A°3 for Z=16. The structure reveals that the 
piperazine ring is in chair conformation. The structure exhibits both inter and 
intramolecular hydrogen bonds of the type C-H· · ·O and N-H· · ·N. 
 
A study of torsion angles, asymmetric parameters and least squares 
plane calculations reveals that the piperazine ring in the structure is in a chair 
conformation with the atoms N8 and N11 deviating 0.2344(26) A° and -
0.2380(24) A° from Cermer and Pople plane defined by the atoms 
C9/C10/C12/C13. This is confirmed by the puckering parameters Q = 0.5786(32) 
A° θ = 0.36(30)° and Φ = 148.786(5)°. Total puckering amplitude for ten 
membered ring O17/C16/C15/C24/C23/C22/C21/C20/C19/C18 is Q = 0.1063(29) A°. 
The dihedral angle between the least-squares plane of piperazine ring bridged 
via -CH2- to the phenyl ring C1-C6 is 83.89(18)° implying that the phenyl ring is 
nearly perpendicular to the plane of the piperazine ring. Piperazine ring and 
the coumarin ring bridged via - CH2- group gives a dihedral angle of 
87.67(12), which reflect that the piperazine ring is perpendicular to the plane 
of the coumarin ring. The dihedral angle between coumarin ring and phenyl 
ring bridged via NH group is 65.51(11)°, implies that phenyl ring is equatorial 
to the plane of coumarin ring. The two phenyl rings and the coumarin ring are 
independently planar. The torsion angle about C6-C7-N8-C9 being -169.34(27)° 
and that about C15-C14-C12-C13 being 174.02(23)° show that they reflect -anti-
periplanar and +anti-periplanar conformation, respectively. At the same time 
torsion angle about C28-C27-N26-C24 is -166.38(26) indicating -anti-periplanar 
conformation. The structure exhibits both inter and intra molecular hydrogen 
bonding of the type C-H· · ·O and N-H· · ·N. The intermolecular hydrogen 
bond C7-H7A· · ·O17 and C10-H10A· · ·O25 has a length of 3.290(4) A° and 
3.460(4) A° and an angle of 130° and 165°, respectively, with symmetry codes 
-3/4+y, 5/4-x, -3/4+z and 5/4-y, 3/4+x, -1/4+z respectively. Intramolecular 
hydrogen bond N26-H26· · ·N11, has a length of 2.861(3) A° and an angle of 
119°. The packing of the molecule along c axis is shown in figure. 
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5.12   ANALYTICAL DATA 
 
4-ANILINO-3-[(4-METHYL PIPERAZIN-1-YL) METHYL]-2H-CHROMEN-2-
ONE (DNJ-1001) : IR (KBr, cm-1): 3381 (-NH), 3074 (Ar-H, str), 2962 (-CH3), 
2809 (-CH2), 1710 (>CO), 1562, 1540, 1470, 1462 (Ar-H, ben), 1336 (C-N, Ar, 
3°), 1306 (C-N, Ar, 2°), 1055 (C-O-C); 1H NMR (400 MHz, CDCl3): δ (ppm) 
2.33 (4H, s), 2.60 (7H, s), 3.77 (2H, s), 6.97 (3H, m, J = 1.12 Hz, J = 0.80 Hz), 
7.11 (1H, s), 7.33 (4H, m, J = 0.44 Hz, J = 1.28 Hz), 7.43 (1H, m, J = 1.52 Hz, 
J = 1.44 Hz), 10.30 (1H, s); 13C NMR (400 MHz, CDCl3): δ (ppm) 162.70, 
153.69, 152.09, 142.07, 131.22, 129.37, 126.12, 123.45, 122.64, 121.02, 
117.26, 115.22, 102.72, 55.36, 54.36, 52.18, 46.05; MS m/z = 349 (M+); Anal. 
Calcd. for C21H23N3O2: C, 72.18; H, 6.63; N, 12.03. Found: C, 72.16; H, 6.65; 
N, 12.01. 
 
4-ANILINO-3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-2H-CHROMEN-2-
ONE (DNJ-1002): IR (KBr, cm-1): 3379 (-NH), 3075 (Ar-H, str), 2969 (-CH3), 
2810 (-CH2), 1708 (>CO), 1556, 1539, 1501, 1470 (Ar-H, ben), 1337 (C-N, Ar, 
3°), 1306 (C-N, Ar, 2°), 1052 (C-O-C); 1H NMR (300 MHz, CDCl3): δ (ppm) 
1.13 (3H, s), 2.48 (4H, m), 2.62 (6H, s), 3.77 (2H, s), 6.93 (3H, m, J = 0.903 
Hz, J = 1.206 Hz), 7.11 (1H, s), 7.32 (4H, m, J = 3.807 Hz, J = 1.173 Hz, J = 
0.912 Hz), 7.44 (1H, m, J = 2.325 Hz, J = 1.059 Hz, J = 1.308 Hz), 10.37 (1H, 
s); 13C NMR (300 MHz, CDCl3): δ (ppm) 163.06, 154.11, 152.48, 142.44, 
131.56, 129.74, 126.51, 123.79, 123.00, 121.40, 117.64, 115.67, 103.24, 
54.81, 53.44, 52.63, 12.44; MS m/z = 363 (M+); Anal. Calcd. for C22H25N3O2: 
C, 72.70; H, 6.93; N, 11.56. Found: C, 72.71; H, 6.91; N, 11.53. 
 
4-ANILINO-3-[(4-BENZYL PIPERAZIN-1-YL) METHYL]-2H-CHROMEN-2-
ONE (DNJ-1003): IR (KBr, cm-1): 3385 (-NH), 3079 (Ar-H, str), 2967 (-CH3), 
2811 (-CH2), 1706 (>CO), 1600, 1539, 1570, 1500, 1460 (Ar-H, ben), 1338 
(C-N, Ar, 3°), 1303 (C-N, Ar, 2°), 1057 (C-O-C); MS m/z = 425 (M+); Anal. 
Calcd. for C27H27N3O2: C, 76.21; H, 6.40; N, 9.87. Found: C, 76.24; H, 6.38; 
N, 9.85. 
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4-[(2-CHLORO PHENYL) AMINO]-3-[(4-ETHYL PIPERAZIN-1-YL) 
METHYL]-2H-CHROMEN-2-ONE (DNJ-1004): IR (KBr, cm-1): 3389 (-NH), 
3070 (Ar-H, str), 2966 (-CH3), 2810 (-CH2), 1707 (>CO), 1570, 1490, 1470, 
1440 (Ar-H, ben), 1336 (C-N, Ar, 3°), 1305 (C-N, Ar, 2°), 1060 (C-O-C), 871 
(C-Cl), 755 (1,2-di sub); MS m/z = 397 (M+); Anal. Calcd. for C22H24ClN3O2: C, 
66.41; H, 6.08; N, 10.56. Found: C, 66.39; H, 6.05; N, 10.53. 
 
4-[(3-CHLORO PHENYL) AMINO]-3-[(4-ETHYL PIPERAZIN-1-YL) 
METHYL]-2H-CHROMEN-2-ONE (DNJ-1005): IR (KBr, cm-1): 3390 (-NH), 
3071 (Ar-H, str), 2967 (-CH3), 2810 (-CH2), 1706 (>CO), 1572, 1488, 1475, 
1440 (Ar-H, ben), 1338 (C-N, Ar, 3°), 1306 (C-N, Ar, 2°), 1076 (C-O-C), 865 
(C-Cl), 770 (1,3-di sub); 1H NMR (300 MHz, CDCl3): δ (ppm) 1.13 (3H, s), 
2.50 (4H, m), 2.62 (6H, s), 3.76 (2H, s), 6.78 (1H, dd, J = 1.635 Hz, J = 1.428 
Hz), 6.92 (1H, t), 7.05 (2H, m, J = 0.957 Hz), 7.21 (1H, s), 7.34 (2H, m, J = 
1.233 Hz, J = 0.723 Hz), 7.48 (1H, dd, J = 1.389 Hz, J = 1.149 Hz, J = 1.362 
Hz), 10.41 (1H, s); 13C NMR (300 MHz, CDCl3): δ (ppm) 162.89, 154.05, 
151.98, 143.99, 135.41, 131.84, 130.67, 126.30, 123.46, 123.31, 120.77, 
118.97, 117.80, 115.53, 105.13, 54.76, 53.43, 52.70, 52.65, 12.43; MS m/z = 
397 (M+); Anal. Calcd. for C22H24ClN3O2: C, 66.41; H, 6.08; N, 10.56. Found: 
C, 66.44; H, 6.09; N, 10.55. 
 
4-[(4-CHLORO PHENYL) AMINO]-3-[(4-ETHYL PIPERAZIN-1-YL) 
METHYL]-2H-CHROMEN-2-ONE (DNJ-1006): IR (KBr, cm-1): 3370 (-NH), 
3080 (Ar-H, str), 2967 (-CH3), 2810 (-CH2), 1706 (>CO), 1572, 1488, 1475, 
1440 (Ar-H, ben), 1337 (C-N, Ar, 3°), 1307 (C-N, Ar, 2°), 1050 (C-O-C), 869 
(C-Cl), 812 (1,4-di sub); MS m/z = 397 (M+); Anal. Calcd. for C22H24ClN3O2: C, 
66.41; H, 6.08; N, 10.56. Found: C, 66.40; H, 6.07; N, 10.58. 
 
3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-[(2-FLUORO PHENYL) 
AMINO]-2H-CHROMEN-2-ONE (DNJ-1007): IR (KBr, cm-1): 3381 (-NH), 
3070 (Ar-H, str), 2962 (-CH3), 2811 (-CH2), 1707 (>CO), 1570, 1484, 1470, 
1438 (Ar-H, ben), 1337 (C-N, Ar, 3°), 1306 (C-N, Ar, 2°), 1054 (C-O-C), 990 
(C-F), 750 (1,2-di sub); MS m/z = 381 (M+); Anal. Calcd. for C22H24FN3O2: C, 
69.27; H, 6.34; N, 11.02. Found: C, 69.23; H, 6.38; N, 11.05. 
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3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-[(4-FLUORO PHENYL) 
AMINO]-2H-CHROMEN-2-ONE (DNJ-1008): IR (KBr, cm-1): 3388 (-NH), 
3080 (Ar-H, str), 2967 (-CH3), 2811 (-CH2), 1707 (>CO), 1607, 1584, 1500, 
1470 (Ar-H, ben), 1335 (C-N, Ar, 3°), 1304 (C-N, Ar, 2°), 1061 (C-O-C), 992 
(C-F), 819 (1,4-di sub); MS m/z = 381 (M+); Anal. Calcd. for C22H24FN3O2: C, 
69.27; H, 6.34; N, 11.02. Found: C, 69.28; H, 6.36; N, 11.04. 
 
3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-[(2-METHYL PHENYL) 
AMINO]-2H-CHROMEN-2-ONE (DNJ-1009): IR (KBr, cm-1): 3389 (-NH), 
3079 (Ar-H, str), 2962 (-CH3), 2809 (-CH2), 1706 (>CO), 1607, 1584, 1500, 
1470 (Ar-H, ben), 1338 (C-N, Ar, 3°), 1307 (C-N, Ar, 2°), 1069 (C-O-C), 755 
(1,2-di sub); MS m/z = 377 (M+); Anal. Calcd. for C23H27N3O2: C, 73.18; H, 
7.21; N, 11.13. Found: C, 73.15; H, 7.24; N, 11.10. 
 
3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-[(3-METHYL PHENYL) 
AMINO]-2H-CHROMEN-2-ONE (DNJ-1010): IR (KBr, cm-1): 3388 (-NH), 
3081 (Ar-H, str), 2962 (-CH3), 2811 (-CH2), 1707 (>CO), 1600, 1575, 1481, 
1465 (Ar-H, ben), 1338 (C-N, Ar, 3°), 1307 (C-N, Ar, 2°), 1072 (C-O-C), 775 
(1,3-di sub); MS m/z = 377 (M+); Anal. Calcd. for C23H27N3O2: C, 73.18; H, 
7.21; N, 11.13. Found: C, 73.20; H, 7.24; N, 11.10. 
 
3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-[(2-METHOXY PHENYL) 
AMINO]-2H-CHROMEN-2-ONE (DNJ-1011): IR (KBr, cm-1): 3380 (-NH), 
3070 (Ar-H, str), 2967 (-CH3), 2809 (-CH2), 1705 (>CO), 1600, 1584, 1507, 
1470 (Ar-H, ben), 1337 (C-N, Ar, 3°), 1305 (C-N, Ar, 2°), 1051 (C-O-C), 758 
(1,2-di sub); MS m/z = 393 (M+); Anal. Calcd. for C23H27N3O3: C, 70.21; H, 
6.92; N, 10.68. Found: C, 70.19; H, 6.95; N, 10.71. 
 
3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-[(3-METHOXY PHENYL) 
AMINO]-2H-CHROMEN-2-ONE (DNJ-1012): IR (KBr, cm-1): 3388 (-NH), 
3080 (Ar-H, str), 2967 (-CH3), 2811 (-CH2), 1707 (>CO), 1602, 1580, 1483, 
1469 (Ar-H, ben), 1336 (C-N, Ar, 3°), 1307 (C-N, Ar, 2°), 1070 (C-O-C), 780 
(1,3-di sub); MS m/z = 393 (M+); Anal. Calcd. for C23H27N3O3: C, 70.21; H, 
6.92; N, 10.68. Found: C, 70.20; H, 6.95; N, 10.67. 
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3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-{[3-(TRIFLUOROMETHYL) 
PHENYL] AMINO}-2H-CHROMEN-2-ONE (DNJ-1013): IR (KBr, cm-1): 3388 
(-NH), 3080 (Ar-H, str), 2967 (-CH3), 2811 (-CH2), 1707 (>CO), 1607, 1571, 
1540, 1481 (Ar-H, ben), 1338 (C-N, Ar, 3°), 1305 (C-N, Ar, 2°), 1071 (C-O-C), 
956 (C-F), 882 (1,3-di sub); 1H NMR (300 MHz, CDCl3): δ (ppm) 1.12 (3H, s), 
2.49 (4H, m), 2.62 (6H, s), 3.76 (2H, s), 7.03 (2H, m, J = 1.155 Hz), 7.13 (1H, 
s), 7.42 (3H, m, J = 1.218 Hz, J = 1.296 Hz, J = 2.313 Hz), 7.44 (1H, m, J = 
1.491 Hz, J = 1.218 Hz, J = 1.464 Hz), 10.54 (1H, s); 13C NMR (300 MHz, 
CDCl3): δ (ppm) 162.83, 154.04, 151.78, 143.29, 132.90, 132.47, 132.03, 
131.60, 129.53, 125.92, 123.59, 122.31, 119.82, 119.77, 119.72, 119.67, 
118.70, 117.12, 117.07, 117.02, 116.97, 115.37, 105.57, 54.78, 53.42, 52.73, 
52.63, 12.38; MS m/z = 431 (M+); Anal. Calcd. for C23H24F3N3O2: C, 64.03; H, 
5.61; N, 9.74. Found: C, 64.07; H, 5.65; N, 9.70. 
 
3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-(OCTYLAMINO)-2H-
CHROMEN-2-ONE (DNJ-1014): IR (KBr, cm-1): 3381 (-NH), 3078 (Ar-H, str), 
2966 (-CH3), 2810 (-CH2), 1705 (>CO), 1600, 1580, 1480, 1469 (Ar-H, ben), 
1337 (C-N, Ar, 3°), 1306 (C-N, Ar, 2°), 1055 (C-O-C); MS m/z = 399 (M+); 
Anal. Calcd. for C24H37N3O2: C, 72.14; H, 9.33; N, 10.52. Found: C, 72.18; H, 
9.37; N, 10.49. 
 
3-[(4-ETHYL PIPERAZIN-1-YL) METHYL]-4-[(2-FURYL METHYL) AMINO]-
2H-CHROMEN-2-ONE (DNJ-1015): IR (KBr, cm-1): 3388 (-NH), 3081 (Ar-H, 
str), 2967 (-CH3), 2811 (-CH2), 1707 (>CO), 1600, 1580, 1480, 1469 (Ar-H, 
ben), 1338 (C-N, Ar, 3°), 1309 (C-N, Ar, 2°), 1074 (C-O-C); MS m/z = 367 
(M+); Anal. Calcd. for C21H25N3O3: C, 68.64; H, 6.86; N, 11.44. Found: C, 
68.60; H, 6.90; N, 11.47. 
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5.13   RESULTS AND DISCUSSION 
 
A known method was adopted for the preparation of aryl amino 
coumarins. As said earlier, unexplored chemistry part of N-substituted fused 
coumarin benzothiazine, novelty and biological importance of targeted 
compounds inspired us to prepare some biologically important N-substituted 
fused coumarin benzothiazine derivatives. But under acidic condition β-keto 
ester of coumarin nucleus tautomarize into enol form and hydrogen present at 
C3 carbon atom became more acidic than secondary amine (-NH) substituted 
at C4 carbon atom. According to principle of Mannich reaction and its 
mechanism, Mannich reaction takes place on acidic hydrogen atom using 
secondary amine and formaldehyde solution or paraformaldehyde and the 
compounds thus prepared are known as Mannich bases. Therefore by 
carrying out Mannich reaction on aryl amino coumarins, we got C-Mannich 
bases instead of N-Mannich bases which was the first principal interesting 
investigation of this study.  
 
In this chapter, different C-Mannich bases have been prepared using 
different aryl amino coumarins and different secondary amines viz. 1-ethyl 
piperazine, 1-methyl piperazine and 1-benzyl piperazine. C-Mannich bases of 
1-ethyl piperazine with all aryl amino coumarins gave products very rapidly 
while C-Mannich bases of 1-methyl piperazine and 1-benzyl piperazine took 
2.5-3 months to fall out which was the second interesting observation. 
Similarly, other secondary amines like piperidine, morpholine etc. were also 
used on trial & error basis but the product did not fall out till 6-7 months. 
  
There was the vast difference in the solubility of the starting material 
i.e. aryl amino coumarins and in the products i.e. C-Mannich bases. The aryl 
amino coumarins were soluble in dimethylformamide while the products got 
dissolved in common organic solvents like acetone and methanol which was 
the third interesting observation. These C-Mannich bases were found 
highly crystalline at the time of isolation and did not require recrystallization 
though they were recystallized in acetone or methanol. The colour of all the 
products varied between white to pale yellow at the time of isolation. 
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Above outcome of the synthetic aspect was further proved by 1H, 13C 
NMR (APT 25) and X-ray crystallography. The crystal structure and all data 
are included.  
 
 
5.14   CONCLUSION 
 
In this chapter, a simple and fast method was developed for the 
preparation of novel C-Mannich bases of aryl amino coumarin using 
formaldehyde solution and different secondary amines for the first time. APT-
25 experiment has proved the possible mechanistic path governing this 
reaction, which is probably hitherto unknown in literature furthermore no 
report of other method for optimization for the synthesis of end products is 
found in literature. 
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5.15  SPECTRAL REPRESENTATION OF SYNTHESIZED 
COMPOUNDS 
 
5.15.1   Mass Spectrum of DNJ-1002 
 
 
 
5.15.2   IR Spectrum of DNJ-1002 
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5.15.3   1H NMR Spectrums of DNJ-1002 
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5.15.5   13C NMR (APT) Spectrums of DNJ-1002 
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5.15.6   Mass Spectrum of DNJ-1005 
 
 
 
5.15.7   IR Spectrum of DNJ-1005 
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5.15.8   1H NMR Spectrums of DNJ-1005 
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5.15.9   13C NMR (APT) Spectrums of DNJ-1005 
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5.15.10   Mass Spectrum of DNJ-1013 
 
 
 
5.15.11   IR Spectrum of DNJ-1013 
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5.15.12   1H NMR Spectrums of DNJ-1013 
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5.15.13   13C NMR (APT 25) Spectrums of DNJ-1013 
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The representative compounds synthesized in earlier chapters were 
evaluated for biological activity. The biological screening protocols and in 
silico study of some of the compounds are reported in this chapter. 
 
6.1   ANTIMICROBIAL SCREENING 
 
Antibiotic resistance is a serious concern worldwide as it would result in 
strains against which currently available antibacterial agents will be 
ineffective. In general, bacterial pathogens may be classified as either gram-
positive or gram-negative pathogens. Antibiotics compounds with effective 
activity against both gram-positive and gram-negative pathogens are 
generally regarded as having a broad spectrum of activity. The synthesized 
compounds were preliminary screened against gram-positive and gram-
negative pathogens. 
 
Gram-positive pathogens, for example Staphylococci, Enterococci, 
Streptococci and Micobacteria bacteria are particular because of the 
development of resistant strain which is difficult to eradicate from the hospital 
environment once established. Example of such strains are methicillin 
resistance Staphylococcus (MRSA), methicillin resistance coagulase negative 
Staphylococci (MRCNS), penicilline resistance Streptococcus pnumaniae and 
multiplied resistance Enterococcus faecium, community acquired pathogens 
(CAP) and so on. 
 
6.1.1   MINIMUM INHIBITORY CONCENTRATION (MIC) 
 
In microbiology, MIC is the lowest concentration of an antimicrobial that 
will inhibit the visible growth of a microorganism after overnight incubation. 
Minimum inhibitory concentrations are important in diagnostic laboratories to 
confirm resistance of microorganisms to an antimicrobial agent and also to 
monitor the activity of new antimicrobial agents. An MIC is generally regarded 
as the most basic laboratory measurement of the activity of an antimicrobial 
agent against an organism.  
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MICs can be determined by agar or broth dilution methods usually 
following the guidelines of a reference body such as the CLSI, BSAC or 
EUCAST. There are several commercial methods available, including the well 
established Etest strips and the recently launched Oxoid MIC Evaluator 
method. 
 
The Etest system comprises a predefined and continuous 
concentration gradient of different antimicrobial agents, which when applied to 
inoculated agar plates and incubated, create ellipses of microbial inhibition. 
The MIC is determined where the ellipse of inhibition intersects the strip, and 
is easily read off the MIC reading scale on the strip. 
 
Clinically, the minimum inhibitory concentrations are used not only to 
determine the amount of antibiotic that the patient will receive but also the 
type of antibiotic used, which in turn lowers the opportunity for microbial 
resistance to specific antimicrobial agents. 
 
The antimicrobial activity of newly synthesized 2-methyl indoline 
derivatives and isatin derivatives synthesized in Chapter – 1 and Chapter – 2 
(i.e. DNJ-101 to DNJ-111, DNJ-210 to DNJ-210, DNJ-301 to DNJ-305, DNJ-
401 to DNJ-405, DNJ-501 to DNJ-505 and DNJ-601 to DNJ-605) is reported 
here in, while the compounds are under investigation for another biological 
activities. 
 
6.1.2   PROTOCOL FOR ANTIBACTERIAL ACTIVITY 
 
The minimum inhibitory concentrations (MIC) of the compounds for the 
microorganisms were determined by preparing working solution for each 
compound of concentration of 128 µg/ml after dissolving it in DMSO. Two fold 
serial dilution of above solution was prepared in duplicate using Muller Hinton 
Borth, in well tissue culture plate with cover flat bottom wells to give a final 
volume of 150 and concentration of compound ranging from 64 µg/ml – 0.12 
µg/ml. 30 µg/ml of standard suspension of each organism which was prepared 
with turbidity equivalent to the 1:10 diluted 0.5 McFarland standard with 
density 107 CFU/ml. These 96-well tissue culture plate containing the test 
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samples and positive and negative controls, were incubated at 37C for 16-18 
hours. The wells were visually inspected for growth and were also reat at 630 
nm by Automated Micropalte Reader [(EL800) Trinity Biotech] and the MICs 
were recorded as the lowest concentration of drug which inhibits the growth of 
bacteria. 
 
MIC (Minium Inhibitory Concentration in vitro activity µg/ml) values of DNJ-
101 to DNJ-111 and DNJ-201 to DNJ-210 
 
Sr. 
No. 
Representative
Compound Bp Se Sp Sa1 Ef1 
1 DNJ-101 0.5 1 4 8 2 
2 DNJ-102 2 0.5 2 16 4 
3 DNJ-103 4 4 1 32 2 
4 DNJ-104 2 0.5 >16 >16 8 
5 DNJ-105 2 2 8 4 >16 
6 DNJ-106 4 1 2 ND 32 
7 DNJ-107 2 4 1 >8 16 
8 DNJ-108 2 0.5 4 >32 8 
9 DNJ-109 1 2 16 16 4 
10 DNJ-110 2 8 32 8 ND 
11 DNJ-111 4 8 >32 ND 8 
12 Linezolid 1 2 0.5 4 4 
 
Sr. 
No. 
Representative
Compound Bp Se Sp Sa1 Ef1 
1 DNJ-201 2 4 1 8 16 
2 DNJ-202 1 8 4 8 8 
3 DNJ-203 0.5 >16 2 16 8 
4 DNJ-204 4 8 8 ND 8 
5 DNJ-205 8 8 4 >32 >32 
6 DNJ-206 2 2 2 64 64 
7 DNJ-207 2 ND 2 ND 4 
8 DNJ-208 4 4 2 8 16 
9 DNJ-209 >8 2 4 4 >64 
10 DNJ-210 16 >16 8 8 32 
11 Linezolid 1 2 0.5 4 4 
 
ND = Not Done 
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Abbreviations 
 
Bp : Bacillus pumilus MTCC 1607 
Se : Staphylococcus epidermidis MTCC 155 
Sp : Staphylococcus pyogenes MTCC 442 
Sa1 : Staphylococcus aureus MTCC 96 
Ef1 : Enterococcus faecalis MTCC 439 
 
MIC (Minium Inhibitory Concentration in vitro activity µg/ml) values of DNJ-
301 to DNJ-305,  DNJ-401 to DNJ-405, DNJ-501 to DNJ-505 and DNJ-601 to 
DNJ-605 
 
Sr. No. Representative Compound Bp Se Sp Sa1 
1 DNJ-301 8 16 >8 64 
2 DNJ-302 16 8 16 32 
3 DNJ-303 16 32 >64 >32 
4 DNJ-304 ND 16 32 16 
5 DNJ-305 8 4 2 >8 
6 Linezolid 4 4 4 2 
 
Sr. No. Representative Compound Bp Se Sp Sa1 
1 DNJ-401 ND ND ND 4 
2 DNJ-402 >32 >32 4 32 
3 DNJ-403 4 8 16 >8 
4 DNJ-404 2 16 >16 4 
5 DNJ-405 0.5 ND ND ND 
6 Linezolid 4 4 4 2 
 
Sr. No. Representative Compound Bp Se Sp Sa1 
1 DNJ-501 4 16 64 4 
2 DNJ-502 8 32 16 8 
3 DNJ-503 16 64 >8 16 
4 DNJ-504 ND 16 ND ND 
5 DNJ-505 16 4 >16 8 
6 Linezolid 4 4 4 2 
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Sr. No. Representative Compound Bp Se Sp Sa1 
1 DNJ-601 8 ND 32 8 
2 DNJ-602 ND 8 8 4 
3 DNJ-603 64 16 16 16 
4 DNJ-604 32 ND ND >32 
5 DNJ-605 16 32 8 8 
6 Linezolid 4 4 4 2 
 
ND = Not Done 
 
6.1.3   RESULTS AND DISCUSSION 
 
From the above mentioned MIC values of antibacterial activity of DNJ-
101 to DNJ-111, it could be concluded that DNJ-101, DNJ-102, DNJ-104 and 
DNJ-108 were found to be highest potent with the MIC value of 0.5 µg/ml 
against the Bacillus pumilus MTCC 1607 and Staphylococcus epidermidis 
MTCC 155 respectively, which were having more inhibitory effect than the 
standard drug Linezolid. DNJ-102 to DNJ-111 were also found to have good 
inhibitory effect with the MIC value between 1-8 µg/ml on both of the bacterial 
strains. Thus it could be concluded that compounds having subunits like 
piperidine, morpholine, piperazine etc and alkyl chains having one to four 
carbons were found to possess good antibacterial activity. 
 
While DNJ-104, DNJ-109, DNJ-110 and DNJ-111 were found to be 
moderate active with the higher MIC values (i.e. >16, 16, 32 and >32 µg/ml 
respectively) against Staphylococcus pyogenes MTCC 442. DNJ-102 to DNJ-
104 and DNJ-107 to DNJ-109 were found to be moderate active with the 
higher MIC values (i.e. 16, 32, >16 µg/ml and >8, >32, 16 µg/ml) against 
Staphylococcus aureus MTCC 96. DNJ-105 to DNJ-107 were found to be 
moderate active with the higher MIC values (i.e. >16, 32 and 16 µg/ml) 
against Enterococcus faecalis MTCC 439. Thus rests of the compounds were 
found to be good active with the MIC value between 1-8 µg/ml against all the 
three bacterial strains. From above data it is clear that all the compounds are 
good active against Bacillus pumilus MTCC 1607 and Staphylococcus 
epidermidis MTCC 155 while they are moderate active against 
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Staphylococcus pyogenes MTCC 442, Staphylococcus aureus MTCC 96 and 
Enterococcus faecalis MTCC 439. 
 
In case of second series of compounds (i.e. DNJ-201 to DNJ-210), only 
one compound DNJ-203 was found to possess highest potency and lowest 
MIC value (i.e. 0.5 µg/ml) against Bacillus pumilus MTCC 1607 which was 
having more inhibitory effect than the standard drug Linezolid. Thus the 
compound possessing trifluoromethyl group has more inhibitory effect than 
the other functional groups and shows highest antibacterial activity. While the 
compound having chloro group possesses second lowest MIC value (i.e. 1 
µg/ml) against Bacillus pumilus MTCC 1607. In short, molecules having 
halogen group show more inhibition to the growth of afore mentioned 
bacterias. Rests of the compounds were found to be good active against the 
same bacterial strain. DNJ-209 and DNJ-210 were found to be moderate 
active against Bacillus pumilus MTCC 1607 with the MIC values >8 and 16 
µg/ml respectively. All the compounds of this series were found to be good 
active against Staphylococcus pyogenes MTCC 442 with the MIC value 
between 1-8 µg/ml. All these compounds did not show good inhibitory effect 
against rests of the three bacterial strains i.e. Staphylococcus epidermidis 
MTCC 155, Staphylococcus aureus MTCC 96 and Enterococcus faecalis 
MTCC 439, only few compounds were found to possess good activity. 
 
Results of antibacterial screening of DNJ-301 to DNJ-305 showed that 
all the compounds were moderate active against all the four bacterial strains 
i.e. Bacillus pumilus MTCC 1607, Staphylococcus epidermidis MTCC 155, 
Staphylococcus pyogenes MTCC 442 and Staphylococcus aureus MTCC 96. 
Only one compound, DNJ-305 was found to possess good inhibitory effect 
with the MIC values of 4 µg/ml and 2 µg/ml on Staphylococcus epidermidis 
MTCC 155 and Staphylococcus pyogenes MTCC 442 respectively. Thus long 
alkyl chain possessing three carbon atoms on nitrogen atom of indoline 
nucleus having secondary amine on the another end did not affect the 
inhibition of the bacterial growth, only the compound (DNJ-305) having benzyl 
piperazine subunit could show good inhibition. 
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In case of DNJ-401 to DNJ-405, DNJ-405 was found to possess 
highest potency and lowest MIC value of 0.5 µg/ml against Bacillus pumilus 
MTCC 1607 while DNJ-404 was found to possess second lowest MIC value of 
2 µg/ml and DNJ-403 was found to possess the MIC value of 4 µg/ml against 
the same bacterial strain. All these compounds were found to be moderate 
active against Staphylococcus epidermidis MTCC 155. DNJ-402 had good 
inhibitory effect on Staphylococcus pyogenes MTCC 442 with the MIC value 
of 4 µg/ml, where DNJ-401 and DNJ-404 were found to possess good 
antibacterial activity with MIC value of 4 µg/ml against Staphylococcus aureus 
MTCC 96. Rests of the compounds were found to be moderate active against 
all the bacterial strains. Thus the compounds possessing –CH2-CO group on 
nitrogen atom in indoline nucleus were found to be comparatively more active 
than the compounds possessing three carbon-alkyl chains on nitrogen atom in 
indoline nucleus. While the scenario was opposite in case of isatin moiety, 
where the compounds possessing three carbon-alkyl chains on nitrogen atom 
in isatin nucleus were found to be comparatively more active than the 
compounds possessing –CH2-CO group on nitrogen atom in isatin nucleus. 
 
In case of DNJ-501 to DNJ-505 only two compounds i.e. DNJ-501 and 
DNJ-505 were found to be good active against Bacillus pumilus MTCC 1607, 
Staphylococcus aureus MTCC 96 and Staphylococcus epidermidis MTCC 
155 respectively with the MIC value of 4 µg/ml. Rests of the compounds were 
found to be moderate active against all the four bacterial strains. 
 
Results of antibacterial screening of DNJ-601 to DNJ-605 showed that 
only one compound DNJ-602 found to possess good antibacterial activity 
against Staphylococcus aureus MTCC 96 with the MIC value of 4 µg/ml. 
While rests of the compounds found to be moderate active against all the four 
bacterial strains. 
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6.2   CYTOTOXICITY ASSAY * 
 
Importance of 2-indolinone derivatives as anticancer and especially as 
tyrosine kinase inhibitors has been discussed in introduction part of Chapter – 
3 under the title “Synthetic oxindoles as enzyme inhibitiors”. Thus indolinone 
derivatives (DNJ-1301 to DNJ-1305, DNJ-1401 to DNJ-1405 and DNJ-1501 to 
DNJ-1505) were screened in vitro for their cytotoxic activity at 1-100 µM 
concentration on a human stomach cancer cell line (Hu Tu 80), breast cancer 
cell line (MDA.MB.453) and lung cancer cell line (L132). Briefly, a three-day 
MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide] in vitro 
cytotoxicity assay was performed. This test is based on the principle of uptake 
of MTT, a tetrazolium salt, by the metabolically active cells where it is 
metabolized by active mitochondria into a blue colored formazan product that 
is read spectrophotometrically. MTT was dissolved in phosphate buffered 
saline at a pH of 7.4 to obtain an MTT concentration of 5 mg/ml; the resulting 
mixture was filtered through a 0.22-mm filter to sterilize and remove a small 
amount of insoluble residue. A total of 10,000 cells were seeded in a 96-well 
culture plate and incubated with various concentrations of indolinone 
derivatives in a CO2 incubator for 72 hours. Control cells, not treated with 
indolinone derivatives were similarly incubated. The assay was terminated 
after 72 hours by adding 125 mg (25 ml) MTT to each well, followed by 
incubation for 3 hours, and finally added 50 ml of 10% SDS-0.01 N HCl to 
each well to lyse the cells and dissolve formazan. After incubating for 1 hour, 
the plate was read spectrophotometrically at 540 nm and the cytotoxicity 
percentage calculated using the formula: cytotoxicity percentage = (1-X/R1) x 
100, where X = (absorbance of treated sample at 540 nm) - (absorbance of 
blank at 540 nm) and R1 = absorbance of control sample at 540 nm. 
 
Results of the cytotoxic assay for above mentioned compounds are 
summarized in the table given on the next page. 
                                                 
* The results are obtained from Dabur Research Foundation, Ghaziabad. 
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ED50 (µg/ml) of DNJ series on Stomach, Breast, Lung cancer cell lines. 
 
Cell Lines 
Sr. No. RepresentativeCompound Hu Tu 80 (Stomach) 
MDA.MB.453 
(Breast) 
L132 
(Lung) 
1 DNJ-1301 42 83 >100 
2 DNJ-1302 >100 >100 >100 
3 DNJ-1303 >100 78 93 
4 DNJ-1304 32 33 30 
5 DNJ-1305 37 52 >100 
6 DNJ-1401 38 35 >100 
7 DNJ-1402 49 >100 >100 
8 DNJ-1403 >100 >100 >100 
9 DNJ-1404 73 61 >100 
10 DNJ-1405 >100 >100 74 
11 DNJ-1501 >100 >100 >100 
12 DNJ-1502 39 >100 >100 
13 DNJ-1503 >100 81 >100 
14 DNJ-1504 89 61 >100 
15 DNJ-1505 30 50 84 
 
 
6.2.1   RESULTS AND DISCUSSION 
 
From the above mentioned ED50 values, it could be concluded that all 
the compounds possess cytotoxic activity. All the compounds were tested in 
vitro against three cancer cell lines (i.e. stomach cancer cell line-Hu Tu 80, 
breast cancer cell line-MDA.MB.453 and lung cancer cell line-L132).  
 
In case of DNJ-1301 to DNJ-1305, DNJ-1304 was found to possess 
highest potency and lowest ED50 value against all the three cancer cell lines 
(i.e. 32, 33 and 30 µg/ml against stomach cancer cell line-Hu Tu 80, Breast 
cancer cell line-MDA.MB.453 and Lung cancer cell line-L132 respectively). 
DNJ-1305 also showed good cytotoxicity activity (ED50 : 37 µg/ml) against 
stomach cancer cell line-Hu Tu 80, while it showed moderate (ED50 : 52 
µg/ml) cytotoxic activity against breast cancer cell line-MDA.MB.453 and it 
was found less  active (ED50 : >100 µg/ml) against  lung cancer cell line-L132. 
DNJ-1301 was found to be moderate active (ED50 : 42 µg/ml) against stomach 
cancer cell line while it was found to be moderate active (ED50 : 83 µg/ml) 
against breast cancer cell line and less active (ED50 : >100 µg/ml) against 
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lung cancer cell line. DNJ-1302 was found to be less active against all the 
three cancer cell lines while DNJ-1303 was found to be moderate active 
against breast cancer cell line and less active against rests of the two cancer 
cell lines. Thus from above results it could be summarized that the compound 
having N-ethyl piperazine subunit (i.e. DNJ-1304) found to be most potent 
molecule against all the three cancer cell lines while the compound having 
piperidine subunit (i.e. DNJ-1302) did not show good cytotoxic activity. 
Furthermore the compound having N-benzyl piperazine subunit (i.e. DNJ-
1305) found to be good active against stomach cancer cell line while it found 
to be moderate active against breast cancer cell line but its activity against 
lung cancer cell line was less. The compound having morpholine subunit (i.e. 
DNJ-1301) found to be good active against stomach cancer cell line while it 
found to be moderate active against breast cancer cell line but its activity 
against lung cancer cell line was less. Moreover, the compound having N-
methyl piperazine subunit (i.e. DNJ-1303) found to be less active against 
stomach and lung cancer cell line while it found to be moderate active against 
breast cancer cell line. 
 
In case of DNJ-1401 to DNJ-1405, DNJ-1401 was found to be good 
active against stomach cancer cell line and breast cancer cell line with the 
ED50 values 38 and 35 µg/ml respectively but it was found less active against 
lung cancer cell line with ED50 value more than 100 µg/ml. DNJ-1402 was 
found to be moderate active (ED50 : 49 µg/ml) against stomach cancer cell line 
while it was found to be less active (ED50 : >100 µg/ml) against rests of the 
two cancer cell lines. DNJ-1403 was found to be less active against all the 
three cancer cell lines. DNJ-1404 was found to be moderate active (ED50 : 73 
µg/ml) against stomach (ED50 : 61 µg/ml) and breast cancer cell line while it 
was found to be less active (ED50 : >100 µg/ml) against lung cancer cell line. 
DNJ-1405 was found to be less active (ED50 : >100 µg/ml) against stomach 
and breast cancer cell lines while it was found to be moderate active (ED50 : 
74 µg/ml) against lung cancer cell line. Thus from above results it could be 
summarized that the compound having morpholine subunit (i.e. DNJ-1401) 
possess good cytotoxic activity against stomach and breast cancer cell lines 
while it showed less activity against lung cancer cell line. Furthermore the 
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compound having piperidine subunit (i.e. DNJ-1402) was found to be 
moderate active against stomach cancer cell line while it was found to be less 
active against rests of the two cancer cell lines. Moreover the compound 
having N-benzyl piperazine subunit (i.e. DNJ-1405) was found to be moderate 
active against lung cancer cell line while it was found to be less active against 
rests of the two cancer cell lines. The compound having N-methyl piperazine 
subunit (i.e. DNJ-1403) was found to possess less cytotoxic activity against all 
the three cancer cell lines while the compound having N-ethyl piperazine 
subunit (i.e. DNJ-1404) was found to possess moderate cytotoxic activity 
against stomach and breast cancer cell lines and less cytotoxic activity 
against lung cancer cell line. 
 
 In case of DNJ-1501 to DNJ-1505, DNJ-1501 was found to possess 
less cytotoxic activity against all the three cancer cell lines. DNJ-1502 was 
found to be good active against stomach cancer cell line with the ED50 value 
39 µg/ml while it was found to be less active against rests of the two cancer 
cell lines with the ED50 value more than 100 µg/ml. DNJ-1503 and DNJ-1504 
were found to possess less cytotoxic activity against stomach (ED50 : >100 
and 89 µg/ml respectively) and lung cancer (ED50 : >100 µg/ml) cell lines  
while they were found to possess moderate cytotoxic activity (ED50 : 81 and 
61 µg/ml respectively) against breast cancer cell line. DNJ-1505 was found to 
be good active (ED50 : 30 µg/ml) against stomach cancer cell line while it was 
found to be moderate active against breast (ED50 : 50 µg/ml) and lung (ED50 : 
84 µg/ml) cancer cell lines. Thus from above results it could be summarized 
that the compound having no substitution in benzothiazole subunit (i.e. DNJ-
1501) found to be less active against all the three cancer cell lines. 
Furthermore the compound having methoxy group at 6th position in 
benzothiazole subunit (i.e. DNJ-1502) was found to be good active against 
stomach cancer cell line while it was found to be less active against rests of 
the two cancer cell lines. Moreover the compounds having halogen group (i.e. 
Cl and F) at 6th position in benzothiazole subunit (i.e. DNJ-1503 and DNJ-
1504) were found to possess less cytotoxic activity against stomach and lung 
cancer cell lines  while they were found to possess moderate cytotoxic activity 
against breast cancer cell line. The compound having nitro group at 6th 
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position on benzothiazole subunit was found to be good active against 
stomach cancer cell line while it was found to be moderate active against 
breast and lung cancer cell lines. 
 
Further study on other molecules is under progress. 
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6.3   IN SILICO STUDY FOR DNJ-701 
 
In silico study for the indolinone derivatives, synthesized in Chapter – 3 
(i.e. DNJ-701 to DNJ-705) and their anticancer activity was carried out at 
Gujarat Cancer Research Institute, (GCRI) Ahmedabad, which has been 
included in this chapter, while another coumarin derivatives synthesized in the 
same chapter are under investigation for their antitubercular and antiviral 
activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Under this title, we are focusing on some advanced comparison data of 
molecule for possible risk assessment and for further development and 
conclusion. 
 
1 – Toxicity Risk assessment 
2 – logs Calculation 
3 – Molecular Weight 
4 – Drug likeness 
5 – Drug Score 
N
O
N
N
Cl
Cl
N+
O-
O
C30H18Cl2N4O3 
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6.3.1   TOXICITY RISK ASSESSMENT 
 
Recent high-profile drug withdrawals increase the pressure on 
regulators and the pharmaceutical industry to improve preclinical safety 
testing. Understanding mechanisms of drug toxicity is an essential step 
toward improving drug safety testing by providing the basis for mechanism-
based risk assessments. Nonetheless, despite several decades of research 
on mechanisms of drug-induced toxicity and the application of various new 
technologies to preclinical safety assessment, the overall impact on preclinical 
safety testing has been modest. Assessing the risk of exposing humans to 
new drug candidates still depends on preclinical testing in animals, which in 
many, but not all cases, predicts outcomes in humans accurately. The 
following offers a perspective on the challenges and opportunities facing 
efforts to improve preclinical safety testing and outlines gaps and needs that 
must be addressed. A case is built for focusing solutions on defined problems 
within the current safety testing paradigm rather than imposing wholesale 
change. Targets for application of new technologies are available now. 
Improving drug safety testing will depend on improving the application of 
mechanism-based risk assessment but will also require improving public and 
private collaborations in order to focus research regarding the mechanism of 
drug-induced toxicity on the most important problems. 
 
Before doing the toxicity prediction we ran a set of toxic compounds 
and a set of presumably non-toxic compounds through the prediction. The 
data below shows the results obtained by predicting all available structures of 
four subsets of the database. E.g. all structures known to be mutagenic were 
run through the mutagenicity assessment. 86 % of these structures where 
found to bear a high or medium risk of being mutagenic. As a control set 
served a collection of traded drugs of which the mutagenicity risk assessment 
revealed only 12 % of potentially harmful compounds. 
 
Results of given substance, which obtain from one of those kind of 
procedures are mentioned. 
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Risk of mutagenicity 
Result 1.0 no risk 
Mutagenicity of currently available drugs 
No. of Drugs  3343  
High risk 09 %  
Medium risk 03 %  
Low risk 88 %  
 
Risk of Tumorigenicity 
Result 1.0 no risk 
Tumorigenicity of currently available drugs 
No. of Drugs 3343  
High risk 05 %  
Medium risk 01 %  
Low risk 94 %  
 
Risk of Irritating effect 
Result 1.0 no risk 
Irritating effect of currently available drugs 
No. of Drug 3343  
High risk 04 %  
Medium risk 04 %  
Low risk 92 %  
 
Risk of reproductive effect 
Result 1.0 no risk 
reproductive effect of current available drug 
No. of Drug 3343  
High risk 09 %  
Medium risk 01 %  
Low risk 90 %  
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(The values are 1.0, 0.8 and 0.6 for no risk, medium risk and high risk, 
respectively.) 
 
The prediction process relies on a precomputed set of structural 
fragment that give rise to toxicity alerts in case they are encountered in the 
given structure. These fragment lists were created by rigorously shreddering 
all compounds of the database known to be active in a certain toxicity class 
(e.g. mutagenicity). During the shreddering any molecule was first cut at every 
rotatable bonds leading to a set of core fragments. These in turn were used to 
reconstruct all possible bigger fragments being a substructure of the original 
molecule. Afterwards, a substructure search process determined the 
occurrence frequency of any fragment within all compounds of that toxicity 
class. It also determined these fragment's frequencies within the structures of 
more than 3300 traded drugs. Based on the assumption that traded drugs are 
largely free of toxic effects, any fragment was considered a risk factor if it 
occurred often as substructure of harmful compounds but never or rarely in 
traded drugs. 
 
6.3.2   logS Calculation 
 
Unfortunately, traditional methods used to measure solubility are 
neither rapid nor cost effective for higher throughput screening. As a result, 
solubility measurements are often pushed down in development process 
where the numbers of active compounds are significantly reduced. As a 
result, direct experimental solubility data is not available to assess of the 
scope of the overall solubility profile of the drug candidates being produced. 
Although there is no general consensus among drug researchers that 
solubility measurements (at early screening phases) are necessary to improve 
the overall a drug space' that compound libraries occupy, there is a common 
appreciation of the need for faster, more affordable solubility measurements 
to improve the drug discovery process as a whole. 
 
The aqueous solubility of a compound significantly affects its 
absorption and distribution like characteristics. Particularly, a low solubility 
goes along with a bad absorption and therefore the general aim is to avoid 
Chapter – 6                                                                 Biological evaluation of newly.....
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005                        343 
 
poorly soluble compounds. Our estimated logS value is a unit stripped 
logarithm (base 10) of the solubility measured in mol / liter. In the left diagram 
you can see that more than 80% of the drugs on the market have a 
(estimated) logS value greater than -4. 
 
 
 
 
 
 
 
 
 
Result of C30H18Cl2N4O3 logS 
Base value - 0.530 
1 * 0.016 Atom type  0 x 41404 
2 * -0.315 Atom type  0 x 60809 
1 * -0.05 Atom type  0 x 80804 
1 * 0.192 Atom type  0 x 81404 
16 * -0.181 Atom type  0 x 8220802 
1 * -1.066 Atom type  0 x 8520802 
1 * 1.327 Atom type  0 x 8520803 
1 * 0.611 Atom type  0 x 20260802 
4 * -1.317 Atom type  0 x 4088220802 
1 * -0.849 Atom type  0 x 4148220802 
2 * -0.602 Atom type  0 x 4248220802 
1 * -1.681 Atom type  0 x 6088220802 
1 * -1.258 Atom type  0 x 6088520802 
1 * 1.07 Atom type 0 x 6088520803 
1 * 1.933 Atom type  0 x 6098240802 
1 * 1.109 Atom type  0 x 8098240802 
1 * 0.128 Atom type  0 x 8150240802 
Result of logS 0.045 
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(Solubility values are estimated applying an atom type based increment 
system. Atom type is 64 bit numbers describing atoms and their near 
surrounding.) 
 
6.3.3   Molecular Weight 
 
Optimizing compounds for high activity on a biological target almost 
often goes along with increased molecular weights. However, compounds 
with higher weights are less likely to be absorbed and therefore to ever reach 
the place of action. Thus, trying to keep molecular weights as low as possible 
should be the desire of every drug forger. The diagram shows that more than 
80 % of all traded drugs have a molecular weight below 550. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Molecular weight of  C30H18Cl2N4O3 = 553.0 gm/mol 
 
6.3.4   Drug Likeness 
 
In the field of drug design, virtual screening is widely used for 
discovering novel lead candidates. By exploring virtual technology, 
compounds having certain activities for target would be found out efficiently. 
One of the most important factors for the success of virtual screening is drug 
likeness. Thus the reliable methodologies to construct high quality database 
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have been expected. It is desired that chemical structures in database exhibit 
drug-like properties in order to avoid problems in the later phase of drug 
development process. Thus statistical model for estimating drug-likeness of 
chemical structures has been required in order to build high quality database. 
 
There are many approaches around that assess a compound's drug 
likeness partially based on fingerprints of MDL structure keys or other 
properties as LogS and molecular weights. Our approach is based on a list of 
about 5300 distinct substructure fragments with associated drug likeness 
scores. The drug likeness is calculated with the following score values of 
those fragments that are present in the molecule under investigation: 
 
The fragment list was created by shreddering 3300 traded drugs 
yielding a complete list of all available fragments. As a restriction the shredder 
considered only rotatable bonds as cuttable. In addition the substitution 
modes of all fragment atoms were retained, i.e. fragment atoms that hadn't 
been further substituted in the original compounds were marked as such and 
atoms being part of a bond that was cut were marked as carrying a further 
substituent. This way fragment substitution patterns are included in the 
fragments. 
 
The occurrence frequency of every one of the fragments was 
determined within the collection of traded drugs and within the supposedly 
non-drug-like collection of compounds. All fragments with an overall frequency 
above a certain threshold were inverse clustered in order to remove highly 
redundant fragments. For the remaining fragments the drug likeness score 
was determined as the logarithm of the quotient of frequencies in traded 
drugs. 
 
A positive value states that your molecule contains predominantly 
fragments which are frequently present in commercial drugs. What it doesn't 
necessarily mean, though, is that these fragments are well balanced 
concerning other properties. For instance, a molecule may be composed of 
drug-like, but lipophilic fragments only. This molecule will have a high drug 
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likeness score although it wouldn't really qualify for being a drug because of 
its high lipophilicity. 
 
6.3.5   Drug Score 
 
The drug score value combines all other predictions into one grand total. 
 
Score from logs 0.045 (logs = -8.046) 
Score from moleweight 0.351 (mol. weight = 553.0) 
Score from druglikeness 0.0 (drug likeness = -8.587) 
No risk of Mutagenicity, Score 1.0 
No risk of Tumorigenecity, Score 1.0 
No risk of Irritating effects, Score 1.0 
No risk of Reproductive effects, Score 1.0 
 
(The drug score combines toxicity risks, drug likeness, logS, molecular weight 
in one handy value than may be used to judge the compound's overall 
potential to qualify for a drug. This value is calculated by multiplying 
contributions of the individual properties.) 
 
6.3.6   Conclusion 
 
With the help of above mention data and other experimental results of 
compound, it is clear that this compound has fulfilled most of the requirements 
of drug like potential and ready for future work and experiment. 
 
 
 
 
 
 
 
 
 
Summary                                                                 Synthesis and biological profile….. 
 
Department of Chemistry, Saurashtra University, Rajkot – 360 005.                       347 
 
SUMMARY 
 
The work represented in the thesis entitled “Synthesis and biological profile of 
some novel heterocyclic moieties bearing Nitrogen, Sulphur and Oxygen 
atoms” is divided into six chapters which can be summarized as under. 
 
Chapter – 1 deals with the 2-methyl indoline derivatives. Being an 
analogue of indole nucleus, 2-methyl indoline is having diversified biological 
profile. It was decided to explore new chemistry involving 2-methyl indoline 
moiety and to carry out their biological evaluation. 
 
Synthesis and yield optimization of the 2-methyl indoline was carried 
out in Chapter – 1. Literature survey revealed that different types of N-
alkylation reactions have been carried out on 2-methyl indoline but only one 
reaction is reported for Mannich reaction on 2-methyl indoline, where 
benzotriazole was used as a secondary amine along with formaldehyde (37-
41% w/w solution). So looking to the unreported chemistry aspect, different 
secondary amines and primary aromatic amines were selected to carry out 
Mannich reaction on 2-methyl indoline in order to acquire N-Mannich bases. 
 
Importance of microwave irradiation in organic synthesis has been 
described in Chapter – 2. Chapter – 2 is also dealing with different 2-methyl 
indoline derivatives and isatin derivatives. Literature survey revealed that N-
alkylation with the chain having three carbon atoms and different secondary 
amines at another end has not been reported using indoline and isatin 
nucleus so far. Thus N-alkylation with different alkyl chains and their biological 
evaluation was the aim behind the work done in this chapter.  
 
The synthesis of pyrazoles remains of great interest owing to the wide 
applications in pharmaceutical for their analgesic, antipyretic, antibacterial and 
anti-inflammatory properties. Chapter – 3 is consisting study of different types 
of reactions involving pyrazole aldehyde as a chemically reactive component. 
In this chapter, five different pyrazole aldehydes were synthesized and 
reacted with 1-(2, 6-dichlorophenyl)-2-indolinone, 3-acetyl-4-
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hydroxycoumarin, 4-hydroxycoumarin with and without urea / thiourea and 
their condensation products were studied. 
 
Chapter – 4 deals with the different type of newly synthesized 
arylaminocoumarin derivatives. Many methods have been reported for the 
synthesis of arylaminocoumarins. Literature survey reveals that in 1982, 
Savel'ev et. al. reported novel arylaminocoumarin derivatives. They prepared 
C-Mannich bases of 4-hydroxy coumarin followed by chlorination at C4 
position and their condensation with different aromatic primary amines. It was 
interesting to study the results of the Mannich reaction on 
arylaminocoumarins. Different types of arylaminocoumarins were synthesized 
by adopting microwave assisted method and Mannich reaction was carried 
out on it. Study of this reaction was of interest due to the presence of two 
active sites in the molecule for Mannich reaction. Mannich reaction goes on 
the atom having hydrogen of pronounced activity irrespective of carbon or 
nitrogen. In this case, due to the tautomerism under acidic conditions, C3 
position of coumarin nucleus became more reactive than the secondary 
nitrogen and it resulted into unexptected products. To confirm the action of 
Mannich reagents, single crystal of one of the derivative was developed which 
clearly shows that the compounds synthesized in this chapter are the C-
Mannich bases and are not the N-Mannich bases.  
 
2-Indolinone derivatives have recently been established as an anti 
cancer compounds and more specifically as tyrosine kinase inhibitors 
(SU5416, SU5614, SU6668, SU6597, SU6663 and SU6561) that block kit 
activation and growth of small cell in lung cancer. Thus the preparation of 
different 2-indolinone derivatives was carried out in Chapter – 5. Three 
different schemes were included in this chapter having isatin and Schiff base 
as core moiety. Schiff bases of isatin were prepared using 2-
propylpentanohydrazide and 2-aminobenzothiazole which subsequently 
underwent Mannich reaction using different secondary amines and 
formaldehyde (37-41% w/w solution). In another approach, Schiff bases were 
prepared using isatin and differently substituted 2-aminobenzothizoles which 
subsequently underwent for N-acetylation in isatin nucleus. 
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Chapter – 6 deals with the biological evaluation of newly synthesized 
compounds. In this chapter, antimicrobial activity of 41 compounds 
synthesized in Chapter – 1 and Chapter – 2 is reported. Furthermore, in silico 
study of N-substituted indolinone derivatives synthesized in Chapter – 3 is 
described. This chapter also includes cytotoxic activity data of the 15 
compounds synthesized in Chapter – 5, while rests of the compounds are 
under investigation. 
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CONFERENCES/SEMINARS/WORKSHOPS ATTENDED
 
1. National Workshop on Management and use of chemistry databases 
and patent literature during February 27th to 29th – 2008 jointly 
organized Department of Chemistry, Department of Computer Science, 
Computer Centre-Saurashtra University and Gujarat Council on 
Science & Technology (GUJCOST)-Gandhinagar held at Rajkot. 
 
2. International Conference On The Interface Of Chemistry-Biology In 
Biomedical Research during February 22nd to 24th – 2008 jointly 
organized by I.S.C.B. and Chemistry Group, Birla Institute of 
Technology & Science, Pilani held at Pilani. (Paper presented) 
 
3. National Seminar on Recent Advances in Chemical Science & An 
Approach to Green Chemistry during October 11th to 13th – 2006 jointly 
organized by Department of Chemistry, Saurashtra University & 
Gujarat Council On Science & Technology (GUJCOST)-Gandhinagar 
held at Rajkot. 
 
4. National Workshop on e-Resources in Chemical Synthesis and Natural 
Products during March 2nd & 3rd – 2006 organized by Department of 
Chemistry, Saurashtra University held at Rajkot. 
 
5. National Workshop on Nanotechnology: Opportunities & Challenges on 
October 17, 2005 jointly organized by Saurashtra University-Rajkot & 
Gujarat Council On Science & Technology (GUJCOST)-Gandhinagar 
held at Rajkot. 
 
6. Regional Workshop-An approach to Analytical Instruments Commonly 
Used in Chemical Industries during September 17th to 18th – 2005 
organized by Department of Chemistry, Bhavnagar University held at 
Bhavnagar. 
 
7. 9th National Conference on Bioactive Heterocycles & Paradigm shift 
(Including one day International Symposium on Drug Discovery – 
Conferences / Seminar / Workshop Attended
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Recent Advances) during January 8th to 10th – 2005 Organized by 
I.S.C.B. & Department of Chemistry held at Saurashtra University – 
Rajkot. 
